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I 
Abstract/ Summary 
The aryl hydrocarbon receptor (AhR) is an important sensor for environmental polyaromatic 
chemicals and plays an essential role in immune regulatory processes, including maintenance 
of intestinal barrier integrity. AhR activity is regulated through the AhR repressor (AhRR), 
which is encoded by an AhR target gene. Regulation and interplay of AhR and AhRR, 
however, remain largely elusive. Using AhRR/EGFP-reporter mice it could be shown that the 
AhRR is specifically expressed in immune cells of barrier organs, but not in intestinal 
epithelial cells, different from the more widespread expression of the AhR. Similar to AhR-
knockout mice, AhRR-deficient mice are highly susceptible to dextran sodium sulfate (DSS)-
induced colitis.  
In this PhD thesis it could be shown that enhanced colitis susceptibility in AhRR-deficient 
mice was accompanied by enhanced Th17/Tc17 and reduced Th1/Tc1 frequencies in the gut. 
In contrast, AhR-deficiency resulted in accumulation of both Th17/Tc17 and Th1/Tc1 cells in 
the intestine. A decreased frequency of intestinal ILC3s, previously held responsible for 
colitis susceptibility in AhR-/- mice, was not observed in AhRR-deficient mice. Yet, 
significantly elevated IL-1β levels could be detected in steady-state colon tissue of AhRR-
deficient mice, indicating enhanced activation of the innate immune system. Using 
conditional macrophage- and neutrophil-specific AhRR-knockout mice, it could be shown 
that these cells types do not convey the enhanced DSS colitis susceptibility noticed in 
complete AhRR-deficient mice. 
Moreover, it was shown that cell type-specific AhRR expression in intestinal immune cells is 
driven by dietary AhR ligands, whereas depletion of microbiota by treatment with broad-
spectrum antibiotics had no effect on AhRR expression. Further, it could be confirmed that 
lack of dietary AhR ligands deteriorates the mucosal intestinal barrier, whereas AhR ligand 
supplementation improves barrier integrity and protects from DSS-induced colitis. 
Interestingly, other synthetic diets like High fat diet and matched control diet protect against 
DSS-induced colitis, despite low AhR ligand content, highlighting the existence of other diet 
related pathways besides AhR signaling with great importance for the intestinal barrier 
function. 
Overall the findings of this thesis underline the physiologic importance of cell-type-specific 
balancing of AhR/AhRR signaling in response to microbial, nutritional and inflammatory 
stimuli.
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II 
Zusammenfassung 
Der Arylhydrocarbon Rezeptor (AhR) ist ein wichtiger Sensor für polyaromatische 
Umweltchemikalien und spielt eine wesentliche Rolle bei immunregulatorischen Prozessen, 
einschließlich der Aufrechterhaltung der Integrität der Darmbarriere. Die AhR-Aktivität wird 
durch den AhR-Repressor (AhRR) reguliert, der durch ein AhR-Zielgen kodiert wird. 
Regulierung und Zusammenspiel von AhR und AhRR bleiben jedoch weitgehend unklar. Mit 
AhRR/EGFP-Reporter Mäusen konnte gezeigt werden, dass der AhRR spezifisch in 
Immunzellen von Barriere Organen exprimiert wird, jedoch nicht in Darmepithelzellen, was 
sich von der weiter verbreiteten Expression des AhR unterscheidet. Ähnlich wie AhR-
Knockout-Mäuse sind AhRR-defiziente Mäuse sehr anfällig für Dextran-Sodium-Sulfat 
(DSS)-induzierte Colitis. 
In dieser Dissertation konnte gezeigt werden, dass eine erhöhte Colitis-Anfälligkeit bei 
AhRR-defizienten Mäusen mit einer erhöhte Th17/Tc17- und reduzierter Th1/Tc1-Frequenz 
im Darm assoziiert war. Das Fehlen des AhR führte zur erhöhten Frequenzen von sowohl 
Th17/Tc17- als auch Th1/Tc1-Zellen im Darm. Eine verringerte Häufigkeit von intestinalen 
ILC3s, die für die Colitis-Empfindlichkeit bei AhR-/- Mäusen verantwortlich gemacht wird, 
konnte bei AhRR-defizienten Mäusen nicht beobachtet werden. Dennoch konnten signifikant 
erhöhte IL-1β Spiegel im Kolongewebe von unbehandelten AhRR-defizienten Mäusen als 
Hinweis für eine verstärkte Aktivierung des angeborenen Immunsystems nachgewiesen 
werden. Mit Hilfe von Makrophagen- und Neutrophilen-spezifischen AhRR-Knockout-
Mäusen konnte gezeigt werden, dass diese Zelltypen nicht die erhöhte DSS-Colitis-
Empfindlichkeit vermitteln. Darüber hinaus wurde gezeigt, dass die zelltypspezifische AhRR-
Expression in intestinalen Immunzellen durch AhR-Liganden in der Nahrung gesteuert wird, 
während die Reduktion der Mikrobiota keinen Einfluss auf die AhRR-Expression hatte. 
Weiterhin konnte bestätigt werden, dass der Mangel an diätetischen AhR-Liganden die 
Darmbarriere Integrität verschlechtert, während AhR-Ligand-Supplementation die Barriere 
Funktion verbessert und vor DSS-induzierter Colitis schützt. Andere synthetische Diäten wie 
eine fettreiche Diät und angepasste Kontrolldiät schützen trotz niedrigem AhR-
Ligandengehalt gegen DSS-induzierte Colitis, was die Existenz anderer 
ernährungsabhängiger Signalwege mit großer Bedeutung für die Darmbarriere unterstreicht. 
Insgesamt zeigen die Ergebnisse dieser Arbeit die physiologische Bedeutung 
zelltypspezifischer Balancierung von AhR/AhRR Expression als Reaktion auf mikrobielle, 
Ernährungs- und Entzündungsreize.  
List of Abbreviations    
 
III
List of Abbreviations 
2-1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methylester ITE 
2,3,7,8-tetrachlordibenzo-ρ-dioxin  TCDD 
4',6-diamidino-2-phenylindole  DAPI 
6-formylindolo[3,2-b]carbazol  FICZ 
AhR nuclear translocator  ARNT) 
AhR repressor  AHRR 
Antigen presenting cell APC 
Antimicrobial peptide  AMP 
Aryl hydrocarbon receptor  AhR 
Aryl hydrocarbon receptor interacting protein  AIP 
benzo[a]pyrene B[a]P 
C-C chemokine receptor  CCR 
Cluster of differentiation  CD 
Cryptopatch CP 
cullin 4B CUL4B 
Dendritic cell DC 
Dendritic epidermal T cell  DETC 
Dextran sodium sulfate  DSS 
Dioxin response element  DRE 
Enzyme-linked Immunosorbent Assay  ELISA 
Follicle associated epithelium  FAE 
Genome-wide significant  GWS 
Granulocyte macrophage colony-stimulating factor  GM-CSF 
Gut associated lymphoid tissue  GALT 
Halogenated aromatic hydrocarbon HAH 
HBV X-associated protein,  XAP-2 
Heat shock protein 90,  HSP 
Immunoglobulin  Ig 
Indole-3-carbinol  I3C 
indolo[3,2-b]carbazol  ICZ 
Inducible NO synthase  iNOS 
List of Abbreviations 
 
IV 
Inflammatory bowel disease  IBD 
Inhibitor of DNA binding 2  ID2 
Innate lymphoid cell ILC 
Interferon  IFN 
Interleukin  IL 
Intestinal epithelial cell IEC 
Intraepithelial lymphocyte  IEL 
Isolated lymphoid follicle ILF 
Lamina propria mononuclear cells LPMC  
Lymphoid tissue inducer  LTi 
Lymphoid tissue organizer  LTo 
Lymphotoxin α1β2  LTα1β2 
Lymphotoxin β receptor  LTβR 
Macrophage colony-stimulating factor  M-CSF 
Mesenteric lymph node mLN 
Microfold cell M cell 
millimeter mm 
Natural cytotoxicity triggering receptor  NCR 
Nuclear factor-κB  NF-κB 
basic helix-loop-helix  bHLH 
Pathogen-associated molecular pattern PAMP 
Pattern recognition receptor PRR 
Polychlorinated biphenyls PCB  
PER-ARNT-SIM  PAS) 
Peyer’s patches PPs 
Polycyclic aromatic hydrocarbon PAH 
Regulatory T cells Treg 
Retinoic acid-related orphan receptor γt  RORγt 
rounds per minute  rpm 
Solitary isolated lymphoid tissue SILT 
Specific pathogen-free  SPF 
T cell receptor  TCR 
T helper  Th 
List of Abbreviations    
 
V
 
 
 
 
 
 
 
 
 
 
T-box transcription factor  T-bet 
TCDD-inducible poly (ADP-ribose) polymerase TiPARP 
thymic stromal lymphopoietin  TSLP 
TNF receptor  TNFR 
Transforming growth factor  TGF 
Tumor necrosis factor  TNF 
Type 1 regulatory cell Tr 1 cell 
Ulcerative colitis  UC 
Xenobiotic response element  XRE 
Table of Figures 
 
VI 
Table of Figures 
Figure 1.1: Architecture of gut-associated lymphoid tissue (GALT) ........................................ 4	
Figure 1.2: T helper cell subset differentiation and function in the intestine ............................. 8	
Figure 1.3: Classification of ILC subsets on the basis of their functional characteristics ....... 10	
Figure 1.4: Aryl hydrocarbon receptor functional domains ..................................................... 18	
Figure 1.5: Ligand-dependent AhR activation and negative feedback control mechanism ..... 19	
Figure 3.1: AhRRfl/fl mice targeting strategy ............................................................................ 40	
Figure 5.1: The intestinal ILC3 frequency is reduced in AhR-/-, but not in AhRRE/E mice. ..... 55	
Figure 5.2: Analysis of IL-17- and IFNγ-producing T cells in the intestinal tissue after 6 days 
of DSS colitis .................................................................................................................... 57	
Figure 5.3: IL-1β levels are increased in colon tissue of AhRRE/E mice .................................. 59	
Figure 5.4: Gating strategy for myeloid cell populations in intestinal tissue ........................... 60	
Figure 5.5: Frequency of DCs and macrophages in intestinal tissue of wild-type and AhRRE/E 
mice after 6 days 5% DSS treatment ................................................................................ 61	
Figure 5.6: Macrophage- and neutrophil-specific AhRR-deficiency does not convey elevated 
susceptibility to DSS colitis .............................................................................................. 64	
Figure 5.7: Antibiotic treatment does not influence AhRR expression in intestinal tissue ...... 67	
Figure 5.8: Dietary AhR ligands drive expression of AhRR in intestinal immune cells ......... 69	
Figure 5.9: Dietary AhR ligands drive expression of cyp1a1 in intestinal tissue .................... 70	
Figure 5.10: AhRR expression in the skin is influenced by dietary AhR ligands .................... 72	
Figure 5.11: HFD and HFD ctrl reduce AhRR expression in immune cells of the lamina 
propria ............................................................................................................................... 74	
Figure 5.12: AhRR expression in DCs of the mesenteric lymph nodes (mLNs) is reduced in 
HFD and HFD ctrl fed mice .............................................................................................. 75	
Figure 5.13: Gating strategy for intraepithelial lymphocytes (IELs) ....................................... 76	
Figure 5.14: AhRR expression in intraepithelial lymphocytes (IELs) is reduced in HFD and 
HFD ctrl fed mice ............................................................................................................. 77	
Figure 5.15: Histological analysis of AhRR expression in colon and skin of mice under 
different dietary conditions ............................................................................................... 79	
Table of Figures    
 
VII
Figure 5.16: Dietary AhR ligands influence the intestinal barrier integrity and susceptibility to 
DSS-induced colitis .......................................................................................................... 81	
Figure 5.17: Influence of dietary AhR ligands on MPO activity and Lipocalin-2 (LCN2) 
levels ................................................................................................................................. 83	
Figure 5.18: Influence of dietary AhR ligands on cytokine production in DSS colitis ........... 84	
Figure 5.19: Different dietary conditions influence the intestinal microbiome composition .. 86	
Figure 5.20: Dependence of the intestinal commensal composition on the AhRR ................. 88	
Figure 5.21: Dietary AhR ligands change the overall intestinal microbiota composition ....... 89	
 
Table of Tables 
 
VIII 
Table of Tables 
Table 3.1: Equipment ............................................................................................................... 26	
Table 3.2: Consumables and plastic ware ................................................................................ 28	
Table 3.3: Chemicals and reagents .......................................................................................... 30	
Table 3.4: Solutions and buffers .............................................................................................. 33	
Table 3.5: Elisa Kits ................................................................................................................ 34	
Table 3.6: Flow cytometry antibodies ..................................................................................... 35	
Table 3.7: Immunohistology antibodies .................................................................................. 36	
Table 3.8: Kits ......................................................................................................................... 37	
Table 3.9: PCR primers ........................................................................................................... 37	
Table 3.10: Software ................................................................................................................ 37	
Table 3.11: Enzymes ............................................................................................................... 38	
Table 3.12: Mouse diets ........................................................................................................... 38	
Table 3.13: Genetically modified mouse lines ........................................................................ 39	
Table 4.1: H&E staining protocol ............................................................................................ 43	
Table 4.2: DSS colitis severity scoring .................................................................................... 44	
Table 4.3: cDNA synthesis Master Mix .................................................................................. 50	
Table 4.4: RPS6 PCR program ................................................................................................ 50	
Table 4.5: qPCR thermocycler program .................................................................................. 51	
Introduction    
 
1
1 Introduction 
1.1 The immune system 
All organisms are confronted with infectious agents or toxic substances throughout their life. 
A variety of organs, cells and molecules protect the body against infectious or harmful insults. 
The sum of these organs, cells and molecules form the immune system. The immune system 
is a complex and interactive network that fulfills four main tasks in order to equip an 
organism with effective protection. First, an infection needs to be detected and recognized in 
order to secondly instruct immune effector functions, which restrict and ideally eliminate an 
infection. Inactivity of the immune system can lead to chronic infections and 
immunodeficiency, whereas overshooting reactions may result in allergy and autoimmune 
diseases. In order to prevent these events, the third task of the immune system is to self-
regulate its own actions. The fourth task is to prevent recurring disease due to infection with 
the same pathogen, by generating immunological memory1,2.  
With regard to speed and specificity of the response, the immune system can be divided into 
innate and adaptive immunity. These two parts consist of different cells types fulfilling 
distinct functions to achieve protection. Nonetheless, in practice none of the two systems 
works independently, as there is much interaction between innate and adaptive immunity. 
1.1.1 Innate immunity 
The innate immune system is the first line of defense, preventing pathogens from infiltrating 
the body. It is the evolutionary oldest part of the immune system and highly conserved even 
in the simplest organisms. Elements assigned to the innate immune system are physical 
barriers, inflammation-related serum proteins, antimicrobial peptides (AMPs), the 
complement system, cytokines and chemokines. Furthermore, cells phagocytozing invading 
pathogens and releasing cytokines or other inflammatory mediators are assigned to the innate 
immune system3. These are for instance neutrophils, monocytes and macrophages (MΦ). 
Together with other innate immune cells, such as innate lymphoid cells (ILCs) and mast cells, 
they endow the organism with immediate protection. In addition, the innate immune system is 
equipped with a variety of receptors to recognize pathogen-associated molecular patterns 
(PAMPs) present on many microorganisms. These pattern recognition receptors (PRRs) exist 
as membrane bound proteins on for example macrophages, neutrophils and dendritic cells 
(DCs), as cytoplasmic PRRs and as secreted molecules4. Activation of PRRs recruits 
signaling adaptors that control processes like the induction of local inflammation, recruitment 
Introduction 
 
2 
of further effector cells, restriction of a local infection and finally triggering of an adaptive 
immune response. However, the innate immune system lacks classical immunological 
memory, meaning its responses remain the same, irrespective of how many times a specific 
infectious agent is encountered. Interestingly, this concept has recently been challenged. 
Organisms lacking adaptive immunity have been shown to develop resistance to reinfections, 
a phenomenon termed “trained immunity”, that hereafter has also been demonstrated for more 
complex organisms5. Furthermore, the innate immune system cannot provide specificity 
against individual pathogens, which depends on activation of the adaptive immune system by 
antigen presenting cells3. 
1.1.2 Adaptive immunity 
The adaptive immune response is of special importance when clearance of a pathogen by the 
innate immune system fails. Antigen presentation by antigen presenting cells accompanied by 
co-stimulation and changes in the cytokine microenvironment, trigger the adaptive immune 
response. Adaptive immunity involves selection and expansion of lymphocytes, bearing 
receptors with high specificity for foreign antigens. These receptors allow for a fine 
discrimination between self and non-self. Additional central features of the adaptive immune 
system are the elimination of pathogens and pathogen-infected cells and the creation of 
immunological memory that provides protection against re-infection6. Two central cells types 
of the immune system are T and B lymphocytes. T lymphocytes (T cells), which mature in the 
thymus are the effectors of the cellular immune response and can be functionally divided into 
subsets either assisting other cells in immunological processes (CD4+ T cells) or directly 
destroying virus-infected cells or tumor cells (CD8+ T cells)7. B lymphocytes (B cells), which 
arise in the bone marrow, develop into antibody producing plasma cells directed by signals 
from CD4+ helper T cells. Antibodies form the humoral component of the adaptive immune 
system and are used to neutralize pathogens, precipitate antigens for phagocytosis and 
activate the complement system1,7. 
1.2 The mucosal immune system of the gut 
Most pathogens enter the body through mucosal surfaces of the respiratory, urogenital and 
gastrointestinal tract. These mucosal surfaces represent an enormous area to be protected. For 
instance, the human small intestine has a surface area of almost 400m2, which is 200 times 
that of the skin1. Besides occasional incorporation of pathogens, the intestine is constantly 
exposed to antigens derived from the diet or the commensal microbiota. Under these 
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influences the gastrointestinal tract has developed into the largest compartment of the immune 
system with functional specialization in order to mount immune responses against pathogenic 
threats, while maintaining tolerance against non-harmful antigens. Distinctive anatomical 
features, specialized mechanisms for antigen uptake and unique effector and regulatory 
responses fulfill these challenges. Further, various mechanical mechanisms, including the 
epithelial cell barrier and extra-epithelial defenses at mucosal surfaces protect the underlying 
tissue from penetration by pathogens. Immune cells are organized in lymphoid tissues and are 
scattered across the surface epithelium of the mucosa and the underlying layer of connective 
tissue, termed lamina propria. Tissue compartments assigned to mucosa-associated lymphoid 
tissue (MALT) are principally divided into inductive sites, where antigens are sampled from 
mucosal surfaces and stimulate cognate naïve T and B cells, and effector sites, where effector 
cells perform their action8.  
1.2.1 Organized mucosa-associated lymphoid tissue 
The gut associated lymphoid tissue (GALT), one of the best-studied mucosal inductive sites, 
is a network of highly organized lymphoid structures including mesenteric lymph nodes 
(mLNs), Peyer’s patches (PPs), isolated lymphoid follicles (ILFs), cryptopatches (CPs) and 
fat-associated lymphoid tissue (Fig.1.1). The different tissues of the GALT differ from each 
other with regard to their location relative to the epithelium. CPs, ILFs and PPs are located 
closely to the gut lumen directly under the epithelial layer, while mLNs as well as fat-
associated lymphoid tissue can be found more distant9. All structures of the GALT represent 
locations for priming of adaptive immune responses in the intestine10. 
1.2.2 Mesenteric lymph nodes 
mLNs are the largest lymph nodes in the body. They are located alongside the anterior 
mesenteric artery in the mesentery and develop independent of PPs and peripheral lymph 
nodes. While development of PPs and peripheral lymph nodes is dependent on tumor necrosis 
factor (TNF), TNF receptor (TNFR), lymphotoxin α1β2 (LTα1β2) and lymphotoxin β 
receptor (LTβR), absence of these molecules does not affect mLN ontogeny11,12. Comparable 
to other lymph nodes, mLNs are encapsulated and drain the surrounding tissue. Migration of 
naïve lymphocytes to the mLNs via high endothelial venules (HEV) is dependent on L-
selectin and α4β7 integrin adhesion molecules. mLNs are an important location of antigen 
processing and presentation. Intestinal DCs sample and process antigen, recirculate to the 
mLNs and in turn induce IgA+ B cells to populate the intestinal lamina propria and become 
IgA+ plasma cells. T cells responding to antigen presented by DCs leave the mLNs by the 
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afferent lymph, enter the bloodstream and finally reach the mucosa through vessels in the 
lamina propria. As a consequence of their pivotal anatomic position, mLNs can be regarded as 
the border between the mucosal immune system and the remainder of the immune 
system9,10,12-15. 
 
 
Figure 1.1: Architecture of gut-associated lymphoid tissue (GALT) 
The GALT consits of a network of highly organized lymphoid structures that comprise mesenteric 
lymph nodes (mLNs), Peyer’s patches (PPs), isolated lymphoid follicles (ILFs), cryptopatches (CPs) 
and fat associated lymphoid tissues. In addition, the lamina propria contains a lot of immune cells. 
CPs, ILFs and PPs are located directly under the epithelium, while mLNs and fat associated lymphoid 
tissue are located more distant. All structures of the GALT share certain similarities with regard to the 
structural organization and basic cellular architecture ensuring optimal interaction between antigen 
presenting cells (APCs) and other lymphocytes. Modified from Brucklacher-Waldert et al., Frontiers 
in Immunology, 2014 
 
1.2.3 Peyer’s patches 
PPs are macroscopic lymphoid structures located in the submucosa along the length of the 
small intestine. They consist of large B cell follicles and interjacent T cell areas. The PPs are 
separated from the intestinal lumen by the follicle associated epithelium (FAE) and the 
subepithelial dome, a diffuse area directly below the epithelium which is rich in DCs, T cells 
and B cells. The FAE differs from the normal epithelium by a reduced release of digestive 
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enzymes, a less pronounced brush border, absence of polymeric IgA-receptors and infiltration 
of a large number of immune cells. Specialized epithelial cells in the FAE, the so called 
microfold or M cells, are very potent in collecting and transcytosing antigen from epithelial 
surfaces of the gastrointestinal tract. These antigens can subsequently be taken up and 
sampled by DCs, located directly below the M cells in the PP dome region. As PPs have no 
afferent lymphatics, M cells represent the only route of antigen entering the PPs. Local DCs 
present the antigens to T cells, which then leave the PPs and migrate to the mLNs via the 
efferent lymphatics, where they further differentiate. Due to their ability to take up luminal 
antigens and bacteria, PPs are considered as immune sensors of the intestine. Several studies 
have indicated that PPs play an important role in the induction of immune tolerance as well as 
in the defense against pathogens. Intriguingly, malfunctions in PPs have been associated with 
inflammatory disorders of the digestive tract like Crohns disease and have also been shown to 
be involved in alloresponses, such as Graft versus Host Disease (GVHD)1,12,14-16. 
1.2.4 Solitary isolated lymphoid tissue (SILT) 
Besides mLNs and PPs, the GALT includes smaller lymphoid aggregates that are collectively 
termed solitary isolated lymphoid tissue (SILT). These structures can only be detected 
microscopically and vary considerably in size from small cryptopatches (CPs) to mature 
isolated lymphoid follicles (ILFs). These different entities of the SILT likely represent 
different stages of maturation or development17. Mice have an estimated number of 1000-
1500 evenly distributed SILT in the small intestine, while colonic SILT are concentrated in 
the distal colon17-19. CPs are aggregates of about 1000 cells composed of lymphoid tissue 
inducer (LTi) cells and lymphoid tissue organizer (LTo) cells, together with T cells and 
DCs19,20. By secretion of chemokines, CPs attract further lymphocytes and develop into ILFs, 
in response to signals from the commensal flora21. As opposed to PPs, ILFs nearly 
exclusively consist of B cells with no clear T cell zones. However, similar to PPs they contain 
germinal centers, indicating constant ongoing activation of humoral immunity. In this line, the 
FAE of ILFs also contains M cells, indicating constant antigen access to the follicle22. It has 
further been proposed that also ILFs have a central role in T cell-dependent IgA class 
switching and the subsequent IgA production by plasma cells23,24. 
1.2.5 Diffuse mucosa-associated lymphoid tissue 
Diffuse mucosa-associated lymphoid tissue consists of leukocytes that are widely scattered 
throughout the intestinal epithelium and the lamina propria of the mucosa, collectively 
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forming the effector sites. These less organized lymphoid elements contain lamina propria 
mononuclear cells (LPMCs) and intraepithelial lymphocytes (IELs).  
The lamina propria is a layer of connective tissue between the epithelium and the muscularis 
mucosae. This layer consists of lymphatics and small blood vessels embedded into smooth 
muscle cells and fibroblasts. The lamina propria comprises a huge number of lymphoid and 
myeloid cells including B cells, T cells and numerous innate immune cells such as DCs, MΦ, 
eosinophils and mast cells. CD4+ and CD8+ T cells are found in the lamina propria at a ratio 
of two to one. They are mostly classified as conventional T cells primed in secondary 
lymphoid organs displaying an effector memory phenotype (CD45RO+CCR7–CD62L–). 
However, the CD4+ T cell compartment is highly diverse with regional differences in 
distribution and function along the intestine13. These T cells might have regulatory functions 
and therefore be involved in maintenance of tolerance to environmental antigens. Lamina 
propria CD8+ T cells can have potent cytolytic activity acting as antigen experienced true 
effector cells12,15. Large numbers of MΦ and DCs in the lamina propria suggest that antigens 
crossing the epithelium are directly processed and presented to CD4+ T cells.  
Besides the lamina propria, also the intestinal epithelium contains a large number of immune 
cells. These intraepithelial lymphocytes (IELs) are located at the basement membrane 
between the enterocytes. IELs comprise antigen-experienced T cells of both the T cell 
receptor (TCR)γδ+ and TCRαβ+ lineages. TCRγδ+ cells can constitute up to 60% of small 
intestinal IELs25. Most of these cells express CD8, while only a minor fraction is CD4+. A 
large fraction of the CD8+ cells express a CD8αα homodimer as co-receptor, which is 
essentially not found in any other location26. 
The majority of the IELs possess cytotoxic activity and express effector cytokines like 
interferon gamma (IFNγ), interleukin-2 (IL-2), IL-4 or IL-1727. Further, all IELs express the 
αEβ7 integrin CD103, which interacts with E-cadherin possibly assisting in anchoring IELs in 
the epithelium28,29. Intestinal T cells can be subdivided into two subsets based on the 
mechanism by which they become activated. Induced IELs, also known as “type a” IELs, are 
the progeny of conventional T cells that are activated post-thymically in response to 
peripheral antigens. Natural IELs, also known as “type b” IELs, develop in the thymus from 
non-MHC restricted triple-positive thymocytes and subsequently migrate as CD8α–CD8β–
CD4– cells to the intestine where they undergo further differentiation30. Due to their position 
at the interface of the organism and the outside environment, IELs need to keep a tight 
balance between protecting the epithelial barrier while staying unresponsive to food antigens 
and other harmless substances. IELs can protect against inflammatory damage and guard the 
Introduction    
 
7
epithelium in response to pathogen-induced stress antigens or pathogen-expressed antigens. 
On the other side IELs can also promote epithelial damage by recruiting inflammatory 
leukocytes or as a response to pathogen-induced stress antigens, microbial or dietary 
antigens27. Taken together IELs form the foremost line of defense at the biggest entry point 
for pathogens of the body. They protect the integrity of the mucosal border, however, can also 
mediate pathological responses driving detrimental inflammatory diseases. 
1.2.6 Immune cells in the mucosal immune system of the gut 
Intestinal T cells (Fig.1.2) play a critical role in sustaining intestinal homeostasis and 
protecting against environmental threats. As described in the previous section, IELs form an 
exclusive population of antigen-experienced T cells scattered throughout the epithelium. In 
addition, the lamina propria is largely populated by T cells, which express TCRαβ together 
with CD4 or CD8αβ co-receptors. These T cells are primed in mLNs or PPs by DCs. During 
priming they acquire gut homing properties, upregulate adhesion receptors including α4β7 
and CCR9 and migrate to the lamina propria where they accumulate as long-lived effector 
memory cells over time. CD4+ T cells in the lamina propria mainly provide help to plasma 
cells and CD8αβ+ memory cells. However, besides the classical helper T cells, the lamina 
propria is enriched in in Foxp3-expressing regulatory T cells (Tregs) and proinflammatory IL-
17-producing Th17 cells under steady state conditions. Tregs accumulating in the gut are 
crucial for keeping gut homeostasis by preventing excessive responses to harmless antigens31. 
Analysis of colonic T cells from mice bread under specific-pathogen-free (SPF) conditions 
revealed that about 30-40% of T cells produce the anti-inflammatory cytokine IL-10, with 
most of these cells also expressing Foxp332. Intriguingly, a dominance of IL-10+CD4+ T cells 
not expressing Foxp3, referred to as Tr1 cells, has been described for the small intestine33. As 
opposed to Tregs, Th17 cells play an important role in the defense against a variety of fungal 
and bacterial infections. In steady state, Th17 cells can be mainly found in the lamina propria 
of the SI and to a lesser extent in the colon. They express the transcription factor retinoic acid-
related orphan receptor γt (RORγt) and produce the cytokines IL-17A, IL-17F, IL-21, IL-22 
and GM-CSF34. Development of Th17 cells in mice requires a combination of TCR signals, 
TGFβ, IL-1β and IL-6 or IL-2135.  IL-23, which was originally thought to be necessary for 
Th17 cell generation, has been shown to be important for the modulation of Th17 effector 
functions and pathogenicity36.  
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Figure 1.2: T helper cell subset differentiation and function in the intestine 
Besides the strength of the T cell receptor (TCR) signal and the quality of co-stimulation, the cytokine 
environment mainly influences CD4+ T cell polarization and differentiation. The cytokines driving the 
differentiation of naïve CD4+ T cells into the respective Th cell fate, the master transcription factor of 
each Th cell subset, cytokines produced by the different subsets and specific functions associated with 
the various subsets are depicted. 
 
Besides Th17 cells, Th1 cells are essential for the response to intracellular bacteria and 
viruses. Development of these T cells is critically dependent on induction of the transcription 
factor T-bet by STAT1 and STAT4 signaling. T-bet in turn drives upregulation of the IL-
12Rβ2, thereby increasing responsiveness to IL-12, which induces optimal expression of the 
Th1 signature cytokine IFNγ37. Th1 and Th17 cells are important mediators of inflammation 
in Crohn’s disease (CD), while Th1 cells also promote mucosal inflammation in celiac 
disease38.  
Th2 cells, expressing the master transcription factor GATA-3, differentiate upon IL-4 and IL-
2 stimulation and produce the cytokines IL-4, IL-13 and IL-5. They predominate in response 
to gastrointestinal nematodes, however, are absent under homeostatic conditions10. 
Interestingly, Th2 responses and elevated levels of IL-5 and IL-15 have been associated with 
Ulcerative Colitis (UC), yet the underlying mechanism remains elusive38.  
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Further, Th22 cells represent a distinct subset of T helper cells, whose differentiation is 
dependent on IL-6, IL-13 and TNFα. They express the aryl hydrocarbon receptor (AhR) as 
master transcriptional regulator and produce the cytokines IL-22, IFNγ and IL-17. These cells 
have been shown to be functionally important for wound repair and the induction of 
antimicrobial peptides, like β-defensin 2 and 310,39. Increased levels of IL-22, likely produced 
by Th22 cells, have been found in patients with inflammatory bowel disease (IBD). Studies 
suggested that IL-22 might contribute to the inflammation, but also plays a beneficial role in 
promoting wound healing40.  
The most recently defined subset of T helper cells are Th9 cells, characterized by production 
of IL-9. However, the functional role of Th9 cells and IL-9 are not well understood yet. Th9 
cells develop in response to a complex cytokine milieu including TGFβ and IL-4, generally 
promote inflammation, and are involved in tumor immunology. They further have been 
implicated in contributing to UC through IL-9 production, which can impair tissue repair, 
increase intestinal permeability and may enhance inflammatory T helper cell responses10,41. 
Innate lymphoid cells (ILCs) are a population of mucosal lymphocytes that were studied 
with increasing interest in recent years. These cells are enriched at barrier surfaces and lack 
antigen-specific receptors found on T and B cells. They further lack myeloid cell and DC 
phenotypical markers and display a lymphoid morphology42. Development of ILCs 
commonly depends on expression of the common cytokine receptor γ-chain (γc) and the 
transcriptional repressor inhibitor of DNA binding 2 (ID2). Further, all subsets rely on 
signaling via the IL-7 receptor subunit-α (IL-7Rα) for their development and maintenance. 
Similar to T helper cell subsets, ILCs are subdivided into different groups based on 
expression of specific transcription factors and effector cytokines (Fig.1.3).  
Group 1 ILCs are primarily characterized by production and release of IFNγ upon stimulation 
with IL-12 and IL-18. They consist of NK cells and other ILC1s. NK cell development is 
regulated in close cooperation of the transcription factors T-bet and eomesodermin (Eomes). 
Murine NK cells can be identified by expression of the natural cytotoxicity triggering receptor 
(NCR) NKp46 (NCR1), although this is not an exclusive NK cell marker.  NK cells are 
characterized by their cytotoxic function, and are therefore considered as the innate 
counterpart of CD8+ cytotoxic T cells43,44. The residual ILC1s are developmentally dependent 
on expression of T-bet but not of Eomes and produce IFNγ but no Th2-, or Th17-cell-
associated cytokines. Some ILC1s have been shown to develop from NKp46+ILC3s that 
downregulate RORγt and upregulate T-bet. These cells have been reported to contribute to 
intestinal inflammation during colitis, presumably through their production of IFNγ45,46. 
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Figure 1.3: Classification of ILC subsets on the basis of their functional characteristics 
Innate lymphoid cells (ILC) develop from a common precursor that depends on the expression of the 
transcriptional repressor inhibitor of DNA binding 2 (ID2). All ILCs depend on the common cytokine 
receptor γ-chain for their development and maintenance. Specific cytokines and several transcription 
factors regulate the differentiation of ILC precursors into distinct subsets. ILCs are classified into 
groups based on functional criteria. Group 1 ILCs are defined by their production of interferon-γ 
(IFNγ). Group 2 ILCs are able to produce T helper 2 (Th2) cell-associated cytokines, including IL-5 
and IL-13. Group 3 ILCs produce the Th17 cell-associated cytokines IL-17 and IL-22. Figure is 
adapted from Spits et al., Nature reviews immunology, 2013. 
 
Group 2 ILCs are distinguished from other ILCs by production of the Th2-associated 
cytokines IL-4, IL-13 and IL-5 upon stimulation with IL-25, IL-33 or thymic stromal 
lymphopoietin (TSLP). Like Th2 cells, ILC2s require expression of the transcription factor 
GATA3 for development and function. Moreover, their development is also dependent on the 
expression of the transcription factor RORα. Different studies have shown importance of 
ILC2s in mediating resistance to certain helminths and nematodes. Due to its broad cytokine 
production profile, including IL-9 and amphiregulin, ILC2s are also involved in metabolic 
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processes, tissue repair, alternative macrophage activation, thermoregulation and mucus 
production46,47.  
Group 3 ILCs are defined by their ability to produce the cytokines IL-17 and IL-22. They 
additionally release lymphotoxins and the granulocyte macrophage colony-stimulating factor 
(GM-CSF). Group 3 ILCs can be further sub-classified into three different categories. 
Lymphoid tissue inducer cells (LTi cells) are a prototypic ILC3 family member and are 
essential for the formation of secondary lymphoid organs. The remaining ILC3s are further 
phenotypically subdivided into NKp46+ and NKp46– ILC3s. All subgroups consistently 
produce IL-22 and IL-17 upon stimulation with IL-23 and IL-1β, and their development and 
function depends on expression of RORγt. However, only NKp46– ILC3 express the Th1 
transcription factor T-bet and produce IFNγ, which is an important mediator of pathology in a 
mouse model of colitis48. In addition, LTi cells and NKp46+ ILC3s depend on expression of 
the aryl hydrocarbon receptor (AhR) for development and optimal maintenance. ILC3s 
promote tissue repair through their IL-22 production, while IL-17 and IFNγ producing ILC3s 
have been associated with intestinal pathology in colitis and infection with Salmonella 
enterica44,45-47. 
Induction of active immunity and maintenance of intestinal homeostasis is tightly controlled 
by intestinal mononuclear phagocytes (MPs) comprising dendritic cells (DCs) and 
macrophages (MΦ). DCs are able to sample antigens from the intestine, migrate to the mLNs 
and initiate adaptive immune responses by priming of naïve T cells. Although routinely 
identified as major histocompatibility complex II (MHCII) and CD11c co-expressing cells, 
this discrimination is insufficient to identify DCs in the intestinal tissue, as all intestinal 
macrophages also express CD11c49. However, intestinal MΦ have been identified to be 
F4/80+CD64+CX3CR1hi/int phagocytes. Thus, DCs can conclusively be identified as 
CD11c+MHCII+CD64– cells. In the GALT, DCs are located in PPs, mLNs, SILT and are 
diffusely scattered through the lamina propria. The majority of intestinal DCs express the 
integrin αEβ7 (CD103). These cells can be further subdivided by their CD11b expression into 
CD103+CD11b+ and CD103+CD11b– DCs. Further, the murine lamina propria contains a 
poorly defined CD103–CD11b+ subset. All three subsets can also be found in gut-draining 
afferent lymph and are all derived from a committed FMS-like tyrosine kinase 3 ligand 
(Flt3L)-dependent precursor. Intestinal DCs can fulfill several different functions. They can 
recieve luminal antigens from goblet cells50. DCs subsequently migrate to the mLNs in a 
CCR7-dependent process and have a central role in priming of naïve T cells, generating active 
immune responses and inducing Treg cells. The CD103+ DC subsets induce Treg 
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development, but can also prime Th17 or Th1 cells if readily activated. CD103– intestinal 
DCs are more immunogenic, inducing effector Th1 and Th17 cells51,52. 
Macrophages (MΦ) are the second cell type constituting the mononuclear phagocytes. These 
cells are resident in the lamina propria engulfing bacteria, secreting cytokines and maintaining 
intestinal homeostasis. Several studies could independently show that MΦ are CD103– but 
express the pan-MΦ marker F4/80, the MΦ-specific high affinity FcγRI (CD64) and high 
levels of the chemokine CX3C receptor (CX3CR)153-55. Although these cells are present 
throughout the whole intestine, their abundance increases towards the colon. In most tissues, 
MΦ arise from yolk sac and fetal liver progenitors, which seed tissues during embryonic 
development. Subsequent self-renewal in situ ensures constant MΦ replenishment. Although 
this mechanism has been proven for microglia, lung alveolar MΦ, liver Kupffer cells and 
epidermal Langerhans cells, MΦ in the intestine need constant replenishment from circulating 
blood monocytes. Ly6Chi monocytes enter the intestinal mucosa, where they differentiate into 
CX3CR1hi MΦ. During this process, precursors upregulate MHCII, F4/80, CD64 and 
CX3CR1 but downregulate Ly6C. This mechanism was first shown by Steffen Jung and 
colleagues and extended by the groups of Allan Mowat and Brian Kelsall51,53,56-59. Intestinal 
macrophages are not only essential for the elimination of invading bacteria or apoptotic cells. 
They may also sample luminal contents in a MyD88 and CX3CR1-dependent process, 
although the in vivo relevance of this process is still controversial60. Macrophages in the 
intestine have very important homeostatic functions. They produce prostaglandins in a 
cyclooxygenase (COX)2-dependent process and thereby inhibit gastric acid secretion and 
protect the intestinal mucosa from inflammation and necrosis. Gut macrophages acquire a 
generally anti-inflammatory phenotype indicated by the constitutive high production of IL-10. 
This process likely involves signals from the microbiota and finally leads to secondary 
expansion of Treg cells61. Even during active colitis, macrophages keep this anti-
inflammatory signature. Interestingly, steady state differentiation and proliferation of 
macrophages collapses during inflammation to some extent57. As a consequence, monocyte-
derived CX3CR1int cells immigrate into in the lamina propria. These cells exhibit a more 
proinflammatory phenotype indicated by expression of TNFα and inducible NO synthase 
(iNOS). It has further been shown that during active immune responses, macrophages may 
produce IL-1β and thereby drive local differentiation or expansion of Th17 cells62. 
Neutrophils are a vital component of the innate immune system and are important first 
responders at sites of inflammation. They are equipped with several mechanisms to eliminate 
microbes and therefore maintain the intestinal homeostasis. Neutrophils produce vast amounts 
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of reactive oxygen species (ROS) and other toxic molecules that effectively destroy 
pathogens. They also carry different intracellular granules containing antimicrobial peptides 
like α-defensins and cathelicidins, myeloperoxidase (MPO), hydrolytic enzymes and metal 
chelators like Lipocalin-2 (LCN2). Moreover, neutrophils also form neutrophil extracellular 
traps (NETs) composed of chromatin mixed with toxic molecules to capture and kill invading 
microorganisms63. Of note, neutrophils can have beneficial, but also detrimental roles during 
intestinal inflammation. They are recruited to inflammatory sites within minutes, with the 
response peaking between 24 and 48 hours. IBD like UC and CD are characterized by 
massive inflammation and concomitant recruitment of neutrophils64. However, the exact 
contribution of neutrophils to the pathogenesis of the disease is not completely unraveled. 
Different studies have suggested a beneficial, a detrimental, or no role at all, suggesting that 
the contribution of neutrophils in regulating intestinal inflammation seems to be highly 
dependent on the conditions and models used63. 
The mucosal B cell system mainly provides a first line of defense through active production 
of secretory immunoglobulin A (SIgA) and the subsequent transport through intestinal 
epithelial cells. These antibodies are produced by plasma cells present at the mucosal wall. 
Naïve precursor B cells are activated in PPs and mLNs by presentation of antigens from 
follicular DCs and by CD40-mediated signals from primed helper T cells. Further, class 
switching to IgA producing B cells or formation of memory B cells is induced in the GALT 
inductive sites (PPs, mLNs), driven by the substances TGFβ, RA, IL-6 and iNOS. IgA+ B 
cells then upregulate gut homing receptors (α4β7) and migrate to the lamina propria, where 
they differentiate into plasmablasts and finally plasma cells, secreting large amounts of 
IgA65,66. The continuous production of large amounts of IgA is almost exclusively driven by 
the resident microbiota. IgA, secreted into the gut lumen by transcytosis through gut epithelial 
cells, inhibits microbial adherence to the epithelium and neutralizes microbial toxins or 
enzymes. In contrast to humans, mice can additionally produce intestinal IgA after T cell 
independent B cell activation, possibly as a result of B cell-DC interaction in solitary 
lymphoid follicles. This pathway involves B-1 cells derived from peritoneal B cell precursors 
and results in IgA antibodies with limited diversity and low antigen affinity1. 
1.3 The gut microbiota 
The sum of microorganisms that live within and on an organism is generally referred to as the 
microbiota. Microbial communities are immensely active and provide crucial signals for 
development and function of the immune system. Especially the gastrointestinal tract harbors 
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an enormous number of commensal bacteria that have co-evolved with its host over millennia. 
The resulting dynamic crosstalk between host and its microbiota is important for maintaining 
homeostasis of immune tissues and the regulation of immune responses67. The human 
microbiota is mainly composed of the dominant phyla Firmicutes (50-75%) and Bacteroidetes 
(15-25%), followed by the much less frequent Proteobacteria and Actinobacteria68. 
Firmicutes and Bacteroidetes also dominate the gut microbiota of mice, although when 
exploring deeper taxonomic classifications, 85% of bacterial genera found in the mouse gut 
microbiota are not present in human69. Due to the technical advances in sequencing 
technologies it has become possible to perform culture-independent microbial analysis, 
revealing microbial complexity and composition by bacterial 16S ribosomal RNA amplicon 
sequencing70. Using mass spectrometry-based and chromatography-based techniques it is 
furthermore possible to target the chemical diversity and also biochemical capacity of 
substances produced by the microbial communities. The systemic study of the unique 
chemical and biochemical metabolite composition that specific microbial communities 
produce is termed metabolomics. Even more sophisticated approaches, like the combination 
of flow cytometry with tandem mass spectrometry are now used to characterize and quantify 
individual microbial cells and in addition measure their metabolic activity71. 
Approaches to understand the importance of the microbiota in shaping the innate and adaptive 
immunity include the use of germ-free mice and the manipulation of the microbiota with 
antibiotic treatment or microbiota reconstitution. These experiments offer valuable insights 
into the regulation of gut immune homeostasis by the microbiota. Intestinal MΦ located in 
close proximity to the microbiota keep a non-inflammatory profile upon encountering 
microbial stimuli72. In addition, a reduced number of intestinal DCs could be observed in 
germ-free animals, although colonization with Escherichia coli was sufficient to recruit DCs 
to the intestine73. In a similar fashion, IL-22 producing NKp46+ ILCs are missing in germ-free 
mice, indicating importance of the gut microbiota in the development or maintainance of 
these cells74. Commensal bacteria have also been shown to be essential for CD4+ T cell 
differentiation. Bacteroides fragilis induce a systemic Th1 response, while segmented 
filamentous bacteria (SFB) were found to be potent inducers of lamina propria Th17 cells75,76. 
In addition, single metabolites derived from the gut microbiota have the ability to influence 
immunes responses through interaction with host cells. One of the most abundant metabolic 
end products from bacterial fermentation are short-chain fatty acids (SCFAs), including acetic 
acid, butyric acid and propionic acid. SCFAs act as potent signaling molecules and can 
therefore influence expansion and function of cells. They are inhibitors of histone 
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deacetylases and they promote a tolerogenic cell phenotype that is very important to maintain 
immune homeostasis. They inactivate nuclear factor-κB (NF-κB) and they inhibit production 
of TNF67. Furthermore they act as ligands for G-protein coupled receptors. 
Another group of substances derived from the metabolism of the gut microbiota are AhR 
ligands. Turnover of dietary components generates metabolites with the ability to bind and 
activate the AhR. In general, activation of the AhR is influenced by composition of the diet 
but also by the composition of the microbiota. Only certain commensal strains of the 
Lactobacilli spp. can metabolize dietary tryptophan and thereby generate AhR ligands that are 
important for conferring protection from inflammation at mucosal surfaces77. 
Polyamines are polycationic molecules that influence a wide range of biological functions, 
such as transcription, translation, cell growth and cell death. The intestinal tract contains a 
high concentration of polyamines derived from the diet and from de novo synthesis from host 
and microbial cells. Studies have demonstrated great importance of polyamines for production 
of intracellular junction proteins and consequently for regulation of the epithelial barrier 
function78. Further, dietary supplementation of polyamines induces production of mucus and 
secretory IgA in the small intestine, underlining an important role for microbiota- and diet-
derived polyamines in regulating important immune functions. 
The pathogenesis of IBD involves genetic predispositions and environmental factors and is 
often associated with a dysbiosis in the gut microbiota. Several studies have revealed a 
reduced diversity of the gut microbiota in IBD patients, the most consistent one being a 
reduction in Firmicutes and an increase in Proteobacteria79-83. It remains however 
controversial whether the dysbiosis is cause or consequence of IBD pathology and if the 
formation of a “dysbiosis index” can be used as a clinical marker to predict disease severity, 
prognosis and response to treatment.  
In addition, the composition of the microbiota is highly dependent on the dietary lifestyle. 
Dietary patterns, specific foods as well as certain food constituents have the ability to 
influence the composition of the microbiota and hence the host immune system and 
metabolism84. Graf et al. summarized effects of western diet, vegetarian diet, whole grain, 
fruit, fiber, fat and much more substances on the composition of the microbiota84. Although 
an important influence of diet on the microbiota composition is obvious, the interpretation of 
long term effects is highly dependent on the methodology. Further, it seems to be increasingly 
complicated to find an agreement on what a healthy microbial composition means and if this 
might not be very different for every individual85. 
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In summary, it is undoubtful that the complex crosstalk between the immune system and 
microbiota has consequences and is likely necessary for an optimal functioning of the host’s 
immune system and metabolism.  
1.4 The immune cells of the skin 
Next to the intestine and the lung, the skin is an important interface between the body and the 
environment. Besides being a very stable mechanical barrier, the skin forms an active barrier 
that provides a strong line of immunological defense against infections. The human skin 
consists of the epidermis, which is mainly formed by several epithelial cell layers, and the 
connective tissue-rich dermis. The most frequent cell type of the epidermis is the 
keratinocyte, however, a lot of immune cells, such as Langerhans cells and dendritic 
epidermal T cells (DETCs), which can only be found in mice, are located in this tissue. The 
dermis contains a lot of extracellular matrix, in which fibroblast are embedded, and is 
additionally rich in blood and lymph vessels. Further a multitude of myeloid and lymphoid 
immune cells like MΦ, mast cells, conventional αβ T cells, γδ T cells and ILCs are distributed 
through the dermis.  
Both resident and trafficking myeloid cells populate the skin. Langerhans cells (LC), a DC 
population seeding the epidermis pre-birth, are of embryonic origin and mainly fetal liver- 
and, to a minor extent, yolk sac-derived86. They are locally maintained, but repopulation from 
circulating monocytes occurs under inflammatory conditions in a macrophage colony-
stimulating factor (M-CSF)- and IL-34-regulated process87. In the murine dermis either 
CD103 or CD11b expressing DCs and double-negative DCs have been identified88. All DC 
subsets perform T cell priming either inducing Th17 (LCs) or Th1 (CD103+DCs) responses, 
or alternatively executing regulatory functions89. Skin resident MΦ originate from the yolk 
sac. They can have a proinflammatory or regulatory character. Moreover, they can promote 
wound healing and support tissue repair by enhancing epithelialization90. In addition, 
circulating monocytes trafficking through the skin give functional support to DCs91. Mast 
cells store preformed proinflammatory mediators within cytoplasmic granules that can be 
quickly released upon antigen contact. They play a role in contributing to the innate immune 
response and have diverse functions in skin pathology92. Different studies have shown the 
presence of epidermis-resident memory CD8+ T cells and a population of recirculating 
memory CD4+ T cells, mainly located in the dermis93. DETCs in mice form a network to 
monitor the integrity of the epidermal layer and further contribute to inflammation and assist 
in wound healing processes94. Persistence of both DETCs and tissue resident memory T cells 
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has been shown to depend on signals via the AhR95. In addition to these, dermal γδ T cells are 
important for the cutaneous immune surveillance, while Tregs in the skin orchestrate hair 
follicle regeneration, augment wound healing and promote tolerance to skin 
commensals89,94,96. Last but not least also ILCs and in particularly ILC3s have been shown to 
contribute to skin inflammation97. 
1.5 The Aryl hydrocarbon receptor (AhR) 
The aryl hydrocarbon receptor (AhR) is a protein that has been identified as a ligand activated 
transcription factor and has been first cloned in the early 90’s98. The AhR belongs to the 
family of basic helix-loop-helix (bHLH)-PER-ARNT-SIM (PAS) proteins, which are all 
heterodimeric transcription factors involved in the response to environmental or physiological 
signals99. The AhR is one of the oldest and best-studied members of the bHLH-PAS family 
and the only ligand-activated member of the family100. Historically the AhR has been studied 
by toxicologists for its response to xenobiotics, which are substances that are not naturally 
produced by an organism. However, several studies also identified the AhR as an important 
regulator for mucosal barrier function101. All members of the bHLH-PAS family are 
structurally similar. They contain a bHLH motif that consist of 4-6 DNA-binding, basic 
amino acids, attached to a HLH dimerization domain and PAS domains, which consist of a 
five-stranded antiparallel β-sheet flanked by α-helices, which can bind a wide array of 
chemically diverse ligands102. The AhR in particular consists of the bHLH domain, two PAS 
domains (PAS-A and PAS-B) and a Q-rich (glutamine-rich) region (Fig.1.4). The bHLH 
domain is involved in DNA-binding, the PAS-B domain forms the ligand-binding pocket and 
the amino-terminal Q-rich region is essential for transcriptional activation. The bHLH domain 
and the PAS-A domain have been shown to be involved in dimerization with the AhR nuclear 
translocator (ARNT), forming a transcriptional active heterodimer. Regions in the bHLH 
domain and the PAS-B domain are involved in binding to the chaperone Hsp90, keeping the 
AhR inactively stabilized in the cytosol103. 
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Figure 1.4: Aryl hydrocarbon receptor functional domains 
The AhR is a member of the basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) family of transcription 
factors. The N-terminal basic part of the bHLH domain conveys DNA binding, while the HLH region 
facilitates protein interactions. Two 200-350 amino acid PAS domains mediate interactions with other 
PAS domain containing proteins, like the AhR nuclear translocator (ARNT). PAS-B contains the 
ligand-binding domain. Regions in the bHLH and PAS domains are involved in Hsp-90 binding. The 
C-terminal located Q-rich domain is involved in transactivation. 
 
1.5.1 The AhR pathway 
In the absence of any ligand, the AhR is located in the cytosol, stabilized in a complex with 
the chaperon proteins Hsp90, aryl hydrocarbon receptor interacting protein (AIP) and p23 
(Fig.1.5). AhR ligands diffuse into the cell and bind the cytosolic AhR complex, thereby 
inducing a conformational change that in turn leads to nuclear translocation. Upon 
dimerization with ARNT the AhR is released from its chaperons and the AhR-ARNT 
complex binds to its cognate DNA binding motif, named dioxin response element (DRE) or 
xenobiotic response element (XRE). To date the number of genes influenced by AhR 
activation through AhR ligands is in the order of about 600104. Genes that contain DRE/XRE 
sites in their promoter region and are therefore directly regulated by the AhR are for example 
the xenobiotic metabolism genes cyp1a1, cyp1a2 and cyp1b1. The arising gene products are 
critically involved in the feedback metabolism of xenobiotics that initially activate the AhR. 
The AhR-induced AhR repressor (AHRR), one of the most strongly upregulated genes upon 
AhR activation, can similarly form dimers with ARNT, forming a transcription-repressing 
complex that competes with the AhR/ARNT complex for binding to DRE/XRE sites. The 
TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin)-inducible poly-ADP-ribose polymerase 
(TiPARP) is a strongly AhR induced gene, acting as an inhibitor of AhR activity by 
increasing the proteolytic degradation of AhR105,106. More indirect transcriptional effects have 
been shown for genes required for development or reproductive physiology99,103. Besides 
metabolism of ligands and inhibition through the AhRR or TiPARP, AhR protein levels are 
controlled via ubiquitin-mediated proteasomal degradation. AIP inhibits ubiquitination of the 
bHLH Q-richPAS-BPAS-A
DNA-binding domain Ligand-binding domain Transcriptional activation domain
Dimerization domain
Hsp90-binding domain
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AhR in its inactive state, however, ligand binding and release from the chaperon complex 
induces AhR ubiquitination and degradation by the proteasome107,108. 
 
 
Figure 1.5: Ligand-dependent AhR activation and negative feedback control mechanism 
Exogenous substances and endogenous metabolites bind the chaperon associated AhR in the 
cytoplasm inducing translocation into the nucleus. There, the AhR forms a heterodimer with the AhR 
nuclear translocator (ARNT) and binds to its genetic target sequence, the DRE (dioxin response 
element) and XRE (xenobiotic response element) sites and induces transcription of target genes. These 
belong to the xenobiotic metabolism and include genes required for development, immunity, 
reproductive physiology and the AhR repressor (AhRR). The AhRR competes with the AhR for 
binding to ARNT, forming a second heterodimer competing with the AhR-ARNT complex without 
activating target gene transcription. Additionally AhR activity is regulated through ubiquitylation and 
proteasome-mediated degradation. PCBs: polychlorinated biphenyls, B[a]P: benzo[a]pyrene, HSP90: 
heat shock protein 90, XAP-2: HBV X-associated protein, cullin 4B:CUL4B;  
Adapted from Murray L. Whitelaw, Nature Reviews Cancer, 2013 
 
Besides the canonical AhR pathway, cross-talk between the AhR and other signaling 
pathways can lead to activation of the AhR and subsequent induction of AhR target genes. 
Several types of cross-talk have been described. For example, the AhR has been shown to 
bind to the transcription factor c-Maf, which plays an important role for type 1 regulatory T 
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cell (Tr1) differentiation109. Moreover, the AhR is able to bind STAT1, influencing NF-κB 
promoter activity, and interacts with the estrogen receptor, β-catenin, Nrf2, RelA and RelB110. 
1.5.2 AhR ligands 
The AhR can be activated by a variety of structurally diverse synthetic or naturally occurring 
ligands. The best-characterized ligands include a variety of environmental toxins like the 
halogenated aromatic hydrocarbons (HAHs) and non-halogenated polycyclic aromatic 
hydrocarbons (PAHs). 2,3,7,8-tetrachlordibenzo-ρ-dioxin (TCDD, dioxin), the prototypical 
and most potent HAH, is highly toxic and biologically persistent111. Dioxin is found in 
industrial byproducts and as a toxic contaminant of some herbicides. Immune and liver 
defects in AhR-deficient mice suggested that in addition to xenobiotics, physiological and 
natural occurring AhR ligands might play an important role under homeostatic conditions112. 
The perhaps greatest exposure to physiological AhR ligands comes from the diet, particularly 
flavonoids in vegetables and fruits have agonistic effects on AhR activation113. An example 
for a physiological AhR ligand precursor is indole-3-carbinol (I3C), which is produced by the 
breakdown of glucobrassicin, a glucosinolate that can be found in high concentrations in 
cruciferous vegetable such as broccoli114. By exposure to the stomach acid, I3C is converted 
into the high affinity AhR ligand indolo[3,2-b]carbazol (ICZ). Other naturally occurring AhR 
ligands are derived from the degradation of tryptophan. L-Kynurenine is an endogenous 
molecule, formed by catalytic breakdown of tryptophan, with low AhR affinity but potential 
physiological relevance110. The indoles 6-formylindolo[3,2-b]carbazol (FICZ) and 2-(1′H-
indole-3′-carbonyl)-thiazole-4-carboxylic acid methylester (ITE) have been shown to strongly 
induce AhR activity115,116. Molecules that do not bind the AhR ligand-binding pocket, but 
activate the AhR via changing molecular levels of FICZ or modulating chaperon activity, 
have been termed AhR activators. This group includes inflammatory mediators, organic 
solvents and metals117. Kaufmann et al. identified a bacterial virulence factor as AhR ligand, 
suggesting the AhR might be a new form of an intracellular PRR that can sense microbial 
insults118. 
1.5.3 AhR in gut immunity 
Expression and consequently functional significance of the AhR strongly varies between 
different tissues. While muscle tissue, testes, kidney and brain show only weak expression of 
the AhR, constitutive high expression can be found in the liver and in barrier tissues such as 
the skin, the lung and the gut. Moreover, the AhR expression differs among cells of the 
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hematopoietic lineage. Cells expressing the AhR at the highest levels are Th17 cells, γδ T 
cells, ILC3s, macrophages, DCs and plasma cells110. 
An organ with particularly high expression of the AhR and of central interest in this thesis is 
the gut. Different groups have described the importance of AhR expression in various cell-
types for maintaining gut barrier integrity and immunological functionality. RORγt+ ILC3s, 
which are a major source of intestinal IL-22, show reduced expression of IL-22 in AhR-/- mice 
as well as a defect in ILC3 maintenance in the intestine119. This was attributed to lack of 
transcription of the cell-specific proliferation factor c-kit that is expressed in an AhR-
dependent fashion120. As a consequence of reduced LTi cell frequency, neither CPs nor ILFs 
are formed in the intestine. AhR-deficient mice also exhibit highly reduced frequency of 
IELs, which is accompanied by low IL-22 levels, reduction in antimicrobial peptide 
production (RegIIIβ, RegIIIγ) and higher microbial load121. These defects render mice more 
susceptible for infections with Citrobacter rodentium and also more sensitive to dextran 
sodium sulfate (DSS)122. In addition, AhR signaling impacts CD4+ T cell immunity. AhR 
signaling in Foxp3+ Tregs triggers Foxp3 demethylation and transactivation, which finally 
leads to expansion of the Treg cell compartment. AhR signaling in Th17 cells promotes IL-22 
expression and limits inhibitory effects on Th17 cell differentiation through IFNγ and IL-2112. 
Further, AhR signaling has been shown to positively influence proliferation of colonic crypt 
stem cells123. Especially dietary AhR ligands strongly impact the gut immunity and immune 
cell homeostasis. Mice colonies fed with experimental diets containing low levels of AhR 
ligands exhibited similar phenotypes as AhR-deficient animals, indicating the importance of 
these micronutrients120. Other studies also showed beneficial effects of dietary AhR ligands 
on oral tolerance124,125. 
Taken together, several independent studies have established a role for AhR activation in 
regulating intestinal homeostasis and barrier integrity. 
1.5.4 The Aryl hydrocarbon receptor repressor (AhRR) 
Although AhR activation and its functional consequences are well-studied, negative 
regulation of the AhR signaling pathway is not that well-understood. A protein that has been 
identified and proposed to negatively regulate AhR actions is the AhR repressor (AhRR). 
Expression of the AhRR is induced by a variety of AhR agonists. The AhRR in turn competes 
with AhR for binding to ARNT and therefore reduces the binding of the AhR-ARNT complex 
to DRE/XRE sites by a negative feedback loop. The AhRR protein shares great structural 
similarities to AhR and ARNT. It contains a bHLH DNA-binding domain and a dimerization 
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domain (PAS-A). However, neither a PAS-B nor a Q-rich domain and ligand-binding pocket 
are present. Due to the structural similarity, the AhRR is able to form a dimer with ARNT. 
The AhRR-ARNT complex can also bind to the genomic target sequences of the AhR, 
however no transcriptional transactivation and consequently no target gene expression is 
induced. It is also further speculated that negative regulation of the AhR might involve 
transrepression through protein-protein interactions instead of inhibiting DNA binding of the 
AhR-ARNT complex126,127. 
Recent studies in our group using AhRR-reporter and knockout mice revealed that the AhRR 
is mainly expressed in immune cells of barrier organs and does not strictly mimic the 
expression profile of the AhR. Thus, the AhRR might be important to regulate AhR 
controlled processes in immune cells. It was further shown that the interplay between the AhR 
and AhRR is highly complex and that differential effects of AhRR-deficiency might be 
explained by tissue and cell-type restricted expression patterns. Investigations of the AhRR in 
inflammatory responses in the intestine revealed that lack of the AhRR results in increased 
susceptibility to colitis, similar to AhR-deficient mice128. How this elevated susceptibility in 
AhRR-deficient mice is mediated, will be elaborated in this thesis. 
1.6 Chronic inflammatory bowel disease 
Chronic inflammatory bowel diseases (IBDs) are a group of diseases, characterized by a 
chronic inflammation of the gastrointestinal tract, associated with an imbalanced microbiota. 
Crohn’s disease (CD) and ulcerative colitis (UC) are the most common types of IBD. In the 
US over 1.4 million people are affected, creating a significant burden on the health system129. 
It is well accepted that the development of IBD has a genetic predisposition, involves the 
immune system and is influenced by environmental factors.  
CD and UC generally develop as polygenic disorders that in most cases arise spontaneously. 
However, 5-10% of IBDs are familial and humans with a family history of IBD have an up to 
5 times higher risk of developing these diseases130. Previous studies have identified over 200 
genome-wide significant (GWS) IBD susceptibility loci in a European population131. Genetic 
risk factors for CD and UC interestingly show a significant overlap. Molecules and pathways 
involved in disease development are highly diverse. For example, components of the immune 
system, like IL-23 and Th17 cells132 but also the autophagy pathway are involved in 
development of IBD133. The autophagy genes ATG16L1 and IRGM, the NOD-like receptor 
NOD2 and the intelectin ITLN1 are highly specific susceptibility genes for CD, while genes of 
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regulatory pathways like IL10 and ARPC2, intestinal epithelial cell (IEC) function (e.g., 
ECM1), and an E3 ubiquitin ligase (e.g., HERC2) appear to be specific for UC134. 
Intestinal homeostasis depends on complex interactions between microbiota, intestinal 
epithelium and host immune system. A breakdown of regulatory pathways that cooperate to 
maintain intestinal homeostasis may critically precipitate the chronic pathology found in IBD. 
Further, an immunological imbalance leads to hyper-responsiveness to self-antigens resulting 
in chronic inflammatory conditions in the intestine135. Thus, it was shown that T cells 
restricted to antigens from microbiota induce intestinal inflammation, whereas non-
specifically activated T cells do not mount an immune response136. UC is often described as a 
Th2-mediated disease, while CD is characterized by Th1 activation. However, this simple 
classification has been challenged as individual cytokines can have diverse and even opposing 
functions in some clinical and immunological settings137,138. Different studies and 
experimental models indicated that TNFα, TGFβ and IFNγ are related with establishment and 
onset of IBD139. More recently, it has been shown that Th17 cell-derived cytokines might 
have opposing effects in IBD. While some Th17-type cytokines (IL-17F/Il-21) may trigger 
inflammatory pathways, other Th17-related cytokines like IL-17A and IL-22 also promote 
counter regulative mechanism that support the recovery of the intestinal epithelium140. 
Development of both common forms of IBD, CD and UC, involve environmental factors. 
One of these environmental drivers is the intestinal microbiota. 16S rRNA sequencing 
identified changes in the composition of the intestinal microbiota in CD and UC patients. A 
significantly lower bacterial diversity especially affecting the two major classes of commensal 
phyla, the Firmicutes and Bacteroidetes, were detected79. The profound influence of the 
microbiota on IBD-like disorders could be particularly shown in murine intestinal 
inflammation models. Several genetic mouse models for inflammatory intestinal disorders do 
not establish the disease when they are maintained under germfree conditions, indicating the 
necessity for commensals in disease development. This could be shown for IL-10-deficient 
mice as well as for HLA-B27 transgenic rats141,142. Further, it could be shown more 
specifically that adequate development of Treg responses is impaired in germfree mice, which 
might have an influence on the development of inflammation in IBD134. Recently, GWAS 
studies identified mutations in the AhR as risk factor for IBD143. Association of the AhR with 
Th17 cell expansion, production of IL-22, maintenance of intestinal homeostasis and controll 
of the microbial load highlight why the AhR might have a pivotal role in IBD 
pathogenesis121,143. 
Introduction 
 
24 
In summary, the cumulative findings about IBD suggest that chronic intestinal inflammation 
requires genetic predispositions, perturbations of the host immune system and changes in 
environmental components such as the microbiota. 
Aim of the Thesis    
 
25
2 Aim of the Thesis 
The AhR has been extensively studied in the field of toxicology for its role in the 
detoxification of xenobiotic substances. It is a ligand activated transcription factor that is 
probably most widely known for binding 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 
inducing enzymes that are involved in detoxifying dioxin. However, investigations of the 
physiological functions and importance of the AhR as an immune regulator have come into 
the focus of immunologists more recently. The AhR has emerged as a regulator of the 
gastrointestinal immune system modulating inflammatory cytokine and chemokine responses, 
enhancing certain T helper cell subset differentiation and mediating interactions between the 
commensal flora and the gut luminal wall. 
This thesis focuses on the AhR repressor (AhRR), a direct target gene and a negative 
regulator of the AhR. Recent studies in our laboratory have shown very strong expression of 
the AhRR in immune cells of barrier organs, like the gastrointestinal tract. Additionally, it 
could be shown that AhRR-deficient mice display similarly enhanced sensitivity to DSS-
induced colitis than AhR knockout mice. The aim of this thesis is hence to understand which 
cells and molecules mediate the enhanced susceptibility and if this mechanism is distinct or 
similar to what has already been found for the AhR. In addition to previously investigated 
AhRR/EGFP reporter and knockout mice, AhRRfl/flLysM-Cre mice were utilized to 
investigate the role of the AhRR in myeloid lysozyme M positive (LysM+) cells in colitis 
induction. 
In the second part of the thesis, the reason for the physiologically high AhRR expression in 
immune cells will be investigated. As a direct AhR target gene, AhRR expression is AhR 
ligand driven. Whether these ligands are derived endogenously, provided by the microbiota or 
from dietary origin, will be investigated in this thesis. Moreover, this study will additionally 
investigate, whether different amounts or types of AhR ligands in certain diets influence the 
intestinal barrier integrity. 
This thesis aims at gaining a better understanding of the role of dietary AhR ligands for AhR-
signaling in the intestinal immune system and what role the AhRR plays in regulating AhR 
signaling processes.  
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3 Materials 
3.1 Equipment 
Table 3.1: Equipment 
Equipment Article/ Company 
Automatic tissue processor Leica TP1020 (Leica Microsystems, Wetzlar, 
Germany) 
Balances 440-35A (Kern & Sohn, Balingen, Germany) 
ABJ-NM (Kern & Sohn, Balingen, Germany) 
EW-N (Kern & Sohn, Balingen, Germany) 
Beaker glass 100ml (Simax Bohemia Cristal, Selb, Germany) 
Cell counting chamber Neubauer improved (La Fontaine via Labotec, 
Göttingen, Germany) 
Centrifuges MicroStar17 (VWR, Wayne, USA),  
5415R (Eppendorf, Hamburg, Germany) 
5424R (Eppendorf, Hamburg, Germany)  
5810R (Eppendorf, Hamburg, Germany)  
Allegra X-15R (Beckman Coulter, Pasadena, USA)  
Cryostat CM3050S (Leica, Wetzlar, Germany) 
ELISA washer CAPP wash 12 (CAPP, Odense, Germany) 
Flow Cytometer BD LSR II Flow (BD Biosciences, Heidelberg, 
Germany) 
BD FACSCanto II (BD Biosciences, Heidelberg, 
Germany) 
Freezer (-20°C) Comfort  (Liebherr, Biberach, Germany) 
Bosch GSD12A20 (Bosch, Gerlingen, Germany) 
Profi Line GG4310 (Liebherr, Biberach, Germany) 
Freezer (-80°C) New Brunswick Ultra-Low Temperature Freezer 
(Eppendorf, Hamburg, Germany) 
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Fridge (+4°C) KTR16A21/02 (Bosch, Gerlingen, Germany) 
MediLine LKUexv1610 (Liebherr, Biberach, 
Germany) 
Gel electrophoresis PerfectBlue Gel System (Peqlab, Erlangen, 
Deutschland) 
Heating devices TS1 ThermoShaker (Biometra, Göttingen, Germany) 
Heatingblock Thermostat TH21 (HLC BioTech, 
Bovenden, Germany) 
Waterbath WNB 22 (Memmert, Schwabach, 
Germany) 
Homogenizer Precellys®24 (Peqlab, Erlangen, Germany) 
Hydrophobic barrier pen ImmEdge pen (Vector Lab Inc., Burlingame, USA) 
Ice machine Scotsman Flockeneisbereiter AF200 (Hubbard 
Systems, Birmingham, USA) 
Incubator CB 150 (Binder, Tuttlingen, Germany) 
Incubator shaker Innova 44 (Eppendorf, Hamburg, Germany) 
Laminar flowWorkbench BDK Laminar Flow (BDK, Sonnenbühl, Genkingen, 
Germany) 
Magnetic stirrer IKA RCT basic (IKA-Werke GmbH & Co. KG, 
Staufen, Germany) 
Measuring cylinder 250ml, 500ml, 1000ml, 2000ml (VWR, Wayne, USA) 
Microscopes BZ-9000 (Keyence, Montabaur, Germany) 
Leica DM2500 (Leica Microsystems, Wetzlar, 
Germany) 
Nikon Eclipse TS100 (Nikon, Amsterdam, 
Netherlands) 
Microtome Leica RM2255 (Leica Microsystems, Wetzlar, 
Germany) 
Leica HI1210 (Leica Microsystems, Wetzlar, 
Germany) 
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Microwave NN-E235M (Panasonic, Osaka, Japan) 
Pipette Controller, cordless MATRIX CellMate II (Thermo Scientific, Waltham, 
USA) 
Pipettes 10µl, 20µl, 200µl, 1000µl (Eppendorf, Hamburg, 
Germany) 
2,5µl ErgoOne (StarLab, Hamburg, Germany) 
Multichannel DV8-10, DV12-50, DV8-300 (HTL Lab 
Solutions, Warszawa, Poland) 
Power supply PowerPacTM (BioRad, Hercules, USA) 
Real-Time PCR Detection System CFX96 TouchReal-Time PCR Detection (Bio-Rad, 
Munich, Germany) 
Spectrophotometer NanoDropTM ND-1000 (NanoDrop Products, 
Wilmington, USA)  
EL 800 (BioTek, Winooski, USA) 
infinite M200 (Group Ltd., Männedorf, Switzerland) 
Thermal cycler T100TM (BioRad, Hercules, USA),  
TProfessional Thermocycler (Biometra, Göttingen, 
Germany) 
T1 Thermocycler (Biometra, Göttingen, Germany) 
Threaded bottles 100ml, 250ml, 500ml, 1000ml (Schott, Mainz, 
Germany) 
Transilluminator Transilluminator UST-30M-8R (BioView, Rehovot, 
Israel) 
Biostep Dark Hood DH-40/50 (biostep, Burkhaltsdorf, 
Germany) 
Vortex shaker Vortex Genie 2 (Scientific Industries, New York, 
USA) 
 
 
3.2 Consumables 
Table 3.2: Consumables and plastic ware 
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Item Company 
BD Plastipak 1ml Sub-Q BD Medical, Le Pont de Claix Cedex, France 
Biopsy punch Kai Europe, Solingen, Germany 
Cell strainer nylon (40µm, 70µm, 100µm) VWR, Radnor, USA 
CellTrics® Partec, Meckenheim, Germany 
Cover slips Roth, Karlsruhe, Germany 
Culture plates (6-well/ 24-well/ 48-well/ 96-well, flat 
bottom) 
Greiner, Frickenhausen, Germany 
Disposal bags Roth, Kalsruhe, Germany 
ELISA plate (half-area, 96 K) Greiner, Kremsmünster, Austria 
Eppendorf Tubes® 5ml Eppendorf, Hamburg, Germany 
Filter tips Sarstedt, Nümbrecht, Germany 
Flow cytometry tubes Sarstedt, Nümbrecht, Germany 
Glass beads Roth, Kalsruhe, Germany 
Gloves Semperit Technische Produkte GmbH, Wien, Austria 
Hard-shell PCR plates Bio-Rad, München, Germany 
Measuring pipettes (5ml, 10ml, 25ml) Greiner, Kremsmünster, Austria 
Micro tube 1.1ml Z-Gel Sarstedt, Nümbrecht, Germany 
Micro tube 2ml + screw cap Sarstedt, Nümbrecht, Germany 
Microplate, 96well (F/U) Greiner, Frickenhausen, Germany 
Microscope slides (Superfrost plus) Thermo Scientific, Waltham, USA 
Multiply®µStrip Pro mix.colour Sarstedt, Nümbrecht, Germany 
Parafilm® American National Cam, Greenwich, USA 
PCR tubes Sarstedt, Nümbrecht, Germany 
Petri dishes Greiner, Kremsmünster, Austria 
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Precision wipes Kimberly-Clark, Reigate, United Kingdom 
Reaction tubes (15ml, 50ml) Greiner, Frickenhausen, Germany 
Reagent reservoirs Thermo Scientific, Waltham, USA 
Safe seal reaction tubes (0,5, 1.5ml, 2.0ml) Sarstedt, Nümbrecht, Germany 
Sterican needles (0.90x40mm, 20G x 1½) Braun, Melsungen, Germany 
Sterile filters (Filtopur S 0.45) Braun, Melsungen, Germany 
Surgical disposable scalpel Braun, Tuttlingen, Germany 
Syringe filtration unit (Filtropur S0.2/0.45) Sarstedt, Nümbrecht, Germany 
Syringes Inject-F Tuberkulin (1ml) Braun, Melsungen, Germany 
Syringes Inject® (2ml, 5ml, 10ml, 20ml) Braun, Melsungen, Germany 
Tissue freezing medium Leica, Nussloch, Germany 
Tissue-Tek® Cryomold (15x15mm, 25x20mm) Sakura Finetek, Torrance, USA 
Weighing pans Roth, Karlsruhe, Germany 
3.3 Chemicals and reagents 
Table 3.3: Chemicals and reagents 
Chemical/ reagent Company 
100bp DNA Ladder New England BioLabs, Ipswich, USA 
10x TAE buffer Invitrogen, Carlsbad, USA 
2-Propanol >99.5% Roth, Karlsruhe, Germany 
3-Methylchloranthren Sigma-Aldrich, St. Louis, USA 
Acetic acid 100% Roth, Karlsruhe, Germany 
Acetone VWR, Darmstadt, Germany 
Albumin Bovine Fraction V, pH=7.0 SERVA Electrophoresis GmBH, Heidelberg, Germany 
Ampicillin-ratiopharm 1g/l Ratiopharm, Ulm, Germany 
Ampuwa Fresenius Kabi, Bad Homburg, Germany 
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Brefeldin A solution (1000x) eBioscience, San Diego, USA 
Ciprofloxacin Kabi 200mg/100ml Fresenius Kabi Deutschland GmbH, Langenhagen, 
Germany 
CountBright™ absolute counting beads Life technologies, Carlsbad, USA 
Dextran Sulfate Sodium Salt, Colitis Grade MP Biomedicals, Solon, USA 
Dithiothreitol (DTT) Molecular Grade Promega, Fitchburg, USA 
DNase/RNase-Free Water Zymo Research, Irvine, USA 
Dulbecco’s PBS Sigma-Aldrich, Steinheim, Germany 
Entellan Merck, Darmstadt, Germany 
Ethanol 70% (methylated) Roth, Karlsruhe, Germany 
Ethanol absolute for molecular biology ApliChem, Darmstadt, Germany 
Ethanol Rotipuran >99.8% Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, St. Louis, USA 
FACS Clean Solution BD Bioscience, Franklin Lakes, USA 
FACS Rinse Solution BD Bioscience, Franklin Lakes, USA 
Fetal Bovine Serum ThermoFischer, Waltham, USA 
FICZ Abcam, Cambridge, UK 
Fixable Viability Dye eFluor 450/ 780 eBioscience, San Diego, USA 
Hank’s Balanced Salt Solution (HBSS) (10x) gibco by Life Technologies, Carlsbad, USA 
HEPES Sigma-Aldrich, St. Louis, USA 
Hydrochloric acid 37% Roth, Karlsruhe, Germany 
Imipenem/Cilastatin Kabi 500mg/500mg (powder) Fresenius Kabi Deutschland GmbH, Langenhagen, 
Germany 
Indole-3-carbinol Sigma-Aldrich, St. Louis, USA 
Ionomycin Sigma-Aldrich, St. Louis, USA 
Metronidazol B. Braun 5 mg/ml (infusion) Braun, Tuttlingen, Germany 
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Monensin Solution (1000x) eBioscience, San Diego, USA 
Myeloperoxidase from human leukocytes  Sigma-Aldrich, St. Louis, USA 
OneComp/ UltraComp ebeads eBioscience, San Diego, USA 
Paraformaldehyde (PFA) Merck, Darmstadt, Germany 
Penicillin-Streptomycin gibco by Life Technologies, Carlsbad, USA 
peqGOLD Universal Agarose peqlab, Erlangen, Germany 
Phorbol myristate acetate (PMA) Sigma-Aldrich, St. Louis, USA 
Phosphate Buffered Saline Dulbecco Merck, Darmstadt, Germany 
Protease Inhibitor cOmplete Tablets, Mini Roche, Indianapolis, USA 
QIAzol Lysis Reagent Qiagen, Hilden, Germany 
RPMI 1640 ThermoFisher, Waltham, USA 
Saponin Sigma-Aldrich, St. Louis, USA 
Sodium hydroxide solution Roth, Karlsruhe, Germany 
Sulfuric acid (H2SO4) Roth, Karlsruhe, Germany 
SYBR® DNA Gel Stain Invitrogen, Carlsbad, USA 
Tissue Freezing Medium Leica Biosystems, Nussloch, Germany 
TruStain fcXTM (anti-mouse CD16/32) (Clone: 93) BioLegend, San Diego, USA  
Trypan Blue Sigma-Aldrich, St. Louis, USA 
Tween-20 Roth, Karlsruhe, Germany 
Vancomycin HEXAL 1.0g (dry solid) Hexal, Holzkirchen, Germany 
Xylol Roth, Karlsruhe, Germany 
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3.4 Solutions and buffers 
Table 3.4: Solutions and buffers 
Solution/buffer Content 
Complete RPMI 1640 RPMI Medium 
8% FCS 
1% L-Glutamine 
1% Penicillin-Streptomycin 
50µM β-Mercaptoethanol 
EDTA (0.5M) 186.g EDTA 
approx. 20g NaOH 
1000ml H2O 
pH 7.8-8.0 
ELISA stopping solution 25% H2SO4 in H2O 
ELISA wash buffer 0.05% Tween-20 in PBS 
HATAB buffer Aqua dest. 
50mM potassium phosphate 
5mg/ml Hexadecyltrimethylammonium bromide 
Histology blocking buffer PBS 
1% FCS 
1% mouse serum 
1% rat serum 
IEL isolation buffer PBS 
10% FCS 
15mM HEPES 
5mM EDTA 
Intestinal digestion solution #1 5mM DTT in HBSS 
2% FCS 
Penicillin: 100U/ml 
Streptomycin: 100µg/ml 
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Intestinal digestion solution #2 5mM EDTA in HBSS 
2% FCS 
Penicillin: 100U/ml 
Streptomycin: 100µg/ml 
Intestinal digestion solution #3 HBSS 
10mM HEPES  
Penicillin: 100U/ml 
Streptomycin: 100µg/ml 
Lysis buffer (tail lysis) A. dest 
5 mM EDTA, pH 8,0 
0,2 % SDS 
200 mM NaCl 
0,1 mg/ml Proteinase K 
MACS buffer PBS 
0.5% BSA 
2mM EDTA 
PERM buffer PBS 
0.5% Saponin 
0.5% BSA 
PFA (4%) 4g PFA 
100ml PBS 
Skin digestion buffer PBS 
DNase I (200 U/ml) 
Liberase™ (0.8 U/ml) 
3.5 Elisa 
Table 3.5: Elisa Kits 
Target molecule/protein Company 
IFNγ R&D Systems, Mineapolis, USA 
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IL-10 R&D Systems, Mineapolis, USA 
IL-17 R&D Systems, Mineapolis, USA 
IL-1β R&D Systems, Mineapolis, USA 
IL-22 R&D Systems, Mineapolis, USA 
IL-6 R&D Systems, Mineapolis, USA 
KC/CXCL1 R&D Systems, Mineapolis, USA 
Lipocalin 2 R&D Systems, Mineapolis, USA 
TNFα R&D Systems, Mineapolis, USA 
3.6 Antibodies 
3.6.1 Antibodies for flow cytometry 
Table 3.6: Flow cytometry antibodies 
Antigen Isotype Clone Conjugate Company 
B220 Rat IgG2a, κ RA3-6B2 APC/Cy7 BioLegend 
CD103 Rat IgG2a, κ M290 BV421 BD Biosciences 
CD11b Rat IgG2a, κ M1/70 APC, PE, BV605 BioLegend 
CD11c Armenian Hamster 
IgG 
N418 APC/Cy7 BioLegend 
CD127 Rat IgG2a, κ  A7R34 PerCp/Cy5.5 ebioscience 
CD19 Rat IgG2a, κ 6D5 PerCP, PerCp-Cy5.5 BioLegend 
CD207 
(Langerin) 
Mouse IgG2a, κ  4C7 APC BioLegend 
CD25 Rat IgG1, λ  PC61 APC/Cy7, APC BioLegend 
CD326  
(Ep-CAM) 
Rat IgG2a, κ  
 
G8.8 APC BioLegend 
CD3ε Armenian Hamster 
IgG 
145-2C11 APC/Cy7, PE, PE/Cy7, 
PerCP-Cy5.5 
BioLegend 
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CD4 Rat IgG2a, κ RM4-5 APC, APC/Cy7, BV605, 
PerCP 
BioLegend 
CD45 Rat IgG2b, κ 30-F11 PE/Cy7, PE, BV510 BioLegend 
CD64 Mouse IgG1, κ  X54-5/7.1 PerCp-Cy5.5 BioLegend 
CD86 Rat IgG2a, κ  GL-1 PE BioLegend 
CD8β Rat IgG2b, κ  YTS156.7.7 PerCP-Cy5.5 BioLegend 
CD8α Rat IgG2a, κ 53-6.7 PE/Cy7 BioLegend 
F4/80 Rat IgG2a, κ  BM8 APC ebioscience 
FoxP3 Rat IgG2a, κ  FJK-16s PE ebioscience 
I-A/I-E (MHCII) Rat IgG2b, κ  M5/114.15.2 APC BioLegend 
IFNγ Rat IgG1, κ XMG1.2 APC BD Biosciences 
IL-17A Rat IgG2a, κ  eBio17B7 PE ebioscience 
Isotype ctrl  Rat IgG1, κ RTK2071 APC, PE BioLegend 
Isotype ctrl  Rat IgG2a, κ  eBR2a APC, PE BioLegend 
NK1.1 Mouse IgG2a, κ PK136 PE BD Biosciences 
NKp46 Rat IgG2a, κ  29A1.4 PE, PE/Cy7 ebioscience 
RORγt Rat IgG1, κ B2D APC ebioscience 
TCR β chain Armenian Hamster 
IgG  
H57-597 PE BioLegend 
TCR γ/δ Armenian Hamster 
IgG  
GL3 APC BioLegend 
3.6.2 Antibodies for Immunohistology 
Table 3.7: Immunohistology antibodies 
Antigen Isotype Clone Conjugate Company 
GFP Rabbit IgG Polyclonal purified Life Technologies 
Rabbit IgG Rabbit IgG (H+L) Polyclonal Alexa Fluor 488 Life Technologies 
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3.7 Kits 
Table 3.8: Kits 
Name Company 
ABsolute qPCR SYBR Green ROX Mix Thermo Scientific, Waltham, USA 
Direct-zol™ RNA MiniPrep Kit Zymo research, Irvine, USA 
LIVE/DEAD® Fixable Violet Dead Cell Stain Kit, 
for 405 nm excitation 
Life Technologies, Carlsbad, USA 
MyTaq HS Red DNA Polymerase  Bioline, London, UK 
QIAamp® DNA Stool Mini Kit Qiagen, Hilden, Germany 
Quick-RNA™ MiniPrep Zymo research, Irvine, USA 
3.8 PCR primers 
Table 3.9: PCR primers 
Target  Sequence 
CYP1A1 fwd 5’-CCTCATGTACCTGGTAACCA-3’ 
 rev 5’-AAGGATGAATGCCGGAAGGT-3’ 
GAPDH fwd 5’-GAGCCAAACGGGTCATCA-3’ 
 rev 5’-CATATTTCTCGTGGTTCACACC-3’ 
RPS6 fwd 5’-ATTCCTGGACTGACAGACAC-3’ 
 rev 5’-GTTCTTCTTAGTGCGTTGCT-3’ 
3.9 Software 
Table 3.10: Software 
Software Company 
Adobe Illustrator CS5 Adobe Systems, Dublin, Republic of Ireland 
Argus X1 biostep, Burkhardtsdorf, Germany 
BZ-II Analyzer Keyence, Montabaur, Germany 
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CFX ManagerTM Software Bio-Rad, Munich, Germany 
FACS Diva BD, Franklin Lakes, USA 
Fiji (Image J) Open source scientific analysis program 
FlowJo 9.9.7/10.4.1 TreeStar, Inc., Ashland, USA 
Gen 5 2.03 BioTek, Winooski, USA 
GraphPad Prism 6 GraphPad, La Jolla, USA 
Microsoft Office 2011 for Mac Microsoft, Redmond, USA 
NanoDropTM ND-1000 NanoDrop Products, Wilmington, USA 
Papers 2 Papers, Dordrecht, The Netherlands 
3.10 Enzymes 
Table 3.11: Enzymes 
Enzyme Company 
DNase I  Roche, Basel, Switzerland 
Horseradish Peroxidase Sigma-Aldrich, St. Louis, USA 
LiberaseTM  Roche, Basel, Switzerland 
Proteinase K Sigma-Aldrich, St. Louis, USA 
3.11 Mouse diets 
Table 3.12: Mouse diets 
Mouse diet Producer 
LASQCdiet® Rod16‐A LASvendi, Soest, Germany 
ssniff® EF R/M acc. AIN 93G ssniff Spezialdiäten GmbH, Soest, Germany 
ssniff® EF acc. D12492 (I) mod. ssniff Spezialdiäten GmbH, Soest, Germany 
ssniff® EF acc. D12450B (I) mod. ssniff Spezialdiäten GmbH, Soest, Germany 
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3.12 Animals for research 
All mice used during the experiments were kept under SPF (specific pathogen free) 
conditions in the Life & Medical Sciences Institute (LIMES) Genetic Resources Center 
(GRC). All experiments were performed in accordance with institutional, state and federal 
guidelines and with permission of the state government of North Rhine-Westphalia 
(Germany). 
Table 3.13: Genetically modified mouse lines 
Mouse line Strain Description 
AhR-/- C57BL/6 Mouse line deficient for the AhR144 
AhRR+/+ C57BL/6 Mouse line expressing the functional AhRR 
AhRRE/+ C57BL/6 Mouse line expressing eGFP under the control of the ahrr promoter on 
one allele and the functional AhRR on the other allele128 
AhRRE/E C57BL/6 Mouse line expressing eGFP under the control of the ahrr promoter 
instead of functional AhRR128 
AhRRfl/fl C57BL/6 These mice are described separately (3.13). 
AhRRfl/fl LysM-Cre C57BL/6 AhRRfl/fl mice are crossed to LysM-Cre mice that express the Cre 
recombinase under the control of the LysM promoter145. 
3.13 Generation of AhRRfl/fl mice 
AhRRfl/fl is a transgenic mouse line generated in our group at the Leibniz Research Institute  
for Environmental Medicine (IUF) Düsseldorf by Heike Weighardt and Markus Korkowski. 
Mice were generated by homologous recombination and subsequent blastocyst injection of a 
targeting vector. LoxP sites were inserted upstream and downstream of exon 3 of the ahrr 
gene, which encodes for the basic helix-loo-helix (bHLH) domain (Fig.3.1). Between the 5’ 
loxP site and exon 3 a flippase recognition target (FRT) site-flanked neomycin selection 
cassette was inserted, facilitating selection of successfully transfected embryonic stem cells. 
After having created mutant mice the neomycin cassette was removed through crossing with a 
transgenic mouse line expressing the flippase (Flp) ubiquitously (Flp-Deleter-strain). The 
resulting AhRRfl/fl mice can be crossed to mice that express the cre recombinase in a cell-type 
specific manner. This results in a cell-type specific excision of the loxP site flanked exon 3 
and as a consequence in a cell-type specific AhRR-deficient mouse. 
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Figure 3.1: AhRRfl/fl mice targeting strategy 
AhRRfl/fl mice were generated by insertion of the targeting vector into the genomic AhRR locus via 
homologous recombination. The neomycin cassette was removed by Flp-mediated deletion before 
excision of exon three by Cre-mediated deletion. This figure was kindly provided by Heike 
Weighardt.
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4 Methods 
4.1 DSS-induced colitis 
Dextran sodium sulfate (DSS) colitis was induced in aged-matched female mice by adding 
2%, 3% or 5% DSS (w/vol) to the drinking water. Mice were kept on DSS-containing water 
for 5 to 7 days. In some experiments DSS water was replaced after 7 days with normal 
drinking water. The general state of health, behavior, posture, stool consistency, rectal 
bleeding and body weight were monitored every other day. At the end of the experiment 
blood was drawn from the facial vein and serum was separated for analysis of inflammatory 
cytokines or markers. Moreover, colons were removed and the colon length was determined. 
Small intestine, colon, PPs, mLNs and spleen were removed and either transferred into 4% 
Paraformaldehyde (PFA) or stored in PBS on ice until further use. 
4.2 Histology 
Directly after removal organs were transferred to 4% PFA in order to preserve tissue 
structures. Organs were kept in PFA-solution either for 4 hours at room temperature or up to 
several weeks at 4°C.  
4.2.1 Preparation of tissue for cryosectioning 
The tissue was dehydrated with sucrose in PBS at rising concentrations (5%, 10%, 20%). 
Therefore, organs were kept for 1 hour in each solution or alternatively in the 20% sucrose 
solution overnight. Afterwards, tissue samples were embedded in cryomedium and frozen 
using dry ice. Subsequently, samples were stored at -80°C until cryosectioning. Using a 
cryostat, tissue sections of 7 to 10µm were produced and mounted on a microscope slide. 
Sections were air dried for 45 minutes and then fixed with acetone for 10 minutes. Slides 
were stored at -80°C.  
4.2.2 Preparation of tissue for paraffin sections  
PFA-fixed tissue samples were transferred into plastic cassettes and further processed with the 
Leica Benchtop Tissue Processor that incubates tissue samples in a series of ascending 
alcohol concentrations for dehydration. Then, tissue samples were embedded into paraffin, 
cooled down and stored at room temperature. Paraffin embedded tissue samples were 
subsequently processed with a rotary microtome to obtain 5µm sections. These sections were 
transferred to a warm water bath (40°C) and afterwards dragged onto microscope slides. After 
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drying in a heating cabinet (2 hours), slides were stored at room temperature until further 
processing. 
4.2.3 Immunofluorescence staining 
Frozen sections were thawed and encircled with a water-repellent pen (ImmEdge Pen), 
creating a hydrophobic barrier around the sample. Specimens were then rehydrated in PBS for 
5 minutes and then placed into a humid chamber. To prevent unspecific binding, sections 
were blocked with self-made histoblock containing 1% murine serum, 1% rat serum and 1% 
FCS for 1 hour at room temperature. Slides were washed three times for 5 minutes in PBS 
before adding antibodies in PBS onto the tissue sections. Antibodies were incubated 2 hours 
at room temperature or overnight at 4°C. Slides were then washed three times for 5 minutes in 
PBS. If necessary, secondary antibodies in PBS were added to the tissue specimens and 
incubated for 2 hours at room temperature before washing the slides three times for 5 minutes 
in PBS. Next, nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) diluted 1:5000 
in PBS for 10 minutes. Slides were washed three times in PBS for 5 minutes and afterwards 1 
minute in distilled water. After air-drying, slides were mounted with Mowiol-DABCO. 
Afterwards the slides were dried overnight at room temperature and then stored at 4°C in the 
dark.  
4.2.4 Hematoxylin and Eosin staining 
Hematoxylin and eosin stain (H&E stain) was performed in order to analyze tissue 
morphology. The protocol is outlined in the table below (Table 4.1). In brief, paraffin sections 
were treated with xylol, alcohol and water to remove the paraffin from the tissue. Afterwards, 
the nuclei of cells were stained with hemalaun. Hemalaun acts as a basic dye and reacts with 
negatively charged cell components, such as nucleic acids in the nucleus, resulting in a blue 
stain. Eosin Y is an acidic, negatively charged dye that reacts with positively charged 
components, such as amino groups in proteins in the cytoplasm, resulting in a pink stain. 
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Table 4.1: H&E staining protocol 
Treatment Time 
Xylol 10 [min] 
Xylol 10 [min] 
100% Ethanol 5 [min] 
100% Ethanol 5 [min] 
95% Ethanol 2 [min] 
70% Ethanol 2 [min] 
Aqua dest. 1 [min] 
Mayer’s hemalaun solution 3 [min] 
0.1% Hydrochloric acid 2 [sec] 
Tab water 3 [min] 
Alcoholic Eosin Y solution 3 [min] 
Tab water 30 [sec] 
95% Ethanol 10 [sec] 
95% Ethanol 10 [sec] 
100% Ethanol 10 [sec] 
100% Ethanol 10 [sec] 
Xylol 5 [min] 
Xylol 5 [min] 
 
4.2.5 Microscopy 
Microscopic analysis of immunoflourescently or H&E stained sections was performed using 
the Keyence BZ-9000 microscope. Afterwards, images were edited and analyzed with the BZ-
II Analyzer or Fiji (ImageJ) software. To determine colitis severity H&E stained samples of 
murine colon sections were scored according to Dieleman et al (Table 4.2)146. 
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Table 4.2: DSS colitis severity scoring 
Feature graded Grade Description 
Inflammation 0 
1 
2 
3 
none 
slight 
moderate  
severe 
Extend 0 
1 
2 
3 
none 
mucosa 
mucosa and submucosa 
transmural 
Regeneration 4 
3 
2 
1 
0 
no tissue repair 
surface epithelium not intact 
regeneration with crypt depletion 
almost complete regeneration 
complete regeneration or normal tissue 
Crypt damage 0 
1 
2 
3 
4 
none 
basal 1/3 damaged 
basal 2/3 damaged 
only surface epithelium intact 
entire crypt and epithelium lost 
Percent involvement 1 
2 
3 
4 
1-25% 
26-50% 
51-75% 
76-100% 
 
 
 
4.3 Isolation of intestinal immune cell subsets 
Mice were sacrificed either by cervical dislocation or by asphyxiation with 100% carbon 
dioxide (CO2). The murine abdomen was opened and colon, SI and mLNs were transferred 
into PBS filled tubes and stored on ice until further processing. Colon and SI were cleaned 
from residual fat tissue using small forceps and flushed with cold PBS in order to remove 
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intestinal content. PPs were removed from the colon with scissors and stored on ice until cell 
isolation. Colon and SI were opened longitudinal and cut into 1-2 cm long pieces. From these 
tissue pieces IELs or lamina propria lymphocytes were isolated. 
4.3.1 Intraepithelial lymphocytes (IELs) 
SI or colon tissue pieces were transferred into 50ml tubes filled with 25ml of IEL isolation 
buffer (3.4) and shaken at 37°C for 45 minutes at 150 rounds per minute (rpm) in a shaking 
incubator. After that the content of the tube was filtered through a 70 µm cell strainer. The 
flow through containing intestinal epithelial cells (IECs) and IELs was further analyzed via 
flow cytometry. 
4.3.2 Lamina propria lymphocytes 
Intestinal tissue pieces were transferred into a 50ml tube containing intestinal digestion 
solution 1 (SI: 20ml, colon: 10ml) and incubated at 37° for 20 minutes while shaking (150 
rpm). Afterwards, the tissue was transferred into a second 50ml tube with solution 2 (SI: 
15ml, colon: 7,5ml) and incubated for 15 minutes in the shacking incubator. Incubation in 
solution 2 was repeated twice. Tissue pieces were subsequently incubated in 10ml intestinal 
digestion solution 3 for 10 minutes at 37°C while shaking. Then, intestinal tissue was 
transferred into a 6 well plate, minced with scissors into small pieces and mixed with 7ml of 
intestinal digestion solution 3. DNase I (200 U/ml) and Liberase™ (0.2 U/ml) were added and 
the 6 well plate was incubated for 45 minutes at 37°C with gentle shaking (60 rpm). After 
that, the tissue was further homogenized by pipetting up and down several times with a 10ml 
serological pipette. The cell suspension was filtered through a 70 µm cell strainer to receive a 
clean single cell suspension and retain undigested tissue. Moreover, an equal volume of 
MACS buffer was added in order to stop the enzymatic activity of DNase I and Liberase. The 
cells were washed twice and then further processed. 
4.3.3 mLNs/ PPs 
Residual fat and connective tissue were removed from mLNs using small forceps and 
scissors. Afterwards mLNs or PPs were mashed through a 100µm cell strainer with the 
plunger of a 2ml syringe. The single cell suspension was washed with PBS and further 
processed as required. 
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4.4 Isolation of dermal and epidermal immune cells 
Ears and tails were harvested and stored in PBS on ice. Dorsal and ventral ear sides were 
separated with forceps. Tail skin was mechanically detached from the spine. 3ml of Trypsin-
EDTA (0.25%) was pipetted into a 6 well plate and tail and ears were floated epidermal side-
up on the Trypsin-EDTA. After 90 minutes incubation period at 37°C epidermis and dermis 
were separated with forceps and processed independently.  
The dermis was transferred into a 12 well plate and minced with scissors and was digested in 
500 µl of digestion buffer at 37°C for 60 to 90 minutes in a shaking incubator at 100 rpm. For 
further separation the cell suspension was resuspended with a blunted tip of a 1000 µl pipette 
and then filtered through a 100 µm cell strainer and subsequently through a 70 µm cell 
strainer in order to separate cells from undigested residual tissue. Lastly, the suspension was 
centrifuged at 4000 rpm for 10 minutes and the cell pellet was suspended in 1ml PBS. Cells 
were afterwards stained for analysis via flow cytometry.  
Epidermal tissue was mashed through a 100 µm cell strainer in a 6 well plate containing 5ml 
PBS. The obtained cell suspension was then filtered through a 70 µm and a 40 µm cell 
strainer, centrifuged at 4000 rpm for 10 minutes, suspended in 1ml PBS and further stained 
for flow cytometric analysis. 
4.5 Flow Cytometry 
Flow cytometry is a laser-based technique to analyze several thousand cells per second with 
regard to multiple parameters simultaneously. Further, this technology can be used to sort 
certain cell populations according to their expression profile of defined biomarkers. Usually 
fluorophore-coupled antibodies or fluorescent dyes are used as labels in flow cytometry. 
Using different laser wavelength, certain bandpass filters and different fluorophores, modern 
flow cytometers allow for analysis of up to 50 different characteristics of one cell. 
4.5.1 Staining of cell surface antigens 
For staining of cell surface antigens, a certain number of cells that have been produced by one 
of the previously described protocols were transferred into FACS tubes. The tubes were filled 
up with PBS and centrifuged at 1400 rpm for 5 minutes. After discarding the supernatant, 
cells were resuspended in 100 or 200 µl PBS or MACS buffer containing a mixture of 
fluorophore-coupled antibodies directed against the antigens of interest. Cells were incubated 
for 15 minutes one ice, protected from direct light. Afterwards, cells were washed with 300 to 
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500 µl cold PBS or MACS buffer (1400 rpm, 5min) and resuspended in 300 µl MACS buffer 
for flow cytometric analysis. 
4.5.2 LIVE/DEAD® Fixable Dead Cell Stain Kit 
The LIVE/DEAD® fixable dead cell stain kit was used to discriminate between living and 
dead cells. Cells were incubated in 100 or 200 µl PBS containing the fixable dye at a dilution 
of 1:1000 for 30 minutes on ice. The staining was typically performed in combination with 
the surface antibody staining. Afterwards, cells were washed with 300 to 500 µl PBS (1400 
rpm, 5min) and then further processed. 
4.5.3 Fixation of cells for flow cytometric analysis or intracellular staining 
After surface staining and optional LIVE/DEAD® staining, cells were fixed with 2% 
Paraformaldehyde (PFA), if required, for 20 minutes at room temperature. Afterwards, cells 
were washed with 300 to 500 µl PBS (1400 rpm, 5min) and resuspended in 300 µl MACS 
buffer. 
4.5.4 Intracellular cytokine and transcription factor staining 
Staining of intracellular proteins was performed following fixation of cells as described in the 
previous section. After PFA fixation, cells were washed with PBS and resuspended in 100 to 
200 µl PERM buffer containing fluorophore-coupled antibodies directed against intracellular 
antigens. Afterwards, cells were incubated for 1 hour at 4°C or alternatively over night if anti-
GFP staining was performed. As the anti-GFP antibody is not directly labeled with a 
fluorochrome, cells were washed with 300 µl PERM buffer on the next day (1400 rpm, 5min) 
and then resuspended in 100 to 200 µl PERM buffer containing a fluorophore-coupled 
secondary antibody directed against the species of the primary anti-GFP antibody. After 45 
minutes cells were washed with 300 µl PERM buffer (1400 rpm, 5min), 300 µl MACS buffer 
(1400 rpm, 5min) and finally resuspended in 300 µl MACS buffer for flow cytometric 
analysis. 
4.6 Colon explant cultures 
To culture colon explants, colons were explanted and intestinal content was removed. Colons 
were opened longitudinal and tissue was cleaned in ice-cold PBS. A biopsy punch was used to 
obtain a 6mm diameter tissue sample. The biopsy was transferred into a 48 well plate with 
300 µl complete RPMI (cRPMI). The plate was incubated at 37°C and 5% CO2 for 6 hours. 
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Afterwards, the concentration of cytokines released from the biopsy was determined in the 
supernatant by Enzyme-linked Immunosorbent Assay (ELISA). 
4.7 Myeloperoxidase (MPO) activity assay 
Measurement of the enzymatic activity of the oxidative enzyme myeloperoxidase (MPO), 
which is the most abundant proinflammatory enzyme stored in granules of neutrophil 
granulocytes, is widely used to evaluate the degree of inflammation in biological samples. 
After DSS colitis, colon tissue samples were snap frozen in liquid nitrogen and subsequently 
stored at -80°C until further processing. After thawing on ice, 350 µl of HATAB buffer were 
added to the tissue in glass bead tubes. The tissue was homogenized using the Precellys®24 
tissue homogenizer (6000 rpm, 3x30seconds) and afterwards snap frozen again. Then, the 
samples were thawed at 55°C using a heating block. The lysate was subsequently cleared by 
centrifugation at 13000 rpm for 15 minutes and the supernatant was transferred into a new 
tube and stored on ice. The protein concentration was determined with the NanoDrop 
spectrophotometer. The cleared lysate was diluted 1 to 5 with HATAB buffer and 50µl were 
transferred into a 96 well flat bottom microtiter plate. Human MPO was diluted in HATAB 
buffer to prepare a standard curve with a top activity of 1 U/ml. An 8-point serial dilution of 
the top standard and three blank wells containing just HATAB buffer were prepared. Then, 50 
µl of TMBplus2 substrate was added to the wells and incubated for approximately 10 
minutes. Substrate reaction was stopped by addition of 50 µl of 2N H2SO4. Absorption was 
determined at 450 nm using a microtiter plate reader. 
4.8 ELISA (Enzyme-linked Immunosorbent Assay) 
The sandwich Enzyme-linked Immunosorbent Assay (ELISA) detects antigens in a fluid 
sample by the application of antibodies and an enzyme-catalyzed color reaction. All ELISAs 
were purchased from R&D Systems and conducted according to the manufacturer’s 
instruction. In brief, antigen capture antibodies were immobilized in a 96-well ELISA plate 
by incubation for 2 hours at room temperature in PBS. After washing once with ELISA wash 
buffer, plates were blocked with blocking buffer (1% BSA in PBS) for 1 hour at room 
temperature. Following three more washing steps, antigen-containing samples were incubated 
for 2 hours at room temperature. To quantify the amount of antigen in the samples, a serial 
dilution of a protein standard in reagent diluent was also applied to antibody-coated wells. 
After three more washing steps, the diluted biotinylated-detection antibody was applied to the 
plate and incubated for 2 hours at room temperature or at 4°C overnight. Subsequently, the 
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plate was washed three more times. Streptavidin-coupled Horseradish Peroxidase in reagent 
diluent was incubated for 20 minutes at room temperature. Following three final washing 
steps 50 µl of TMB PLUS2 was added to the plate and incubated until appearance of blue 
color indicates turnover of added substrate.  To stop the reaction, the same volume of 0.5M 
sulfuric acid was added, leading to a yellow color development. Absorption was measured at 
450nm/630nm using a microtiter plate reader. 
4.9 Real Time Quantitative PCR (qPCR) 
4.9.1 RNA isolation 
In order to isolate whole RNA from SI, colon or any other tissue, small tissue samples were 
explanted, cleaned from intestinal content or fat and transferred into glass bead tubes. These 
tubes were snap frozen in liquid nitrogen and subsequently stored at -80°C until further usage. 
600µl of QIAzol Lysis Reagent were added to the tissue samples immediately before thawing. 
Tissue lysis and homogenization was performed with the Precellys®24 homogenizer at 
6000rpm (3x20 seconds). RNA was isolated using the Zymo Research Direct-zol MiniPrep 
kit according to the manufacturer’s instructions. RNA was eluted with 50µl of DNase/RNase 
free water and RNA concentration was determined using the NanoDrop1000 
Photospectrometer. The RNA was stored at -80°C for further procedures. 
4.9.2 cDNA synthesis 
Isolated whole RNA was transcribed into complementary DNA (cDNA) by the enzyme 
reverse transcriptase. The employment of Oligo(dT) primers ensures the transcription of in 
particular messenger RNA (mRNA), which is protected against degradation by exonucleases 
by modification with a 3’ poly(A) tail. For all experiments between 0.5 and 1 µg of RNA was 
used for the transcription. The RNA was diluted to the desired concentration in DNase/RNase 
free water. A maximum volume of 10 µl RNA was used. RNA was mixed with 3 µl 
Oligo(dT)12-18 primer, which hybridize to the poly(A) tail of mRNA. The mixture was 
incubated for 10 minutes at 70°C in order to unfold and denature the RNA and allow the 
primers to anneal to the RNA. Afterwards the samples were cooled down on ice. Then, a 
master mix consisting of other reagents needed (Table 4.3) were added and the cDNA 
reaction mix was incubated for 1 hour at 40°C. A final 5 minute incubation at 95°C 
inactivated the reverse transcriptase and stopped the reaction. 
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Table 4.3: cDNA synthesis Master Mix 
 Volume (1 reaction) 
DEPC water 9.4 µl 
5x RT buffer 8.0 µl 
dNTP (10mM) 4.0 µl 
DTT (100mM) 4.0 µl 
RiboLock (40U/µl) 0.8 µl 
RT (200U/µl) 0.8 µl 
 27 µl 
4.9.3 RPS6 PCR 
In order to control the efficiency of cDNA synthesis, a polymerase chain reaction (PCR) for 
the ribosomal protein S6 (RPS6) was performed. RPS6 is a constitutively expressed gene and 
can therefore be used to evaluate the cDNA quality. A PCR mix containing 1.5 µl cDNA, 
13.05 µl water, 4 µl 5x MyTaq reaction buffer and 0.05 µl MyTaq DNA polymerase was 
prepared and run in a thermocycler according to the program in table 4.4. The PCR product 
was analyzed on an agarose gel, and the band strength was compared between samples as a 
measure of comparable cDNA synthesis efficiency.  
Table 4.4: RPS6 PCR program 
 Incubation time Temperature 
1x 5 [min] 95°C 
 1 [min] 95°C 
35x 1 [min] 55°C 
 1 [min] 72°C 
1x 10 [min] 72°C 
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4.9.4 qPCR 
The real-time polymerase chain reaction (qPCR) is a technique that is commonly used to 
monitor amplification of targeted DNA in real-time in order to quantify an amount of DNA 
molecules, which has been transcribed from mRNA previously. After conversion of RNA in 
cDNA (4.9.2) the cDNA was used as a template for amplification via PCR. The 2x ABsolute 
qPCR SYBR Green Mix contains all components for the quantitative PCR reaction, except 
primer and template. The mix contains appropriate amounts of SYBR Green I dye and 
Thermo-Start DNA Polymerase. SYBR Green preferentially intercalates into newly 
synthesized double-stranded DNA and subsequently emits green light at a wavelength of 
520nm. The CFX96 Touch™ Real-Time PCR Detection System detects the signal that 
increases with advancing DNA amplification. One PCR reaction had a volume of 15 µl and 
included 7,5 µl 2x ABsolute qPCR SYBR Green Mix, 0,3 µl forward primer, 0,3 µl reverse 
primer, 1,9 µl water and 5 µl cDNA. The cDNA, synthesized according to section 4.9.2, was 
diluted 1:5 with water prior to the qPCR reaction. The CFX96 thermocycler program is listed 
in the table below (Table 4.5). 
Table 4.5: qPCR thermocycler program 
 Incubation time Temperature 
1x 15 [min] 95°C 
 20 [min] 95°C 
44x 40 [min] 60°C 
 60 [min] 40°C 
 
Following the amplification, a melting curve analysis of the synthesized double stranded 
DNA fragments was performed in order to check if the PCR primers produce one specific 
PCR product or potential unwanted unspecific products or primer dimers. For this purpose the 
thermo cycler raises the temperature in steps of 0.5°C from 65 to 95°C. The melting 
temperature was determined by a strong reduction of SYBR Green fluorescence signal as a 
consequence of its dissociation from the DNA.  
4.9.5 Comparative Ct Method Quantification  
The comparative Ct Method of quantification is a relative quantification method based on an 
internal reference gene that is used to determine fold-difference expression of a target gene. 
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The quality of this method largely depends on the selection of a good reference or 
housekeeping gene that is stably expressed and largely independent of any experimental 
conditions. A housekeeping gene corrects for differences in the quality and quantity of the 
RNA that was initially utilized, which can affect the whole PCR process. During the PCR the 
accumulation of the SYBR Green fluorescence signal was measured. A threshold cycle (Ct) 
was determined at the time-point where the amount of SYBR green fluorescence exceeds the 
background fluorescence. Ct values are inversely correlated to the amount of nucleic acid 
within the sample. Ct values of the target gene were corrected for the Ct values of the 
reference gene forming the ΔCt value in treated and control samples (ΔCt1=CtTarget treated-Ct 
Reference treated, ΔCt2=CtTarget control-Ct Reference control). In a second step control Ct values were 
subtracted from the Ct values of treated samples (ΔΔCt=ΔCt1-ΔCt2). Normalized target gene 
expression as fold change of treated over control samples was finally determined by the 
formula “Fold Change=2-ΔΔCt”. 
4.10 Determination of intestinal permeability 
Intestinal barrier function and intestinal barrier permeability can be determined by oral 
application of the FITC-coupled anhydroglucose polymer dextran and subsequent 
measurement of the amount of FITC that is transmitted to the circulation. As the intestinal 
barrier is normally not permeable for FITC-dextran, high FITC fluorescence in the murine 
serum indicates a defect and leakiness of the intestinal barrier. Thus, FITC-dextran was orally 
applied and subsequently FITC fluorescence was determined in serum. Mice were fasted 4 
hours prior to FITC-dextran administration to facilitate absorption from the intestinal lumen. 
Then, mice were orally gavaged with 600mg per kg body weight with FITC-dextran in PBS 
using a gavage needle. Mice were left without food for 4 more hours and then blood was 
taken from the facial vein and serum was separated using 1.1ml Serum Gel with Clotting 
Activator Micro tubes. In order to quantify the amount of FITC-dextran transmitted over the 
intestinal barrier into the blood, FITC fluorescence of 40µl serum, pipetted into a 96 well flat 
bottom microtiter plate, was determined with the Tecan infinite M200 plate 
spectrophotometer at an excitation wavelength of 492nm and an emission wavelength of 
525nm. Fluorescence intensity was plotted as arbitrary units (AU). 
4.11 Statistical analysis 
Statistical analysis was performed using the unpaired students t-test, if just two independent 
groups or two conditions on one experimental group were compared. For the determination of 
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any statistical difference between three or more independent experimental groups the one-way 
ANOVA was used. The two-way ANOVA was used when analyzing the mean differences 
between groups that have been split on two independent variables. All data are presented as 
mean plus standard error of the mean (SEM) if not stated otherwise in the figure legend. 
Significance was defined by reaching certain p-values in the statistical tests (* p<0.05, ** 
p<0.01, *** p<0.001). All statistical analysis was conducted with the software GraphPad 
Prism. 
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5 Results 
5.1 AhRR-deficient mice are highly susceptible to DSS colitis 
The AhR pathway has been shown to be very important for the intestinal immune system in 
health and disease. Recent studies have identified the genetic locus of the AhR as a 
susceptibility locus in inflammatory bowel disease (IBD)143. In line with mediation of several 
anti-inflammatory effects147, activation of the AhR leads to protection from DSS-induced 
colitis, whereas mice deficient for the AhR are highly susceptible to IBD148. In this context, 
the AhR has been shown to be important for the maintenance of intraepithelial lymphocytes 
(IELs)121 and for the production of the barrier protective cytokine IL-22 by ILC3s in the 
intestine119,120. Actions of the AhR are regulated through the AhRR by negative feedback 
inhibition. Previous studies performed in our group by Dr. O. Brandstätter could show that 
mice deficient for the AhRR show, similar to AhR knockout mice, high susceptibility to DSS 
colitis128,149. These mice showed greater tissue damage, more weight loss and higher 
production of proinflammatory cytokines early in the disease. However, neither higher 
intestinal barrier permeability nor changed frequencies of myeloid cells or lamina propria T 
cells could be observed in AhRR-deficient mice compared to wild-type littermates. Similar to 
AhR-deficient mice, a reduced frequency of CD8α+TCRγδ+ IELs could be shown. However, 
IEL frequency was not affected as strong as in AhR-deficient mice. Furthermore, reduced 
fecal and higher serum IgA titers of AhRR-knockout mice indicated a potential migration 
defect of IgA producing B1-cells from the peritoneal cavity to the gut149.  
The aim of this study was to understand, if the susceptibility of AhRR-deficient mice to DSS 
colitis is mechanistically linked to the same cells and molecular drivers as in AhR-deficient 
mice or if different pathways, possibly independent of the AhR, are of additional importance. 
5.1.1 Innate lymphoid cell frequency is unchanged in AhRR-deficient mice 
Colitis susceptibility of AhR-/- mice can be largely attributed to the lack of IL-22-producing 
ILC3s in the intestinal lamina propria119,150. Therefore the presence of ILC3s in the small 
intestinal lamina propria of untreated WT, AhR-/- and AhRRE/E mice was compared. Lamina 
propria lymphocytes were isolated and ILC3s were identified by flow cytometry as 
CD45+CD3– non-T cells expressing the transcription factor RORγt151. Furthermore, two 
different subsets of ILC3s were discriminated by their expression of NKp46/NCR1 (Natural 
cytotoxicity triggering receptor 1). In addition to the overall ILC3 frequency, presence of 
Results    
 
55
AhRR-expressing ILC3s was determined in AhRRE/E mice using the EGFP reporter 
(Fig.5.1a). 
 
Figure 5.1: The intestinal ILC3 frequency is reduced in AhR-/-, but not in AhRRE/E mice. 
The frequency of ILC3s was determined in the small intestinal lamina propria of untreated WT, 
AhRRE/E and AhR-/- mice. (a) Gating strategy for group 3 ILCs. Lymphocytes and singles cells were 
gated from the FSC/SSC and SSC-W/SSC-H signals. Living cells were selected as viability dye 
negative events. ILC3s were identified as CD45+CD3– cells expressing RORγt and NKp46 (b) 
Frequencies of NKp46 positive and negative subsets were determined. (c) ILC3s were further 
analyzed for the frequency of AhRR expressing cells. Data in b and c is pooled from three 
independent experiments (n=5-7 mice). Results are given as mean +/– SD. This data has been 
published in Brandstätter et al., Sci Rep, 2016128. 
 
Similar to previous studies, the frequency of NKp46+ and NKp46– ILC3s was reduced in the 
intestinal lamina propria of AhR-/- mice (Fig.5.1b). NKp46+RORγt+ ILC3s were about 50% 
reduced, while NKp46–RORγt+ ILC3s were about 20% reduced in AhR-/- mice compared to 
WT animals. Although the reduction was visible, the effect was not statistical significant. In 
contrast, a reduction of both ILC3 subsets could not be observed in AhRRE/E mice. 
Interestingly, 70% of the NKp46+ and 15% of the NKp46– ILC3s were positive for the 
AhRR/EGFP reporter (Fig.5.1c). 
Taken together, these experiments confirm previous studies observing reduced frequency of 
ILC3s in AhR-/- mice although the reduction was not as pronounced. However, no such 
reduction could be observed in AhRR-deficient mice, likely excluding an involvement of this 
cell type in the colitis susceptibility of AhRRE/E mice. 
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5.1.2 AhR- and AhRR-deficiency alter T helper cell differentiation in DSS colitis 
Besides ILCs also T cells have been shown to be important for the pathogenesis of IBD. 
Enhanced retention in the tissue as well as production and release of proinflammatory 
cytokines by T cells contribute to the pathogenesis of the disease. Chronic IBD in humans and 
also DSS colitis in mice are predominantly Th1- and Th17-mediated diseases. Further, the 
AhR was shown to balance Treg and Th17 cell differentiation152 and is therefore linked to the 
inflammatory processes in colitis153. In order to find out if AhRR-deficiency might likewise 
be involved in the differentiation of effector T cells in colonic and small intestinal lamina 
propria as well as in the mLNs during colitis, frequencies of the aforementioned cell types 
were investigated in AhRRE/E mice treated with 5% DSS for 6 days, in order to induce an 
acute colitis. Frequencies of effector T cells in AhRR-deficient mice were compared to WT 
and AhR-deficient mice. 
CD45+Live/Dead– cells were gated based on their expression of CD3 and CD4 or CD3 and 
CD8, respectively (Fig.5.2a/b). Th17, Th1, Tc17 and Tc1 cells were identified by the 
expression of their signature cytokines IL-17 or IFNγ. AhRRE/E mice showed elevated 
frequencies of Th17 cells from 10% to 17% and Tc17 cells from 2% to 8% in the small 
intestinal lamina propria compared to WT animals (Fig.5.2c/d). Frequency of Th1 cells was 
significantly reduced from 20% to under 5% IFNγ positive cells in the SI lamina propria and 
also slightly reduced in the colon (Fig.5.2c). Tc1 cell frequencies were comparable in WT and 
AhRRE/E mice in SI and colon (Fig.5.2d). All effector T cell subsets showed similar 
frequencies in the mLNs when comparing WT and AhRRE/E mice. AhR-/- mice showed 
significantly elevated frequencies of Th17 cells in SI, colon and mLNs. Th1 cell frequencies 
were elevated from 10% to 30% IFNγ+ cells in the colon but not in SI and mLNs compared to 
WT mice (Fig.5.2c). AhR knockout mice displayed similar numbers of Tc17 cells as WT 
mice and significantly elevated frequencies of Tc1 cells in SI, colon and mLNs (Fig.5.2d). 
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Figure 5.2: Analysis of IL-17- and IFNγ-producing T cells in the intestinal tissue after 6 days of 
DSS colitis 
(a) Intestinal immune cells were identified by flow cytometry, gating on lymphocytes, single cells and 
CD45+ living cells. (b) T cells subsets were discriminated by the expression of CD3 and of CD4 or 
CD8. Th17, Tc17, Th1 and Tc1 cells were identified by production of their signature cytokine. 
Frequencies of Th17 and Th1 (c) and Tc17 and Tc1 (d) cells were determined in single cell suspension 
of SI and colon lamina propria as well as mLNs. Data is pooled of two to five independent 
experiments (n=5-10). Results are given as mean +/– SEM and significance was determined by 
ordinary one-way ANOVA corrected for multiple comparisons by the Bonferroni’s method (*p<0.05, 
**p<0.01, ***p<0.001). (c)/(d) This data has been published in Brandstätter et al., Sci Rep, 2016128. 
Th= helper T cell, Tc=cytotoxic T cell 
 
Results 
 
58 
In summary AhRRE/E mice showed higher frequencies of IL-17-producing T cells and reduced 
frequencies of IFNγ-producing T cells indicating a more Th17/Tc17 directed effector T cell 
differentiation in the SI during DSS colitis. AhR-/- mice show elevated frequencies of IL-17- 
and IFNγ-producing T cells, however, no higher numbers of Tc17 cells, which was 
exclusively observed in AhRRE/E mice. Thus, there appear to be clear differences in the 
phenotype of AhR-/- and AhRRE/E mice regarding T cell differentiation in the cause of colitis. 
5.1.3 Intestinal IL-1β production is altered in AhRRE/E mice 
Differentiation of Th17 cells is generally described to be dependent on the presence of the 
cytokines IL-6 and TGFβ154-156. However, it has also been shown that the combination of IL-
23 and IL-1β157 or a combination of TGFβ and IL-1β158,159 is able to induce Th17 
differentiation. Similar conditions for the differentiation of Tc17 cells in mouse and humans 
have been described160. In order to find out, if the cytokine microenvironment might be 
responsible for the enhanced Th/Tc17 differentiation in AhRRE/E mice, cytokines released by 
colonic tissue were determined under homeostatic and inflammatory conditions.  
Cytokine levels in colonic tissue protein lysates were measured and normalized to the whole 
protein concentration of these lysates. No differences in IL-22, IL-10, TNFα, IL-6 and IFNγ 
levels could be observed in colons of untreated mice under homeostatic conditions, 
comparing WT and AhRRE/E mice. After 6 days of 5% DSS application in the drinking water, 
cytokine levels were generally elevated two to four times (Fig.5.3a). However, the increase 
was similar in WT and AhRRE/E mice. As IL-1β could not be detected in colon protein lysates 
(data not shown), colonic punch biopsies were taken and incubated in complete cell culture 
medium for 6 hours at 37°C. IL-1β released into the medium was measured by ELISA 
(Fig.5.3b). Interestingly, the amount of IL-1β released from the biopsies of untreated AhRRE/E 
mice was significantly higher than from WT mice. Punch biopsies taken from both WT and 
AhRR-deficient mice after DSS application released more IL-1β than those of naïve mice. 
Under inflammatory conditions however, there was no difference in IL-1β release from punch 
biopsies of AhRR-deficient and WT mice. 
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Figure 5.3: IL-1β levels are increased in colon tissue of AhRRE/E mice 
Cytokines in the colonic tissue or released from colonic biopsies from untreated WT and AhRRE/E 
mice and after six days of 5% DSS treatment were measured. (a) IL-22, IL-10, TNFα, IL-6 and IFNγ 
levels were measured in protein lysates of colon tissue by ELISA and normalized to total protein 
levels. (b) IL-1β was measured in the supernatant of colon biopsies that were incubated in complete 
RPMI for six hours at 37°C. Data is pooled of at least two independent experiments (n=5-6 mice). 
Results are given as mean +/– SEM and significance was determined by two-tailed students t test 
(*p<0,05). The data in (b) has been published in Brandstätter et al., Sci Rep, 2016128. 
 
Overall, colonic cytokine composition was unchanged comparing WT and AhRRE/E mice. 
However, significantly elevated IL-1β levels released from cultured colon biopsies of 
untreated AhRRE/E mice might hint to IL-1β as a potential driver of Th/Tc17 biased effector 
cell differentiation. 
5.1.4 Myeloid cell frequency is normal in AhRRE/E mice under inflammatory 
conditions in DSS colitis 
IL-1β is a proinflammatory cytokine with systemic and local effects on immune cell and non-
immune cell function161. It is produced by innate leukocytes, such as intestinal DCs and 
macrophages. Changes in specific DC or macrophage subsets might be partially responsible 
for elevated IL-1β levels and therefore indirectly influence differentiation of IL-17-producing 
effector T cells. Further, changed myeloid cell frequencies might also directly affect effector 
T cell differentiation or the colitis susceptibility of AhRRE/E mice. 
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In order to analyze the frequency of intestinal myeloid cells, leukocytes were isolated from 
organs of the gastrointestinal tract and analyzed by flow cytometry. Cell gating was 
performed as shown in Fig.5.2a and Fig.5.4. DCs were identified by expression of the surface 
marker profile CD64–MHCII+CD11c+ (Fig.5.4a). Using the surface markers CD11b and 
CD103 three different DC subsets, CD11b–CD103+, CD11b+CD103+ and CD11b+CD103–, 
were discriminated51. Macrophages were identified as CD64+F4/80+ cells (Fig.5.4b). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Gating strategy for myeloid cell 
populations in intestinal tissue 
Cells were gated for single living CD45+ cells, 
as shown in Fig.5.2a. (a) DCs were identified as 
CD64–MHCII+CD11c+ cells in the SI and colon 
lamina propria and as MHCII+CD11c+ cells in 
the mLNs and PPs. Three DC subsets were 
defined using the surface marker CD11b and 
CD103 (CD103+CD11b-, CD103+CD11b+, 
CD103–CD11b+). (b) Macrophages were 
defined by the expression of CD64 and F4/80 in 
the SI and colon lamina propria. 
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The macrophage numbers in the lamina propria of the SI and the colon were unchanged 
comparing WT and AhRRE/E mice (Fig.5.5a). Insufficient macrophage numbers in mLNs and 
PPs did not allow for quantification of this cell-type in these organs (data not shown). This 
might be a result of the relinquishment of collagenase in the cell isolation of mLNs and PPs. 
DCs were detected in the mLNs, the PPs and the lamina propria of SI and colon. While 
similar DC frequencies were detected in PPs and colon, AhRRE/E mice had reduced DC 
frequencies in the mLNs and elevated frequencies in the SI (Fig.5.5a).  
 
Figure 5.5: Frequency of DCs and macrophages in intestinal tissue of wild-type and AhRRE/E 
mice after 6 days 5% DSS treatment 
(a) Frequency of DCs was determined in mLNs, PPs and the lamina propria of SI and colon. MΦ 
frequency was determined in SI and colon lamina propria. (d) Frequencies of intestinal DC subsets of 
total CD11c+MHCII+ were determined in mLNs, PPs, SI and colon using the markers CD11b and 
CD103. Data is pooled of two independent experiments (n=3-6 mice total). Results are given as mean 
+/– SEM and significance is determined by two-tailed students t-test corrected for multiple 
comparisons by the Holm-Sidak method (*p<0.05). This data has been published in Brandstätter et al., 
Sci Rep, 2016128. 
 
As DC subsets are functionally diverse with regard to priming or expansion of different T cell 
subsets, frequencies of all three DC subsets were investigated. However, frequencies of 
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CD11b–CD103+, CD11b+CD103+, CD11b+CD103– DCs did not differ in the lamina propria of 
SI and colon (Fig.5.5b). The experiments identified the CD11b+CD103– DCs as the major 
subset in the colon, while equally high frequencies of CD11b+CD103+and CD11b+CD103– 
DC could be detected in the SI. In PPs, AhRRE/E mice showed elevated frequencies of all 
three mentioned DC subsets compared to WT mice, but no differences in total DC frequency, 
suggesting changes in the CD11b–CD103– DC subset (data not shown). The latter population 
was even slightly bigger in the WT mice. In mLNs a reduction of CD11b+CD103+ DCs in 
AhRRE/E mice compared to WT mice was apparent (Fig.5.5b). 
In summary, the frequencies of myeloid cells within the organs of the gastrointestinal tract 
were relatively similar. However, slight differences in the total DC frequency in mLNs and SI 
and some differences with regard to subset distribution in PPs an mLNs could be observed 
comparing WT and AhRRE/E mice. 
5.1.5 Macrophage- and neutrophil-specific AhRR-deficiency does not convey elevated 
susceptibility to DSS colitis 
In order to investigate which cells specifically mediate increased colitis susceptibility in 
AhRR-deficient mice, AhRRfl/fl mice were created, in which the third exon was flanked by 
loxP sites (Fig.3.1). Crossing mice expressing the Cre recombinase under the control of a cell 
type-specific promoter, results in a cell type-specific AhRR-knockout. Crossing the AhRRfl/fl 
mice with LysM-Cre mice, which express the Cre recombinase under the control of the 
lysozyme M promoter145, results in a mouse line deficient for the AhRR in macrophages and 
neutrophils. This line allows investigating the contribution of the AhRR in macrophages and 
neutrophils to enhanced susceptibility to colitis observed in the full AhRR knockout. 
AhRRfl/flLysM-Cre, AhRRE/E and WT mice were treated with 3% DSS in the drinking water 
for 7 days in order to induce colitis, followed by 5 days of normal drinking water to analyze 
the ability to recover from inflammation (Fig.5.6a). Over the course of the experiment the 
body weight of the mice was monitored. All mice showed weight loss from day four (100 
hours) onwards. Weight loss stopped in WT and AhRRfl/flLysM-Cre after changing to normal 
drinking water, demonstrating their ability to recover from the disease. However, AhRRE/E 
mice lost more weight and did not recover (Fig.5.6b). Determination of colon length after the 
12 days revealed a significant shortening of colons from all DSS-treated mice, compared to 
control WT mice just receiving water. However, no apparent genotype specific differences 
could be observed (Fig.5.6c).  
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Figure 5.6: Macrophage- and neutrophil-specific AhRR-deficiency does not convey elevated 
susceptibility to DSS colitis 
(a) WT, AhRRE/E and AhRRfl/fl LysM-Cre mice were treated with 3% DSS in the drinking water for 
seven days before returning to normal drinking water for five days. (b) Body weight changes were 
monitored over the course of the experiment. (c) Colon length was determined at the end of the 
experiment (day12). (d)/(e) Paraffin sections of colon tissue were stained with hematoxylin and eosin 
and the Histological score was determined as described in the Methods section. (f) CXCL1 and IL-6 
levels in serum were measured by ELISA. (g) LCN2 levels were determined in serum and stool lysate. 
Data is representative of at least three independent experiments, of which one is shown here (n=2-5 
mice). Results are given as mean +/– SEM and significance is determined by two-way ANOVA (b) 
corrected for multiple testing by the Dunnett’s method or ordinary one-way ANOVA corrected for 
multiple comparisons by the Bonferroni’s method (*p<0.05, **p<0.01, ***p<0.001). Significance is 
calculated in comparison to WT/H2O (c/e/f/g). These experiments were performed together 
L.Schlautmann. 
 
Paraffin sections of distal colon tissue of DSS-treated mice and WT mice just receiving water 
were stained with hematoxylin and eosin to visualize tissue morphology (Fig.5.6d). Colitis 
severity and tissue destruction was histologically scored as described in the methods section 
(4.2.5). All DSS-treated mice showed significantly elevated histological scores compared to 
untreated mice, but no differences between the different genotypes could be observed 
(Fig.5.6e).  
The cytokine profile in IBD is very complex and might have an important influence on 
disease severity. The cytokine IL-6, which is among others macrophage derived, as well as 
the chemokine CXCL1 have been shown to be highly upregulated in serum of DSS-treated 
mice162. IL-6 and CXCL1 were upregulated in DSS-treated mice, but there was no difference 
between WT, AhRRE/E and AhRRfl/flLysM-Cre mice (Fig.5.6f). Recent reports identified the 
small, mainly neutrophil-secreted protein Lipocalin-2 (LCN2) as a non-invasive biomarker 
for intestinal inflammation163. Concordantly, LCN2 was highly upregulated in serum and 
stool of mice treated with DSS (Fig.5.6g). About 1000-fold higher levels of LCN2 in serum 
and stool samples were detected compared to WT mice just receiving water, however, LCN2 
levels in WT, AhRRE/E and AhRRfl/flLysM-Cre mice treated with DSS were not different.  
In summary, AhRR-knockout mice showed signs of enhanced colitis susceptibility, indicated 
by increased weight loss. AhRRfl/flLysM-Cre mice did not show elevated susceptibility, as 
weight loss was similar to WT mice over the course of the experiment. Interestingly, apart 
from elevated weight loss, AhRRE/E mice did not show any signs of stronger disease 
development with regard to the examined parameters in this experimental setup. 
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Overall, the data shown in section 5.1 indicated that the mechanism of disease in AhRRE/E 
mice is different from AhR-/- mice. AhRRE/E showed no defect in intestinal ILC3s and only 
minor differences with regard to IEL frequency149. Instead, these mice seemed to have more 
IL-17-producing T cells under inflammatory conditions while the frequency of IFNγ 
producing cells was reduced. Further, AhRR-knockout mice showed elevated colonic IL-1β 
levels under homeostatic conditions and only minor differences in myeloid cell frequency. It 
was moreover shown that the cell type-specific deletion of the AhRR in LysM+ cells was not 
sufficient to recapitulate the colitis susceptibility of the full AhRR knockout. 
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5.2 Dietary AhR ligands drive AhRR expression in immune cells of barrier 
organs 
The AhRR is a protein with AhR suppressing functions that is strongly induced by the AhR as 
part of a negative feedback regulation mechanism105,164. AhR activation and target gene 
induction is dependent on binding of various AhR ligands, such as xenobiotics, environmental 
toxins, endogenous ligands derived from the tryptophan metabolism, bacterial pigments, or 
diet-derived substances118,123,165. Previous studies revealed a cell-type specific expression of 
the AhRR that is basically absent in AhR-deficient animals128. Hence, measurement of AhRR 
expression can be used to detect AhR activation. However, it is still elusive, which type of 
AhR ligands drives the high expression of the AhRR in barrier organs under physiological 
conditions.  
5.2.1 Oral antibiotic treatment does not influence intestinal AhRR expression 
Intestinal commensals or their metabolites are potential AhR ligands. In order to investigate 
the influence of these bacterial components on AhRR expression following AhR activation, 
AhRRE/+ mice were treated with antibiotic in the drinking water for 6 weeks. Oral antibiotic 
treatment reduces the commensal load and also changes the composition of intestinal 
microbes166,167. This was confirmed, since no bacteria could be cultured from fecal samples in 
thioglycolate culture medium or on Columbia blood agar plates (data not shown). T cells and 
myeloid cells were isolated from the colonic and small intestinal lamina propria and from the 
mLNs. Frequencies of AhRR-expressing cells were determined by flow cytometry as 
described previously (Fig.5.2/5.4). Furthermore, the AhRR mean fluorescent intensity (MFI) 
was determined for the analyzed immune cell subsets. Similar frequencies of CD4+ T cells, 
CD8+ T cells, DCs and macrophages expressed the AhRR in the SI (Fig.5.7a), colon 
(Fig.5.7b) and mLNs (Fig.5.7c) of antibiotic-treated mice and control mice receiving water 
only. Only the DC frequency in the colon was slightly increased in antibiotic-treated mice 
(Fig.5.7b). Likewise, no differences in MFI of the AhRR in intestinal T cells, DCs and 
macrophages could be observed comparing antibiotic-treated and control mice in one 
representative experiment (Fig.5.7a/b/c). 
Histological analysis of DAPI-stained cryosections from the colon and mLNs of AhRRE/+ 
mice treated with antibiotic revealed high numbers of AhRR expressing cells in these organs 
(Fig.5.7d/e). In line with the data obtained from flow cytometry, no differences in comparison 
to untreated mice were apparent.  
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Figure 5.7: Antibiotic treatment does not influence AhRR expression in intestinal tissue 
CD4+ T cells, CD8+ T cells, DC and MΦ were analyzed for frequency of AhRR+ cells and AhRR MFI 
in SI (a) and colon (b) of AhRRE/+ mice after four weeks of antibiotic treatment (Ampicillin 1g/l, 
Vancomycin 500mg/l, Ciprofloxacin 200mg/l, Imipenem 250mg/l, Metronidazole 1g/l in drinking 
water). (c) Frequency of AhRR+ DCs and mean AhRR expression in mLN of antibiotic-treated and 
control mice. AhRR expression was analyzed by histology in colon (d) and mLN (e) [scale bar = 
100µm]. Data is pooled from two independent experiments (n=4 mice) or exemplary shown for one of 
at least two independent experiments (MFI). Results are shown as mean +/– SEM and significance 
was determined by two-tailed student’s t-test corrected for multiple comparisons by the Holm-Sidak 
method (*p<0.05). 
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Overall, antibiotic treatment and the resultant changes of the intestinal commensals did not 
alter AhRR expression indicating that microbiota-derived AhR ligands did not influence 
AhRR expression in immune cells of the intestine. 
5.2.2 Food-derived AhR ligands enhance AhR target gene expression in the intestine 
Small lipophilic components in the diet can also be responsible for AhR activation in the 
intestine. The phytochemical indole-3-carbinol (I3C) has been shown to increase the 
expression of AhR target genes in the gastrointestinal tract165. Further, dietary tryptophan and 
tryptophan metabolites can be converted into the high affinity AhR ligand 6-
formylindolo[3,2-b]carbazole (FICZ), which has been shown to activate the AhR 
transcriptional program168. 
In order to investigate the role of diet-derived AhR ligands for AhR target gene expression 
and especially for AhRR expression, AhRRE/+ mice were fed with different diets either 
containing or lacking AhR ligands. Therefore, mice were fed with a purified diet (AIN-93G) 
that is formulated with a refined and restricted set of ingredients such as isolated proteins, 
sugar, vegetable oil and crude cellulose. Due to the lack of plant derived phytochemicals 
activating the AhR, this diet was termed ligand-reduced diet (LRD). The latter was 
additionally supplemented with the single AhR ligand precursor I3C, which is converted to 
the high affinity AhR ligands ICZ and DIM by the stomach acid, and fed to a second group of 
mice. Control mice received normal chow, a grain-based diet containing plant-derived 
phytochemicals and therefore potent AhR activators. 
Immune cells of the gastrointestinal tract were isolated and analyzed for expression of the 
AhRR by flow cytometry. Previous work in our group already showed128,149 that intestinal T 
cells, DCs and macrophages of mice fed with normal chow comprise a large proportion of 
AhRR-positive cells (Fig.5.8a). The highest frequencies of AhRR expressing cells could be 
detected in the lamina propria of the SI and colon. Further, DCs in the mLNs showed a high 
frequency of AhRR+ cells, while lower frequencies were observed in the PPs. Interestingly, 
mice that were fed with LRD for four weeks showed significantly lower frequencies of 
AhRR-positive immune cells in all organs. This effect could be observed in CD4+ and CD8+ 
T cells, DCs and macrophages. However, the reduction of AhRR+ cells was strongest for T 
cells in the colon and DCs in the mLNs (Fig.5.8a). Analysis of the MFI of the AhRR in the 
intestinal immune cell subsets revealed a clear reduction of AhRR expression in T cells, DCs 
and macrophages in all analyzed intestinal organs (Fig.5.8b). This reduction in AhRR 
expression was strongest in DCs of the colon and mLNs and macrophages of the colon 
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whereas decrease of AhRR expression was lower in CD4+ and CD8+ T cells, except for CD8+ 
T cells in the PPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Dietary AhR ligands drive expression of AhRR in 
intestinal immune cells 
AhRRE/+ mice were fed for four weeks from weaning onwards 
with normal chow, AhR ligand reduced diet (LRD) or LRD 
supplemented with indole-3-carbinol (LRD+I3C)(2g/kg). (a) 
Frequencies of AhRR expressing CD4+ T cells, CD8+ T cells, 
DCs and MΦ were determined in the lamina propria of SI and 
colon, in the PPs and in the mLNs. (b) AhRR MFI is shown for 
the same organs and cells as in (a). Data is pooled from at least 
two independent experiments (a) or shown from one 
representative experiment (b) (n=2-9 mice). Results are shown as 
mean +/– SEM and significance was determined by one-way 
ANOVA corrected for multiple comparisons by the Bonferroni’s 
method (*p<0.05, **p<0.01, ***p<0.001). 
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Interestingly, AhRRE/+ mice, which were fed with LRD supplemented with 2g/kg I3C 
(LRD+I3C), showed similar frequencies of AhRR-expressing immune cells as mice fed with 
normal chow (Fig.5.8a). DCs and macrophages in the SI lamina propria, CD8+ T cells in the 
PPs and CD4+ T cells in the colonic lamina propria showed even higher numbers of AhRR-
expressing cells as observed in normal chow fed animals. Only frequencies of CD8+ T cells in 
the SI were not restored by I3C supplementation. The MFI of the AhRR was similar in mice 
receiving the I3C supplemented diet compare to normal chow fed mice (Fig.5.8b). AhRR 
expression was even higher in DCs of the small intestinal lamina propria and mLNs, while 
slightly lower MFI values could be measured for DCs and macrophages in the colon. 
As a second AhR target gene, expression of cyp1a1 was analyzed by qPCR in the SI of WT 
and AhRRE/E mice either fed with LRD or LRD+I3C (Fig.5.9). cyp1a1 expression was low in 
mice fed with LRD, but was about 100fold upregulated in mice fed with LRD+I3C. This 
effect could be observed in WT animals as well as in mice deficient for AhRR (Fig.5.9). 
 
 
Figure 5.9: Dietary AhR ligands drive expression of 
cyp1a1 in intestinal tissue 
Relative expression of cyp1a1 was determined by RT-
PCR in SI tissue samples of WT and AhRRE/E mice fed 
with LRD or LRD+I3C for four weeks after weaning. 
Data is pooled from at least two independent 
experiments (n=2-9 mice). Results are shown as mean 
+/– SEM and significance was determined by two-tailed 
student’s t-test (**p<0.01, ***p<0.001). 
 
 
In summary, these experiments revealed that AhRR expression in gastrointestinal immune 
cells is highly dependent on dietary AhR ligands. Noteworthy, AhRR expression can be 
driven by a variety of ligands contained in the normal chow or by one discrete ligand 
precursor in LRD+I3C. Further, this effect could also be confirmed for a second AhR target 
gene cyp1a1, encoding a member of the cytochrome P450 superfamily of enzymes.  
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5.2.3 AhRR expression of dermal and epidermal immune cells is influenced by diet-
derived AhR ligands 
In addition to the gut, AhR activation by AhR ligands is also of great importance for 
homeostasis of skin cells and skin immunity95. Keratinocytes, fibroblasts, melanocytes, 
endothelial cells and immune cells like Langerhans cells and γδ T cells show expression of 
the AhR169. Recent experiments in our institute highlighted that especially Langerhans cells 
and γδ T cells of the epidermis and dermis show high expression of the AhRR (unpuplished 
data, P. Jäger). Therefore it was investigated, whether dietary AhR ligands are also capable to 
influence AhRR expression in the skin. 
As shown for the gastrointestinal immune cells, AhRR expression in mice on normal chow 
diet, LRD and LRD+I3C was investigated. In order to test the influence of dietary AhR 
ligands on AhRR expression in the skin, leukocytes were isolated from the epidermis and 
dermis of AhRRE/+ mice separately and analyzed by flow cytometry. Leukocytes were gated 
for single, CD45+, living cells (Fig.5.10a). γδ T cells in the epidermis were identified by high 
expression of the γδ T cell receptor (TCR), while Langerhans cells showed expression of 
MHCII and CD207 (langerin) (Fig.5.10b). Dermal γδ T cells were identified similar to the 
epidermis by high expression of the γδ TCR (Fig.5.10c). Epidermal and dermal immune cells 
were subsequently analyzed for the frequency of AhRR expressing cells (Fig.5.10d) as well as 
for the MFI of the AhRR.  
Analysis of AhRR expression on γδ T cells in epidermis and dermis showed that independent 
of the diet between 95% and 100% of these cells expressed the AhRR (Fig.5.10e). The MFI 
of the AhRR in γδ T cells was high in mice fed with normal chow, but was significantly 
reduced in mice fed with LRD for four weeks, although a residual AhRR expression could 
still be detected. In mice fed with LRD+I3C the MFI of the AhRR in γδ T cells was stronger 
than in mice fed with LRD and even significantly increased compared to control mice 
receiving normal chow (Fig.5.10f). This effect was similarly observed in epidermis and 
dermis of AhRRE/+ mice. 
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Figure 5.10: AhRR expression in the skin is influenced by dietary AhR ligands 
AhRRE/+ mice were fed with different diets (Normal chow, LRD, LRD+I3C) for four weeks from 
weaning onwards. Afterwards, single cell suspensions of epidermis and dermis were produced and 
analyzed for AhRR-expressing cells by flow cytometry. (a) Cells were gated for single CD45+ and 
living cells. In the epidermis (b) γδ T cells were distinguished from conventional T cells by expression 
of the γδ T cell receptor (TCR). LCs were identified by expression of MHCII and CD206 (langerin). 
(c) Dermal γδ T cells were identified similarly by high expression of the γδ TCR. (d) AhRR-
expressing cells were identified by expression of the EGFP reporter, exemplary shown for γδ T cells 
of the epidermis. (e) Frequency of AhRR-expressing epidermal γδ T cells and Langerhans cells as well 
as dermal γδ T cells was quantified. (f) Mean fluorescent intensity (MFI) of the AhRR in the analyzed 
cell subsets was determined. Data is pooled from two independent experiments (n=3-6 mice). Results 
are shown as mean +/– SEM and significance was determined by one-way ANOVA corrected for 
multiple comparisons by the Bonferroni’s method (*p<0.05, **p<0.01, ***p<0.001). 
 
About 90% of the Langerhans cells in normal chow fed mice were found to be AhRR-
positive. The frequency was reduced to about 60% in LRD fed mice and restored to 90% in 
mice receiving LRD+I3C (Fig.5.10e). Analysis of the AhRR MFI on Langerhans cells 
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revealed reduced AhRR expression under the influence of LRD and higher levels when 
feeding LRD+I3C compared to normal chow fed control mice (Fig.5.10f).  
Overall these experiments revealed that dietary AhR ligands also influence AhR target gene 
expression in immune cells of the skin, here demonstrated for the AhRR. However, changes 
in frequency and MFI were not as pronounced as in the gastrointestinal tract (Fig.5.8), 
suggesting that other sources of AhR ligands, next to the diet, drive AhR target gene 
expression in the skin.  
5.2.4 LRD, high fat diet and matched control diet reduce AhRR expression in lamina 
propria lymphocytes, mLN DCs and IELs 
Experimental and purified diets for laboratory rodents are extensively used to study all kinds 
of topics. Especially metabolic studies using high fat diets or western diets have gained 
interest over the last years, addressing common problems of the western society. Similar to 
the LRD these purified diets are composed of isolated proteins, carbohydrates, fats and fiber. 
Therefore, it is of common interest to investigate if high fat diet (HFD) and a matched control 
diet with reduced fat content (HFD ctrl) are similarly reduced in the content of AhR ligands, 
as shown for AIN 93G, and hence will alter AhR/AhRR signaling in the body. 
To answer the question whether these diets also lead to reduced AhR activation, immune cells 
of the intestine of AhRRE/+ mice were investigated for their frequency of AhRR+ cells and, 
additionally, the MFI of AhRR. Experiments were performed after feeding HFD and HFD ctrl 
for four weeks in direct comparison to the LRD and LRD+I3C used in the experiments of 
sections 5.2.2 and 5.2.3 (Fig.5.11). First, immune cells of the lamina propria were 
investigated, as previous experiments showed a huge influence of LRD on these cells 
(Fig.5.8). Overall the immune cells (T cells, DCs, macrophages) of SI and colon were 
similarly influenced by LRD and LRD+I3C as observed before. Frequency of AhRR+ cells 
and the MFI of AhRR were reduced under influence of LRD in SI (Fig.5.11a) and colon 
(Fig.5.11b). Furthermore, a strong enhancement of the expression of AhRR in LRD+I3C fed 
mice could be demonstrated here (Fig.5.11). However, frequencies of CD4+ and CD8+ T cells 
expressing the AhRR in the SI were similar in mice on normal chow and LRD. CD4+ and 
CD8+ T cells previously comprised 70 to 80% AhRR+ cells in normal chow fed mice, whereas 
only 10 to 20% expressed the AhRR after feeding LRD (Fig.5.11/Fig.5.8). While the 
proportion of AhRR+ cells was similar in LRD fed mice in these experiments, normal chow 
fed mice showed clearly reduced frequency of AhRR+ immune cells as previously observed.  
Results 
 
74 
Small intestinea
DC
0
20
40
60
80
M
0
20
40
60
80
CD8
0
20
40
60
CD4
0
10
20
30
40
50
DC
0
500
1000
1500
2000
M
0
2000
4000
6000
CD8
0
200
400
600
800
1000
CD4
0
200
400
600
800
colonb
DC
0
20
40
60
M
0
20
40
60
80
DC
0
500
1000
1500
2000
M
0
1000
2000
3000
4000
CD8
0
20
40
60
80
CD4
0
10
20
30
40
50
CD8
0
500
1000
1500
2000
CD4
0
200
400
600
%
 A
hR
R
+
%
 A
hR
R
+
%
 A
hR
R
+
%
 A
hR
R
+
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
%
 A
hR
R
+
%
 A
hR
R
+
%
 A
hR
R
+
%
 A
hR
R
+
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
M
FI
 [A
hR
R
]
*
**
*
* *
* *
***
*
****
*
** **
*
**
Normal Chow
LRD
LRD+I3C
HFD
HFD ctrl
 
Figure 5.11: HFD and HFD ctrl reduce AhRR expression in immune cells of the lamina propria  
AhRRE/+ mice were kept under different dietary conditions for four weeks. (a)/(b) DCs, MΦ, CD8+ T 
cells and CD4+ T cells were isolated from the lamina propria of SI and colon. Cells were analyzed for 
the frequency of AhRR+ cells and AhRR MFI via flow cytometry. Data is pooled from two 
independent experiments (n=3-5). Results are shown as mean +/– SEM and significance was analyzed 
by one-way ANOVA corrected for multiple comparisons by the Bonferroni’s method (*p<0.05, 
**p<0.01, ***p<0.001). LRD=ligand reduced diet, I3C=Indole-3-carbinol, HFD=high fat diet, HFD 
ctrl=HFD control, NC=normal chow 
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However, inductive effects of AhRR expression in LRD+I3C fed mice were as strong as 
observed before. Expression intensity (MFI) of the AhRR in LRD+I3C fed mice was even 
higher than in normal chow fed mice. Mice receiving HFD or HFD ctrl showed reduced 
frequencies of AhRR+ cells in all cell types analyzed and lower MFI of the AhRR compared 
to normal chow and LRD+I3C fed mice (Fig.5.11), indicating clearly reduced AhR ligand 
concentration in these diets. 
To check in more detail, whether HFD and HFD ctrl do not only influence AhRR expression 
in the lamina propria but also in the mLNs, DCs from mLNs were isolated and investigated 
for their AhRR expression in dependence of the different dietary conditions. In line with the 
observations made in the lamina propria, mLNs of mice fed with LRD, HFD and HFD ctrl 
had a significantly reduced frequency of AhRR+ DCs. DCs of mLNs of normal chow and 
LRD+I3C fed mice both displayed high frequencies of AhRR+ cells. The modification of 
AhRR expression by different diets was also reflected in the MFI indicating a reduction in the 
intensity of AhRR/EGFP expression per cell (Fig.5.12). 
 
Figure 5.12: AhRR expression in DCs of the mesenteric lymph nodes (mLNs) is reduced in HFD 
and HFD ctrl fed mice 
AhRRE/+ mice were kept under different dietary conditions for four weeks. DCs were isolated from the 
mLNs and analyzed for the frequency of AhRR-expressing cells and for the mean fluorescent intensity 
(MFI). Data is pooled from two independent experiments (n=3-5). Results are shown as mean +/– 
SEM and significance was analyzed by one-way ANOVA corrected for multiple comparisons by the 
Bonferroni’s method (*p<0.05, **p<0.01, ***p<0.001). LRD=ligand reduced diet, I3C=Indole-3-
carbinol, HFD=high fat diet, HFD ctrl=HFD control, NC=normal chow 
 
Besides lamina propria lymphocytes that did not show as strong differences in AhRR 
expression as seen in the previous experiments (Fig.5.8), AhRR expression of intraepithelial 
lymphocytes (IELs) was investigated. These cells are residing between the intestinal epithelial 
cells and are therefore the first immune cells in the gastrointestinal tract confronted with 
luminal antigens, including dietary products. Cells were isolated as described in the methods 
section and analyzed by flow cytometry. After setting a lymphocyte gate, CD45+ cells were 
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analyzed for viability. Different IEL subsets were identified by the expression of either the 
TCRγ/δ or the TCRβ chain. Both populations were subsequently divided into CD8αα- and 
CD8αβ-positive cells resulting in four main IEL populations that were further analyzed for 
proportion of AhRR+ cells as well as for the MFI of the AhRR (Fig.5.13). 
 
Figure 5.13: Gating strategy for intraepithelial lymphocytes (IELs)  
Leukocytes were gated in the FSC/SSC diagram. CD45-positive, living cells were divided into 
TCRγδ- or TCRβ-positive T cells. Each population was afterwards divided based on expression of 
CD8 (CD8αα+/CD8αβ+). The four IEL subsets (TCRγδ+CD8αα+, TCRγδ+CD8αβ+, TCRβ+CD8αα+, 
TCRβ+CD8αβ+) were analyzed for their expression of the AhRR, here shown exemplary for the two 
CD8αα+ IEL subsets. 
 
IELs were isolated from the SI and colon. As already shown in previous studies128, all IELs 
posses a high proportion of AhRR expressing cells in the SI and colon (Fig.5.14). TCRβ- and 
TCRγδ-expressing subsets contained about 80% to 90% of AhRR+ cells in the SI (Fig.5.14a, 
top panel) and between 40% and 70% in the colon (Fig.5.14b, top panel).  
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Figure 5.14: AhRR expression in intraepithelial lymphocytes (IELs) is reduced in HFD and HFD 
ctrl fed mice 
AhRRE/+ mice were kept under different dietary conditions for four weeks. IELs were isolated from 
the SI (a) and the colon (b) and analyzed by flow cytometry for AhRR expressing cells as well as the 
MFI of AhRR (gated according to Fig.5.13). Data is pooled from two independent experiments (n=5). 
Results are shown as mean +/– SEM and significance was analyzed by one-way ANOVA corrected 
for multiple comparisons by the Bonferroni’s method (*p<0.05, **p<0.01, ***p<0.001). LRD=ligand 
reduced diet, I3C=Indole-3-carbinol, HFD=high fat diet, HFD ctrl=HFD control, NC=normal chow 
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As already observed in previous experiments for lamina propria and mLNs, mice fed with 
LRD showed severely reduced frequencies of AhRR+ cells, whereas percentages of AhRR+ 
cells were comparable high between mice on normal chow and LRD+I3C. Interestingly, 
frequencies of AhRR+ cells in AhRRE/+ animals fed with HFD or HFD ctrl, were similarly 
reduced as in mice on LRD. In line, also the intensity of AhRR expression (MFI) was 
similarly reduced in IELs of mice fed the LRD, HFD or HFD ctrl (Fig.5.14a/b, lower panel). 
Further, IELs from normal chow or LRD+I3C fed animals showed a consistently high MFI 
for AhRR, which was different from the unusual low AhRR expression of lamina propria 
immune cells from normal chow fed mice (Fig.5.11). These observations could be 
additionally made in both SI and colon. 
In summary, feeding of both, HFD and HFD ctrl leads to reduced frequencies of AhRR+ 
immune cells in the lamina propria, mLNs and IELs, indicating that these diets influence AhR 
signaling in vivo. This effect was overall slightly stronger in mLNs and in IELs in comparison 
to cells of the lamina propria. In line with previous experiments it could be shown that dietary 
AhR ligands have a profound effect on the MFI of the AhRR in immune cells of the 
gastrointestinal tract, in addition to reducing the frequency of AhRR expressing cells. 
5.2.5 Histological analysis of AhRR expression in colon and skin 
In addition to flow cytometric analysis, the influence of the different dietary conditions (NC, 
LRD, LRD+I3C, HFD, HFD ctrl) on AhRR expression was also investigated histologically. 
Cryosections of PFA-fixed colon and skin tissue samples were counterstained with DAPI. 
AhRR-expressing cells were identified by EGFP reporter expression in AhRRE/+ mice. 
AhRR/EGFP-positive cells could be readily detected in the colon of mice on normal chow 
and LRD+I3C (Fig.5.15a). However, expression of the EGFP reporter was strongly reduced 
in mice fed with LRD, HFD or HFD ctrl. In contrast, EGFP-expressing cells were equally 
detected in the skin of all five groups (Fig.5.15b). A slightly stronger AhRR/EGFP expression 
was detected in histological skin samples from mice fed with LRD+I3C. 
In summary, these experiments illustrated that purified diets are reduced in AhR ligands and 
therefore lead to reduced expression of AhR target genes, here shown for the AhRR in 
immune cells of the gastrointestinal tract and skin. These experiments further underlined the 
crucial role of dietary AhR ligands for AhR target gene expression and suggest that low AhR 
ligand concentration in HFD and HFD ctrl might have a general influence in studies using 
these diets. 
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Figure 5.15: Histological analysis of AhRR expression in colon and skin of mice under different 
dietary conditions 
AhRRE/+ mice were fed with different diets (NC, LRD, LRD+I3C, HFD, HFD ctrl) for four weeks 
from weaning onwards. After PFA fixation, cryosections of the colon (a) and the skin (b) were stained 
with DAPI in addition to the endogenous EGFP reporter. Pictures are representative of at least three 
different mice from at least two independent experiments. LRD=ligand reduced diet, I3C=Indole-3-
carbinol, HFD=high fat diet, HFD ctrl=HFD control, NC=normal chow, DAPI= 4′,6-Diamidin-2-
phenylindol 
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5.2.6 AhR ligand reduced diet leads to higher intestinal permeability and higher 
susceptibility to DSS-induced colitis 
The previous section highlighted that dietary AhR ligands have a profound influence on AhR 
activation and subsequent target gene expression. It has further been shown that the AhR and 
its activation is of great importance for functional gut immunity119. Another study 
demonstrated increased susceptibility for DSS colitis as a consequence of a reduction of 
dietary AhR ligands121. In this context, it is obvious to speculate that HFD and HFD ctrl 
might have similar consequences for the function of the intestinal immune system. 
In order to investigate the integrity of the intestinal barrier under the influence of different 
diets containing or lacking AhR ligands, an intestinal permeability assay was performed. 
After feeding WT mice and AhRR-deficient mice with one of the five different diets for four 
weeks, intestinal permeability was assessed by oral application of FITC-dextran and 
measurement of the amount of FITC-dextran transmitted to the circulation. All mice that 
received FITC-dextran via oral gavage showed FITC fluorescence in the serum. This 
fluorescence was higher than background fluorescence in serum of mice that did not receive 
any FITC-dextran (Fig.5.16a) indicating transmission FITC-Dextran from the gut lumen to 
the serum. However, only mice that were fed with LRD showed significantly elevated FITC 
fluorescence compared to normal chow fed mice. Mice on LRD+I3C, HFD or HFD ctrl did 
not show increased intestinal permeability compared to normal chow fed mice. This 
observation could be made for WT mice as well as AhRR-knockout mice.  
In order to investigate, if lack of dietary AhR ligands possibly influences the intestinal 
immune system and intestinal barrier under inflammatory conditions, C57BL/6 mice were fed 
with one of the five experimental diets for four weeks before treating them with 2% DSS in 
the drinking water for seven days, followed by five days of normal drinking water. Body 
weight changes over the course of the experiment were monitored in order to evaluate 
differences in colitis susceptibility. All mice lost weight from day three onwards, however, 
weight loss of mice on LRD was significantly higher in this initial phase of the colitis 
(Fig.5.16b). Over the course of the experiment the LRD group continued to lose more weight 
than the normal chow control group, finally resulting in an earlier exclusion of these animals 
from the experiment at day six. Mice on normal chow, HFD and LRD+I3C showed similar 
weight loss during DSS administration, however, the LRD+I3C group did not recover from 
colitis after changing to normal drinking water. These mice were consequently removed from 
the experiment at day ten.  
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Figure 5.16: Dietary AhR ligands influence the intestinal barrier integrity and susceptibility to 
DSS-induced colitis 
C57BL/6 and AhRRE/E mice were fed with different diets (NC, LRD, LRD+I3C, HFD, HFD ctrl) for 
four weeks. (a) Mice were fasted for four hours, orally gavaged with 600mg/kg FITC-dextran and four 
hours later FITC fluorescence in the serum was determined. (b) C57BL/6 mice were fed with different 
diets for four weeks and afterwards treated with 2% Dextran sodium sulfate (DSS) via the drinking 
water for seven days, followed by five days normal drinking water. Body weight was monitored over 
the course of the experiment. (c) C57BL/6 mice were treated for five days with 3% DSS and colon 
length was compared to WT mice just receiving water. Data is pooled from two independent 
experiments (n=2-9). Results are shown as mean +/– SEM and significance was analyzed by one-way 
ANOVA corrected for multiple comparisons by the Bonferroni’s method (a, c) or by ordinary two-
way ANOVA corrected for multiple comparisons by the Dunneet’s method (b) (*p<0.05, **p<0.01, 
***p<0.001). LRD=ligand reduced diet, I3C=Indole-3-carbinol, HFD=high fat diet, HFD ctrl=HFD 
control NC=normal chow 
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Interestingly, mice that were fed with HFD ctrl showed just mild colitis symptoms, indicated 
by minimal weight loss. In addition these mice showed complete recovery of body weight by 
the end of the experiment.  
In order to further investigate, if besides changes in body weight and overall appearance 
during colitis, often referred to as disease activity index (DAI) (not shown), other differences 
in colitis susceptibility can be observed between mice fed the different diets, animals were 
treated with 3% DSS for five days in order to establish a severe inflammation. Colon length 
was measured at day five and compared to control animals that did not receive DSS. All DSS-
treated mice showed highly significant differences in colon length compared to untreated 
control mice. Only LRD fed mice exhibited significant shorter colons compared to DSS-
treated normal chow fed animals (Fig.5.16c), whereas this was not observed for the groups 
fed with LRD+I3C, HFD, or HFD ctrl. 
In summary, these experiments confirmed previous studies indicating intestinal barrier defects 
and increased colitis susceptibility of mice fed with diet poor in AhR ligands. Intriguingly, 
neither a barrier defect nor increased colitis pathology was observed for mice fed with HFD 
or HFD ctrl, although previous experiments identified these diets as poorly activating the 
AhR. Interestingly, HFD ctrl even conferred a notable protection from DSS colitis. 
5.2.7 Reduced dietary AhR ligands lead to altered cytokine production in DSS colitis 
In order to understand the mechanisms responsible for the different disease outcome in mice 
fed with distinct diets, further analyses were conducted. To investigate the inflammatory 
response in colitis, myeloperoxidase (MPO) activity and fecal or serum Lipocalin-2 (LCN2) 
content were determined as surrogate markers163,170. Further, it was shown that disease 
severity is correlated with higher levels of proinflammatory cytokines in the serum, such as 
IL-6 or Il-1β 162.  
MPO activity in colon tissue and LCN2 content in stool and serum after five days of acute 3% 
DSS colitis were compared to healthy control WT mice. All mice showed significantly 
upregulated MPO activity after treatment with DSS compared to control mice (Fig.5.17a). 
This effect appeared to be independent of dietary conditions. Also fecal and serum levels of 
LCN2 were elevated in mice treated with DSS, compared to untreated control mice 
(Fig.5.17b). Interestingly, these measurements revealed small differences between mice on 
different dietary conditions. While mice fed with HFD showed the highest levels of LCN2 in 
stool and serum, HFD ctrl fed mice had the lowest levels of LCN2. The amount of LCN2 was 
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relatively similar in stool and serum of LRD and LRD+I3C fed mice. These values were 
slightly decreased in stool and increased in serum compared to normal chow fed mice. 
Taken together LCN2 and MPO proved to be valid surrogate markers to detect intestinal 
inflammation, however, no major differences could be detected between the groups fed with 
different diets. HFD fed mice showed the highest LCN2 levels despite not showing the 
strongest inflammatory reaction after DSS application. In contrast, low levels of LCN2 in 
HFD ctrl fed mice correlated with the reduced susceptibility of these mice to colitis as 
indicated by lesser weight loss. 
 
 
Figure 5.17: Influence of dietary AhR ligands on MPO activity and Lipocalin-2 (LCN2) levels  
C57BL/6 mice were fed with different diets (NC, LRD, LRD+I3C, HFD, HFD ctrl) for four weeks 
and afterwards treated with 3% DSS in the drinking water for five days. (a) Myeloperoxidase (MPO) 
activity is measured in the colonic tissue of DSS treated mice and untreated control mice. (b) LCN2 
levels were measured in stool lysates and serum of DSS-treated mice under different dietary 
conditions and untreated control mice. Data is pooled from two independent experiments (n=3-9). 
Results are shown as mean +/– SEM and significance was analyzed by ordinary one-way ANOVA and 
two-tailed students t-test. LRD=ligand reduced diet, I3C=Indole-3-carbinol, HFD=high fat diet, HFD 
ctrl=HFD control, NC=normal chow 
 
To answer the question if quantitative differences in cytokine production might be associated 
with differential disease progression, protein lysates of colonic tissue after five days of 3% 
DSS colitis were analyzed for their cytokine profile. Disregarding some outliers, nearly all 
mice showed elevated cytokines levels in the colonic tissue after DSS treatment compared to 
untreated mice (Fig.5.18). This observation was consistent for IL-22, IL-17, CXCL1, IL-6 and 
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IL-1β. However, the degree of induction of certain cytokines varied selectively between the 
different dietary conditions. Mice on LRD showed only very low levels of IL-22 in the colon 
tissue. Mice on LRD+I3C, HFD and HFD ctrl had higher levels, despite not reaching the IL-
22 levels of normal chow fed mice. IL-17 upregulation after colitis was strongest in LRD, 
LRD+I3C and HFD fed mice. CXCL1, IL-6 and IL-1β levels were regulated in a similar 
fashion: normal chow fed mice showed the highest levels of these cytokines, whereas animals 
on LRD and LRD+I3C had a markedly decreased colonic cytokine content. The degree of 
cytokine production of HFD and HFD ctrl fed mice was in between the aforementioned 
groups. 
 
 
 
 
 
 
 
 
Figure 5.18: Influence of dietary AhR ligands on cytokine 
production in DSS colitis 
C57BL/6 mice were fed with different diets (NC, LRD, LRD+I3C, 
HFD, HFD ctrl) for four weeks and afterwards treated with 3% DSS 
in the drinking water for five days. Protein lysates of colonic tissue 
were analyzed for IL-22, IL-17, CXCL1, IL-6 and IL-1β. Data is 
pooled from two independent experiments (n=3-9). Results are shown 
as mean +/– SEM and significance was analyzed by ordinary one-way 
ANOVA. LRD=ligand reduced diet, I3C=Indole-3-carbinol, 
HFD=high fat diet, HFD ctrl=HFD control, NC=normal chow 
 
 
Overall only one clear correlation between proinflammatory cytokine production and disease 
outcome was observed. Thus, LRD fed mice displayed very low levels of the barrier 
beneficial cytokine IL-22, providing a possible explanation for the high susceptibility of these 
mice to DSS colitis.  
Overall, these experiments demonstrated that expression of the AhRR and presumably also of 
other AhR target genes is largely driven by diet-derived AhR ligands. This was shown for 
intestinal immune cells and to a lesser extent also for immune cells in the skin. Further, it was 
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demonstrated that the single AhR ligand precursor I3C has the same if not a bigger potential 
in inducing AhR target genes than a variety of AhR ligands contained in the normal chow, 
although an AhR ligand dose effect cannot be ruled out. Changes in the intestinal microbiota 
had negligible effects on AhRR expression. Interestingly, also HFD and HFD ctrl exhibited 
low AhR activation, indicating a low content of AhR ligands in these diets. Nevertheless, only 
LRD affected intestinal barrier permeability and evoked high susceptibility to DSS colitis, 
possibly due to the presence of other barrier protective substances in HFD and HFD ctrl. 
Apart from a significant difference in the serum LCN2 levels after DSS treatment, there was 
no major difference in cytokine production comparing HFD and HFD ctrl. 
5.2.8 Dietary AhR ligands change the composition of the intestinal microbiota 
The composition of the gut microbiota has been shown to vary considerably depending on 
various factors, including the diet84. Recently, certain bacterial strains have been shown to 
have a big impact on DSS colitis susceptibility in mice171. In order to investigate if different 
dietary conditions and specifically dietary AhR ligands influence the intestinal gut microbiota 
and might explain different colitis susceptibilities the composition of the gut microbiota was 
determined by 16S ribosomal DNA sequencing. These experiments were performed in 
cooperation with the group of Haruko Takeyama from the TWIns Institute of the Waseda 
University in Tokyo. 
The Ribosomal Database Project (RDP) Classifier is used to accurately classify 16S rDNA 
sequences into higher-order taxonomy. Comparison of different bacterial phyla present in WT 
mice receiving different diets revealed major differences between the groups (Fig.5.19a). 
Normal chow fed mice possessed around 80% Bacteroidetes, 15% of Firmicutes and a small 
population of Proteobacteria. LRD fed mice showed expansion of Proteobacteria and a 
reduced frequency of Firmicutes. Supplementation of I3C expanded Firmicutes at the cost of 
Proteobacteria and Bacteroidetes. HDF fed mice had a huge expansion of Firmicutes (60%), 
a smaller population of Bacteroidetes (30%) and only few Proteobacteria. Mice on HFD ctrl 
had around 40% to 50% Bacteroidetes, 30% to 40% Firmicutes and around 10% 
Proteobacteria (Fig.5.19a). 
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Figure 5.19: Different dietary conditions influence the intestinal microbiome composition  
C57BL/6 mice were fed with different diets (NC, LRD, LRD+I3C, HFD, HFD ctrl) for four weeks. 
Stool samples were collected and genomic DNA was isolated. Bacterial 16S ribosomal DNA was PCR 
amplified and sequenced by Illumina MiSeq. Gut microbiome composition prediction was performed 
with the RDP-Classifier tool. (a) Relative abundance of bacterial phyla in C57BL/6 mice after feeding 
different diets for four weeks. (b) Relative abundance of bacterial families is shown for C57BL/6 
mice. NC=normal chow, LRD=ligand reduced diet, I3C=Indole-3-carbinol, HFD=high fat diet, HFD 
ctrl=HFD control 
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Additionally, frequencies of bacterial families constituting the bacterial phyla were 
determined. Analysis of relative abundance of bacterial families revealed distinct differences 
between mice receiving different diets, while mice on the same diet had a similar microbial 
composition (Fig.5.19b). Normal chow fed animals had the biggest population of the 
Bacteriodales S24-7 group and a high representation of Rikenellaceae, both belonging to the 
Bacteroidetes. In addition, all normal chow fed mice had an expanded population of 
Lachnospiraceae, belonging to the Firmicutes phylum.  
Mice on LRD had a big population of Porphyromonadaceae (Bacteroidetes). Moreover, LRD 
led to an expansion of Bacteroidaceae (Bacteroidetes), Enterobacteriaceae (Proteobacteria) 
and additionally Desulfovibrionaceae (Proteobacteira). Enterobacteriaceae were reduced in 
mice on LRD+I3C, but Ruminococcaceae (Firmicutes) and Lachnospiraceae (Firmicutes) 
were expanded compared to mice on LRD. Further, also Desulfovibrionaceae (Proteobacteira) 
were expanded by I3C supplementation (Fig.5.19b).  
Mice on HFD and HFD ctrl showed a relative similar microbial composition on family level. 
All of these mice had big populations of Lachnospiraceae, Ruminococcaceae and 
Rikenellaceae. Frequency of Porphyromonadaceae was clearly reduced in comparison to 
LRD and LRD+I3C fed mice while the frequency of Desulfovibrionaceae was similar in 
LRD+I3C, HFD and HFD ctrl fed mice (Fig.5.19b). 
Since dietary AhR ligands had a big influence on microbial composition in the intestine, 
relative abundance of bacterial families was compared between WT mice and AhRR-deficient 
mice (AhRRE/E) in order to investigate, if presence of the AhRR has an influence on microbial 
composition. WT and AhRRE/E mice were compared under the influence of normal chow, 
LRD and LRD+I3C (Fig.5.20, Fig.5.21). No big differences in microbial composition were 
observed between WT and AhRRE/E mice fed mice receiving normal chow, LRD or LRD+I3C 
(Fig.5.20). Nevertheless, some small differences with regard to the appearance of bacterial 
families were observed comparing WT and AhRRE/E mice. Analysis of relative abundance of 
bacterial families in LRD fed mice revealed presence of Prevotellaceae in some of the 
AhRRE/E mice on LRD, which could not be observed in LRD fed WT mice. Interestingly, 
Prevotellaceae could be detected in LRD+I3C fed mice, independent of the genotype 
(Fig.5.20). 
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Figure 5.20: Dependence of the intestinal 
commensal composition on the AhRR  
C57BL/6 mice and AhRRE/E mice were fed with 
different diets (NC, LRD, LRD+I3C) for four 
weeks. Stool samples were collected and 
genomic DNA was isolated. Bacterial 16S 
ribosomal DNA was PCR amplified and 
sequenced by Illumina MiSeq. Gut microbiome 
composition prediction on was performed with 
the RDP-Classifier tool and relative abundance 
of bacterial families is shown for C57BL/6 and 
AhRRE/E mice. NC=normal chow, LRD=ligand 
reduced diet, I3C=Indole-3-carbinol 
 
 
The general similarity between WT and AhRRE/E mice was also reflected by principle 
component analysis (PCA) of weighted and unweighted UniFrac distance analysis. The 
analysis revealed one coherent population of mice receiving normal chow diet that was 
clearly distinct from mice receiving LRD or LRD+I3C (Fig.5.21). No genotype specific 
clustering could be observed using the PCA of UniFrac distance analysis. LRD fed mice were 
slightly more scattered in the PC analysis indicating a generally higher diversity between 
individual mice, but also no clear genetic differences in microbial composition (Fig.5.21). 
Mice on LRD+I3C showed a clearly different microbial composition from normal chow or 
LRD fed mice, but also no genotype specific clustering (Fig.5.21).  
Results    
 
89
 
Figure 5.21: Dietary AhR ligands change the overall intestinal microbiota composition  
C57BL/6 and AhRRE/E mice were fed with different diets (NC, LRD, LRD+I3C, HFD, HFD ctrl) for 
four weeks. Bacterial 16S rDNA was PCR amplified from stool samples and sequenced by Illumina 
MiSeq. Weighted and unweighted UniFrac distance analysis was used to determine differences in 
composition of the microbiota between mice on different diets. Principle component analysis of 
UniFrac distances was plotted for the indicated genotypes and diets. 
 
In summary, this analysis revealed that dietary conditions severely change the microbiota of 
mice. Dietary AhR ligands but also other substances regulate these changes. However, only 
minor differences between WT and AhRR-deficient mice could be detected, suggesting that 
the AhRR does not impair the composition of the intestinal microbiota. 
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6 Discussion 
The AhR has been extensively studied in the field of toxicology as an environmental sensor, 
as a receptor for xenobiotics and for its role in the detoxification of chemicals. More recently, 
the AhR has gained increasing interest in the field of immunology, since it is involved in 
mediating TCDD-induced immunosuppresion172. Expression of the AhR is widespread in 
cells of the immune system and particularly high in different cell types of barrier organs110, in 
line with its main function as environmental sensor. In the gut mucosa the AhR has been 
shown to be essential as a transcription factor for maintaining IEL and ILC populations123. 
Mutations in the AhR have been further identified as a risk factor for IBD143. Moreover, 
different studies have shown that AhR-deficient mice are highly susceptible to colitis, largely 
as a consequence of the loss of IELs and ILCs48,120,121.  
The activity of the AhR is regulated by a negative feedback loop through the AhRR, which is 
a direct target gene of the AhR. In this thesis, the functional importance of the AhRR in the 
gut immune system was investigated. In the second part of the thesis the activation of the 
AhR by dietary AhR ligands and subsequent AhRR expression was examined. In addition, the 
functional importance of dietary AhR ligands for the intestinal immune system and the 
intestinal microbiota was investigated. 
6.1 Regulation of gut immunity through the AhRR in homeostasis and in DSS-
induced colitis 
Studies in our group revealed that mice deficient for the AhRR (AhRRE/E mice) are more 
susceptible to DSS colitis than wild-type littermates149. This was somewhat surprising, since 
other studies already showed increased colitis susceptibility of AhR-deficient mice119,120. 
Hence, it is important to study why AhR and AhRR do not act anatgonistically and how both 
molecules contribute to intestinal barrier maintenance. Extensive research on the AhR and its 
role for the immune system showed that AhR-deficient mice are highly susceptible to DSS 
colitis due to an impaired maintenance of IELs and ILC3s121,173. Previous experiments by Dr. 
O. Brandstätter revealed that the presence of IELs in the intestine of AhRR-deficient mice 
was only moderately affected in comparison to AhR-deficient mice121,149. Only a relatively 
small reduction of colonic CD8α+TCRγδ+ IELs was apparent in AhRRE/E mice which might 
partially contribute to the DSS colitis susceptibility of these mice. Further experiments 
showed that AhRRE/E mice had no elevated barrier permeability and no apparent changes in 
microbiota diversity, which could have additionally explained enhanced DSS colitis 
susceptibility. In addition, AhRRE/E mice showed reduced fecal IgA titers but elevated serum 
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IgA titers, indicative of a disturbed IgA production or defective migration of IgA-producing B 
cells, which might contribute to elevated colitis susceptibility149. However, it is not clear 
whether these collective findings alone explain the increased colitis susceptibility of AhRRE/E 
mice. 
6.1.1 AhRRE/E mice do not exhibit reduced ILC3 frequency in the gut 
Besides affecting the survival of ILC3s, lack of AhR signaling additionally impairs IL-22 
production by ILC3s and Th17 cells in the intestine123,174. IL-22 has been described to be of 
great importance in the pathology of intestinal diseases, inhibiting inflammation and 
protecting the barrier against pathogens175.  
In the present work, reduced frequencies of NKp46+ and NKp46– ILC3s could be confirmed 
in AhR knockout mice, however to a lesser extend as has been described previously122. In 
contrast, a normal presence of these cells was shown in the SI of AhRRE/E mice, suggesting a 
normal functionality of intestinal ILC3s in these mice. Indeed, resistance of AhRRE/E mice to 
infection with Citrobacter Rodentium has been shown, further supporting normal ILC3 
function128. Therefore, a role for ILC3s in the susceptibility of AhRRE/E mice to DSS colitis 
seems rather unlikely. In line with the high AhR expression by ILC3s174,176, these cells also 
comprised a high proportion of AhRR positive cells, as a direct target gene of the AhR. 
Around 80% of the NKp46+ ILC3s expressed the AhRR/EGFP reporter under homeostatic 
conditions. Interestingly, just 20% of the NKp46– ILC3s expressed the AhRR indicating less 
AhR activation or expression in this cell population. Notably, in these experiments, only a 
slight reduction of the NKp46– ILC3 subset in AhR-/- mice was apparent. Therefore, 
maintenance of ILC3s seems to be only partially dependent on AhR signaling. In this context, 
it is interesting to mention that Qiu et al, who initially described the loss of RORγt+ILC3s in 
AhR-/- mice, observed residual lineage negative cells expressing RORγt in AhR-/- mice, 
presumably ILC3s119. It would hence be interesting to investigate the role of other 
transcriptional programs or molecules important for ILC maintenance in this context. In fact, 
besides AhR-/- mice, animals deficient for RORγt, CXCR6 or Rag2 and IL-2R show reduced 
ILC populations177-179. Incomplete loss of intestinal ILC3s might also be explained by a 
different intestinal microbiota. Reduced numbers of NKp46+ ILC3s in germ-free or antibiotic-
treated mice indicated an effect of the microbiota on ILC development or survival74,177. These 
findings highlight the complex regulation of ILC survival after birth, presumably involving 
more signals than just the AhR pathway. 
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Since number of colonic IELs were just slightly reduced and small intestinal ILC3 
frequencies were unchanged in AhRRE/E one might suggest that these cells are not critically 
involved in the elevated colitis susceptibility. However, previous studies showed that 
defective AhR signaling not only leads to loss of these cells but also to impaired functionality. 
Thus, additional analysis investigating ILC3 functionality, such as IL-22 and IL-17 
production, is necessary to completely rule out a role of these cells. 
6.1.2 AhRR-deficiency affects T helper cell differentiation in DSS colitis 
The intestinal immune system has to respond to dangerous substances and infectious threats 
while remaining unresponsive to harmless food antigens or the commensal microbiota1. 
Likewise also T cells are either able to maintain immune tolerance in the gut mucosa or play a 
key role in the pathogenesis of IBD38. Unlike human disease, DSS colitis does not necessarily 
require T and B cells for development and has a bigger contribution of the innate immune 
system180. Nonetheless, T cells are still involved in the colitis pathology. Due to this reason 
the differentiation status of T cells during colitis was analyzed. Considering that Th17 cells 
and IL-22 production by Th17 and Th22 cells are regulated by AhR-activation123, an 
involvement of AhRR in regulating the function and development of T cells is plausible. 
Analysis of the frequency of Th17, Th1, Tc17 and Tc1 cells in DSS colitis revealed that lack 
of the AhRR caused an enhanced differentiation of Th17 and Tc17 cells, whereas the 
frequency of the IFNγ-producing Th1 and Tc1 cells was reduced. While more Th17 cells 
could also be observed in AhR-/- mice, the increased frequency of Tc17 cells was exclusive for 
AhRRE/E mice. It has been previously shown that the AhR regulates Treg and Th17 
differentiation in a ligand-dependent fashion152. Application of FCIZ has been shown to boost 
the differentiation of Th17 cells in in vitro studies as well as in an in vivo model of 
experimental autoimmune encephalomyelitis (EAE)181. Stronger AhR signaling in the absence 
of the AhRR might therefore lead to augmented intestinal Th17 cell differentiation and 
consequentially to a reduced frequency of other T helper cell subsets. As Th17 cells have 
been shown to infiltrate the inflamed gastrointestinal mucosa of CD and UC patients and 
produce an excess of Th17 related cytokines182, the elevated frequency of Th17 and Tc17 
cells in AhRR-deficient mice might be responsible for the stronger colitis. However, also 
protective effects of Th17 cytokines in colitis have been described. Blocking of IL-17A by 
antibody or genetic ablation exacerbates colitis symptoms, indicative of a protective effect of 
IL-17A183. Furthermore, the Th17-derived cytokine IL-22 has been attributed with tissue 
protective functions, indicating that Th17 cells might have a dual role. This phenomenon has 
also emerged as a general concept in Th17 cell biology, since it could be shown that exposure 
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to IL-23 confers pathogenic properties to Th17 cells, whereas absence of IL-23 results in 
induction of an inhibitory module in Th17 cells184. 
In vitro T cell differentiation studies performed by Dr. J. König could not show differences in 
Th17 and Th1 differentiation comparing WT and AhRRE/E mice128, indicating that altered T 
cell differentiation in vivo is not T cell intrinsic. Therefore, we speculate that the intestinal 
microenvironment during DSS colitis might be changed in the absence of the AhRR and 
subsequently drive Th17/Tc17 cell differentiation. It has been shown that IL-6, TGFβ and IL-
1β produced by antigen presenting cells, in particular monocytes and cDCs, promote 
polarization of naïve CD4+ T cells into Th17 cells182. Indeed, assessment of the intestinal 
cytokine milieu in WT and AhRRE/E mice under homeostatic conditions and in DSS colitis 
revealed significantly higher IL-1β levels in untreated AhRRE/E mice, potentially contributing 
to the elevated frequency of Th17 cells observed in AhRRE/E mice during colitis. High IL-1β 
concentrations might facilitate the Th17/Tc17 differentiation early in the inflammation and 
therefore eventually result in more IL-17 producing effector T cells in colitis, although IL-1β 
levels were not significantly enhanced at day six. Mechanistically, it has been shown that IL-
1β inhibits TGF-β-induced Foxp3 expression and additionally augments expression of the 
Th17 cell-specific transcription factors NFKBIZ and BATF185. In addition the AhR is able to 
regulate the balance of Treg and Th17 cell differentiation in a ligand dependent-fashion152. 
Therefore it might be possible that the enhanced Th17 cell frequency influences Treg 
numbers in AhRRE/E mice. However, experiments performed by Dr. O. Brandstätter showed 
no differences in Treg frequencies between AhRRE/E and WT mice in inflammation and under 
homeostatic conditions149. This argues against a misbalance in Th17/Tc17–Treg 
differentiation as an explanation for the elevated frequency of IL-17-producing T cells in 
AhRRE/E mice. 
Tc17 cells have received only marginal attention, as they are a relative newly defined subset 
of CD8+ T cells. In the current understanding, IL-6 and TGFβ together with activators of 
STAT3 and RORγt are necessary for the differentiation of Tc17 cells186. In humans, also the 
combination of IL-1β and IL-23 has been shown to induce the production of IL-17 in 
circulating CD8+ T cells187. Therefore, it cannot be ruled out that IL-1β is important for the 
induction of Tc17 cells in mice as additional cytokine requirements for Tc17 cells in general 
appear to be similar to Th17 cells188. 
Intestinal tissue macrophages are potent producers of IL-1β, especially under inflammatory 
conditions, thus driving local differentiation but also expansion of Th17 cells62,189,190. 
Therefore, macrophages might be involved in driving Th17/Tc17-biased T cell differentiation 
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in AhRRE/E mice. In addition, also DCs are of importance in inducing Th17 responses in the 
intestine. Intestinal DCs are discriminated from macrophages by the lack of CD64 and F4/80 
expression and are subdivided into four populations based on their expression of CD103 and 
CD11b51. To investigate the influence of these antigen-presenting cells on T cell 
differentiation, the frequencies of DCs and macrophages in the different compartments of the 
intestine were analyzed. However, no differences in macrophage frequencies in colon and SI 
were observed, indicating that the elevated IL-1β levels in AhRRE/E mice cannot be attributed 
to increased macrophage frequency. Therefore, it is likely that AhRR-deficient macrophages 
produce more IL-1β or that the absolute number of intestinal leukocytes is elevated, as the 
frequency of macrophages was unchanged. This has to be analyzed in more detail in future 
experiments.  
AhRR-deficient mice showed elevated overall DC frequencies in the SI, whereas DC 
frequencies in the mLNs were reduced. This might hint at a migratory defect in AhRRE/E 
mice, preventing DCs from leaving the lamina propria to enter the mLNs191. Again these data 
do not give information about absolute cell numbers in the lamina propria and mLNs. Of note, 
the increased frequency of DCs in the SI correlated with the strongest Th17 and especially 
Tc17 induction in the SI, suggesting that DCs also have a local influence on T cell 
differentiation processes in the small intestinal lamina propria. DC subsets differ to some 
extent with regard to their ability to prime and polarize naïve CD4+ and CD8+ T cells. 
Especially CD103+CD11b+ DCs are potent Th17 inducers192,193. In addition, also the smaller 
population of CD103– DCs is able to promote Th1 or Th17 differentiation54. As none of the 
Th17 cell-inducing DC subsets was particularly expanded in WT and AhRRE/E mice, it seems 
unlikely that the stronger Th17/Tc17 differentiation is explained by expansion of one specific 
DC subpopulation.  
In summary, in vitro studies highlighted that T cells in AhRRE/E mice do not have an intrinsic 
differentiation defect128. It is possible that enhanced Th17/Tc17 differentiation in vivo might 
be caused by an altered cytokine micromilieu in AhRR-deficient mice. More detailed analysis 
of DCs that accumulate in the SI of AhRRE/E mice and determination of the source of elevated 
IL-1β levels in AhRRE/E mice could extend the current understanding of the molecular 
processes leading to elevated susceptibility in AhRRE/E mice. 
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6.1.3 AhRR expression in macrophages and neutrophils is dispensable for protection 
against colitis 
Although the frequency of macrophages was unchanged in AhRRE/E mice, a role of these cells 
for colitis susceptibility in AhRR-deficient mice cannot be excluded. Macrophages are potent 
innate effector cells, eliminating invading bacteria, dead epithelial cells and apoptotic 
material1. Further, macrophages are important for maintaining intestinal homeostasis through 
their cyclo-oxygenase (COX)2-dependent prostaglandin production and secondary expansion 
of regulatory T cells through IL-1051,194. It has further been shown previously that depletion 
of macrophages enhances the susceptibility to DSS colitis195. In order to investigate more 
closely, if the lack of AhRR expression in macrophages is responsible for enhanced colitis 
susceptibility, a cell type-specific knockout of the AhRR was generated. AhRRfl/fl mice were 
crossed to LysM-Cre mice145, resulting in deletion of the AhRR in all lysozyme M-expressing 
cells, comprising macrophages and neutrophils. As previous experiments showed no 
expression of the AhRR in bone-marrow neutrophils (unpublished observation), the lack of 
AhRR in neutrophils should not have a major input. AhRRfl/flLysM-Cre mice did not show 
enhanced weight loss after colitis induction in contrast to complete AhRR-deficient mice. All 
other parameters did not reveal any significant differences between WT, AhRRE/E and 
AhRRfl/flLysM-Cre mice. This was unexpected and might be explained by a change in the 
DSS colitis model. In contrast to previous experiments with 5% DSS over the course of six 
days, these experiments were performed with 3% DSS over the course of seven days, 
followed by a five day recovery phase, in which mice received normal drinking water. 
Administration of a lower DSS dose prevented exacerbated weight loss and allowed us to 
extend the experiment in order to monitor potentially small differences in colitis severity 
between AhRRfl/flLysM-Cre mice and WT mice or AhRRE/E mice that become more obvious 
when putting mice back on normal water after DSS administration196,197. However, in the 
recovery phase obvious signs of colitis were ameliorated, resulting in a milder phenotype also 
in AhRRE/E mice. Although the weight curve indicates that AhRRfl/flLysM-Cre mice are as 
affected as WT mice, future experiments using the 5% DSS colitis model will be necessary to 
clearly define the differences in colitis susceptibility between AhRRE/E and AhRRfl/flLysM-
Cre mice.  
The high frequency of macrophages expressing the AhRR suggests a great importance of the 
repressor in regulating AhR driven processes. As normal colitis development was observed by 
knocking out the AhRR in macrophages and neutrophils, it is conceivable that AhR ligand 
degradation through cytochrome p450 enzymes or AhR-activity inhibition through TiPARP 
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might substitute for the AhRR and ensure a properly balanced AhR signaling105,111. It is also 
conceivable that a cooperation of several different cell types with AhRR-deficiency is 
necessary to observe any effects in DSS colitis. 
The phenotype of AhRRfl/flLysM-Cre mice cannot be easily awarded to one of the two 
affected cell types, but more collectively to all LysM+ cells. Although neutrophils did not 
show expression of AhRR under homeostatic conditions (unpublished observation), it cannot 
be fully excluded that the AhRR is of functional importance for neutrophils under 
inflammatory conditions in DSS colitis. The experiments conducted with AhRRfl/flLysM-Cre 
mice did not show differences to WT mice with regard to intestinal inflammation. MPO 
activity in colon tissue, which is generally associated with influx of neutrophils and 
concomitant inflammation, was not elevated (Data not shown), which might again be partially 
attributed to late analysis in the colitis model used here. Further, no differences in histological 
scores, inflammatory serum cytokine levels and fecal and serum Lipocalin-2 levels were 
apparent. Application of the 5% DSS colitis model will be necessary to ultimately clarify, if 
there are differences in colitis susceptibility between AhRRfl/flLysM-Cre and WT mice.  
Overall these experiments revealed that lack of AhRR in LysM+ cells, namely macrophages 
and neutrophils, does not influence DSS colitis susceptibility in the low dose DSS colitis 
model after recovery phase. This might be either explained by a negligible role of the AhRR 
for the function of macrophages and neutrophils or by the colitis model itself as well as the 
time point of analysis. This issue needs to be addressed in future studies. 
6.2 Dietary AhR ligands have a profound influence on AhR signaling and 
immune function in barrier organs  
AhR ligands are of various origins. Oxidation and chemical condensation of dietary 
tryptophan leads to formation of the high affinity AhR ligand FICZ. Further tryptophan-
derived AhR ligands are kynurenine, derived from the indoleamine 2,3-dioxygenase (IDO) 
and tryptophan 2,3-dioxygenase (TDO) metabolism, and indoles generated by bacterial 
tryptophan metabolism. Furthermore, the phytochemical indole-3-carbinol (I3C) is converted 
to the AhR ligands indolo-[3,2-b]-carbazole (ICZ) and 3,3′-diindolylmethane (DIM) under 
influence of the stomach acid114,168. It is interesting to speculate, which ligands drive the AhR 
pathway and the high expression of the AhRR during steady state. The ligand sources that 
should be considered in this context are dietary, bacterial metabolism-derived and endogenous 
AhR ligands. In particular the influence of different dietary conditions on the intestinal 
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immune system, intestinal barrier integrity and gut microbiome composition was investigated 
in this thesis. 
6.2.1 AhR target gene expression is mainly driven by dietary AhR ligands 
This study demonstrated that changes in composition and amount of intestinal commensals by 
oral antibiotic treatment have no influence on the AhRR expression in intestinal immune 
cells. Depletion of the resident intestinal microbiota in general has been shown to have 
diverse effects on the AhR signaling pathway. For example, reduction of tryptophan 
metabolizing bacteria, such as certain Lactobacilli strains, might result in reduced AhR ligand 
supply and thereby decreased AhR activation and target gene transcription77. However, AhRR 
expression in immune cells of the lamina propria and the mLNs was not affected by antibiotic 
treatment suggesting that AhR ligand providing bacterial strains might not have been fully 
depleted or are not present in the microbiota of the animals analyzed in this study. While truly 
germfree or axenic mice are free of all microorganisms and kept in controlled isolators, a 
broad spectrum-antibiotic approach cannot remove 100% of all gut bacteria, as shown by at 
least two independent studies198,199. Another explanation might be that bacterial derived AhR 
ligands are not quantitatively involved in activating AhR signaling and that therefore 
removing the intestinal microbiota does not influence AhRR expression. Indeed, indoles 
derived from bacterial metabolism are only low affinity AhR activators, as opposed to FICZ 
or I3C114. This study focused on AhRR expression in immune cells as indicator for AhR 
activation. However, it is still conceivable that other AhR target genes, for example cyp1a1, 
and other cells like intestinal epithelial cells might be more affected by antibiotic treatment. A 
recent study by Schiering et al. highlighted that expression of cyp1a1 is particularly important 
in intestinal epithelial cells as opposed to T and B cells200. Future experiments should focus 
on the influence of oral antibiotic treatment on additional AhR target genes in an organ and 
cell-type specific manner. 
In contrast to antibiotic treatment, feeding a purified diet reduced in plant-derived 
phytochemicals and consequently AhR ligands strongly reduced AhRR expression in immune 
cells of the intestine, indicating that AhRR expression is controlled by foodborne AhR 
ligands. Additionally, it was shown that also cyp1a1 was strongly downregulated in mice 
receiving LRD. However, the presence of residual AhRR expressing cells, especially in SI 
and PPs, indicates the existence of other AhR ligands in the diet or endogenous metabolites 
that activate the AhR and thereby induce AhRR expression. An alternative explanation might 
be that in absence of diet-derived phytochemicals, intestinal bacteria are able to compensate 
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lack of dietary AhR ligands by efficiently metabolizing dietary tryptophan and providing AhR 
ligands. The considerably lower AhRR expression levels in the more distant parts of the 
gastrointestinal tract (colon, mLNs) might be a consequence of consumption of residual 
dietary tryptophan or phytochemicals in the upper parts of the gastrointestinal tract.  
Addition of I3C to the diet led to similar frequencies of AhRR-expressing cells as in normal 
chow fed mice. The I3C degradation products ICZ and DIM have been shown to be potent 
AhR activators leading to high expression of cyp1a1201. Addition of I3C to LRD restores 
frequencies of AhRR-expressing cells, indicating that one or two AhR ligands can substitute 
for a variety of ligands present in normal chow. Notably, in some experiments even higher 
frequencies of AhRR expressing cells and higher MFI of the AhRR in mice on LRD+I3C 
compared to normal chow were noted. It has to be clarified, if higher frequencies of AhRR-
expressing immune cells in mice receiving LRD+I3C are due to the high affinity of ICZ to the 
AhR or due to the higher AhR ligand dose. The I3C concentration in LRD was chosen 
according to published work120. However, neither the concentration of other substances with 
AhR activating properties in the LRD nor AhR ligand content in the normal chow is known. It 
is also possible that I3C influences AhRR expression via other pathways than AhR. I3C has 
been shown to interact with numerous other nuclear receptors like the estrogen and androgen 
receptor and modulates multiple signaling pathways, which could influence gene expression 
independently of the AhR202,202. 
Interestingly, AhRR expression of immune cells in the skin was also influenced by dietary 
AhR ligands, suggesting a systemic effect of foodborne AhR ligands. Nevertheless, the 
effects were not as strong as in the intestine, as proportions of AhRR-expressing γδ T cells in 
epidermis and dermis were independent of dietary conditions. Yet the MFI of the AhRR in γδ 
T cells was reduced in LRD fed mice. Langerhans cells showed a reduced frequency of AhRR 
positive cells and lower AhRR fluorescence intensity in mice fed with LRD. Similar to 
intestinal immune cells, diet supplementation with I3C restored frequency of AhRR+ cells in 
the skin and led to even higher MFI values of the AhRR as observed in normal chow fed 
mice. As in the gastrointestinal tract, AhR ligands are also abundant in the skin, controlling 
AhR target gene expression. AhR activators in the skin can be derived from dietary plants, the 
skin microbiota or can be endogenously produced 95,203. Moreover, UVB irradiation can 
induce FICZ as an intracellular tryptophan photoproduct, which in turn activates the AhR204. 
The relatively lower relevance of dietary Ahr ligands in the skin indicates that physiological 
AhR activation in the skin may be induced by different sources of AhR ligands. While the 
contribution of diet-derived compounds is very strong in the intestine, endogenous AhR 
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ligands from the tryptophan metabolism might be the crucial activators of AhR target gene 
expression and therefore AhRR expression in the skin. Moreover, another feasible hypothesis 
is that AhRR expression in the skin might be partially independent of stimulation through 
AhR ligands or even independent of the AhR per se. This hypothesis is supported by previous 
experiments that revealed a high frequency of residual AhRR expressing cells in mice 
deficient for the AhR128, implying that AhRR induction in skin might occur independent of 
the AhR. However, until now other pathways activating AhRR in absence of AhR have not 
been identified. Interestingly, the promoter sequence of the AhRR contains three GC box 
sequences and one NF-κB site in addition to XRE sites205, suggesting the possibility of AhRR 
induction by other transcription factors than AhR. Thus, it is very likely that AhRR 
expression can also be regulated independently of the AhR in a tissue and cell type-specific 
fashion. Nonetheless, I3C was able to increase AhRR expression in the skin in comparison to 
normal chow fed mice, which might be explained by high affinity of ICZ or by the AhR 
ligand dose.  
In summary, these experiments highlighted that dietary AhR ligands are strong activators of 
the AhR signaling pathway. Moreover, the influence of dietary AhR ligands on AhRR 
expression is largely organ and cell type-specific. Surprisingly, the microbiota itself 
seemingly had no influence on AhRR expression. 
6.2.2 Modified diets change AhRR expression through altered activation of the AhR 
signaling pathway 
Since more than 40 years, scientists work on establishing guidelines for experimental 
nutrition that help to standardize studies among laboratories206. The common method for 
standardization is the usage of purified diets that are formulated with a restricted set of 
ingredients. Soybean protein isolate and casein are used as protein sources, sugar and starch 
as carbohydrate sources, vegetable oil and lard as fat sources and pure cellulose as source of 
fiber. In addition inorganic salts and vitamins are added207. The AIN76 purified diet, which 
was replaced by the improved AIN93G and AIN93M in 1993207, was published by the 
National Institutes of Health (NIH) in 1977 as the first purified diet to be used as standard 
reference diet for rodents208. Widely used diets in the rapidly advancing field of 
immunometabolism are high fat diet (HFD) and a matched control diet (HFD ctrl), 
recommended by the manufacturer. Surprisingly, experiments in an initially unrelated project 
in our laboratory revealed strong influences of these diets on AhRR expression. To analyze 
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this further, a systematic comparison between HFD, HFD ctrl, normal chow, LRD and 
LRD+I3C was carried out. 
The percentage of AhRR-expressing cells and MFI of AhRR expression was investigated in 
IELs and immune cells of the lamina propria and the mLNs. The strongest influence of 
dietary AhR ligands, independent of which diet was used, could be observed on IELs. A 
plausible explanation for this phenomenon might be the close proximity of IELs to the gut 
lumen, facilitating exposure of these cells to dietary components. The strongest reduction in 
the proportion of AhRR+ IELs could be observed for mice fed with LRD. Confirming 
previous findings, LRD+I3C fed mice displayed similar AhRR+ cell frequencies and AhRR 
expression levels as normal chow fed mice, pointing out a similar AhR activation through I3C 
supplementation and naturally occurring flavonoids and phytochemicals in grain based diet. 
As expected, mice fed with HFD and HFD ctrl had equally low frequencies of AhRR-
expressing IELs as mice fed with LRD, confirming that HFD and HFD ctrl are low in AhR 
ligand concentration.  
Analysis of AhRR-expressing cells in the lamina propria in a setup with all five different 
dietary conditions revealed the same tendencies as observed for the IELs, although reduction 
of AhRR expression through purified diets (LRD, HFD and HFD ctrl) in comparison to 
normal chow was not as strong as in the previous experiments. In contrast, clearly elevated 
frequencies and MFI values were observed in the experimental group receiving LRD+I3C. 
Interestingly, in particular the frequency of AhRR expressing cells in the animals receiving 
normal chow diet was lower as previously observed. 80% of the CD8+ T cells in the SI of the 
first experiments expressed the AhRR, while only 20% of the CD8+ T cells in the second 
comparison expressed the AhRR. This difference could possibly be attributed to experimental 
variations, however only in the normal chow fed group. Neither the normal chow 
manufacturer nor any other factor with regard to diet application, timing or handling has been 
changed, making this variation hard to explain.  
DCs from mLNs showed the same tendencies and similar strong differences in frequency of 
AhRR+ cells as observed for the IELs. Of note, mLN DCs showed much bigger differences in 
AhRR expression between the dietary groups than lamina propria lymphocytes isolated from 
the same mice. Especially frequency of AhRR+ DCs in normal chow fed mice was as high as 
expected and not uncharacteristically low as observed in the lamina propria, suggesting AhRR 
expression differences in the lamina propria as a consequence of the cell isolation procedure 
or other technical aspects rather than reflecting a true effect through the diet.  
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Flow cytometric analysis of intestinal immune cells indicated that the reduction of AhRR+ 
lymphocytes was slightly lower in HFD and HFD ctrl fed mice than in LRD fed mice. This 
observation might be explained by a higher concentration of residual AhR ligands in these 
diets compared to the LRD. However, the spectrum of AhR activating substances is very 
broad and structurally diverse AhR agonists lead to ligand-selective differences in gene 
expression209. Moreover, it is complicated to determine the amount of AhR ligands in a 
certain type of food. Combinations of methanol/water extraction, silica gel batch purification 
and several high-performance liquid chromatography (HPLC) steps have been used in this 
context before, and could therefore help to determine AhR ligand concentration in different 
diets. An alternative would be the usage of AhR reporter gene assays116. Similar to LRD also 
HFD and HFD ctrl influence AhRR expression not only in the gastrointestinal tract, but also 
in the skin, although to a lesser extent. However, detailed flow cytometric analysis of the 
influence of HFD and HFD ctrl on AhRR expression by immune cells in the skin has not been 
conducted yet. 
Ssniff, the company producing the laboratory mouse diet used in this study, provides 
information about the amount of tryptophan in the experimental diet, whereas no information 
about plant-derived phytochemicals and other potential AhR activators are available. While 
LRD contains 0.22% tryptophan, HFD and HFD ctrl contain 0.31% and 0.23% tryptophan, 
respectively. However, it is debatable if this marginal difference in tryptophan content, 
especially the slightly higher concentration in HFD, might influence the AhRR expression to 
a measurable extent. Another potential source of AhR ligands might be the lard that is added 
to the HFD as a source of fat. As pig lard represents a natural product, it cannot be excluded 
that it also contains AhR activators. Studies could show that prostaglandins, which are lipid 
mediators derived from fatty acids that are abundant in HFD, are able to displace TCDD from 
the AhR binding site210. Although they are weak agonists, prostaglandins might represent a 
novel class of AhR activators, which might be specifically present in the HFD. 
Judging AhR activation by expression of known AhR target genes is a well-accepted method 
in the field101,200. In order to understand the influence of dietary AhR ligands on AhR target 
gene expression in more depth, future studies and experiments should concentrate on 
additional target genes next to the AhRR105, thereby improving reliability of the readout 
compared to just using AhRR. The enzymes of the cytochrome P450 family CYP1A1, 
CYP1A2 and CYP1B1 and also TiPARP are prime candidates that have been described to be 
strongly differentially regulated through the AhR and might therefore be investigated in more 
depth in future studies211. 
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In summary, these experiment showed that HFD and HFD ctrl are almost equally reduced in 
AhR ligands as the prototypic ligand-reduced diet (AIN-93G), judged by the reduced 
expression of AhRR. Future studies using these diets should consider that reduced AhR 
activity could influence experimental settings.  
6.2.3 AhR ligand reduced diets exercise different effects on the intestinal barrier 
function 
Maintenance of ILCs and IELs, production of IL-22, resistance to Citrobacter rodentium 
infection, susceptibility to DSS-induced colitis and oral tolerance efficiency have been shown 
to depend on AhR activation by AhR ligands in the murine gut 119,120,212. It has further been 
shown that AhR ligand exposure is linked to gastritis and colitis in humans110. Since we 
noticed that not only LRD but also HFD and HFD ctrl showed reduced AhR ligands, 
functional consequences of low AhR activation were investigated and compared between the 
different dietary groups.  
Previous studies indicated that healthy AhR-/- mice do not show increased intestinal barrier 
permeability, tested by feeding FITC-dextran121. This finding was partly explained by a 
decreased epithelial cell turnover in AhR-/- mice, which might help keeping barrier integrity in 
absence of IELs and ILCs. Although feeding an AhR ligand reduced diet is believed to mimic 
the phenotype of AhR-/- mice, elevated transmission of FITC-dextran over the intestinal 
barrier could be observed for mice on LRD, but not with any other dietary condition. Thus, 
the lack of AhR ligands in diet affects barrier integrity already under homeostatic conditions. 
This defect could be rescued by the addition of I3C, which is in line with the literature, where 
I3C has been shown to act through the AhR in promoting normal intestinal immune 
function114. Interestingly, although having a strong influence on AhRR expression, HFD and 
HFD ctrl do not influence intestinal barrier permeability. Analysis of additional AhR target 
genes could potentially help to understand this aspect and clarify if more residual AhR ligands 
in HDF and HFD ctrl might explain the absence of elevated barrier permeability in mice fed 
with these two diets. Moreover, HFD and HFD ctrl might contain other immunostimulatory 
substances that support barrier function and thus substitute for the lack of AhR ligands.  
Barrier integrity of mice under different dietary conditions was further tested by treatment 
with DSS to induce a strong colitis. Deficits in coping with DSS have been demonstrated 
already for mice receiving a diet that is low in AhR ligands121. Consistently, also in our 
experiments WT mice receiving LRD lost significantly more weight and showed elevated 
colon shortening. Interestingly, supplementation with I3C was not fully sufficient to rescue 
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mice from severe weight loss, which has been demonstrated in a previous study121. This might 
be explained by the utilization of different inbred mouse strains, which have shown very 
different susceptibilities to DSS-induced colitis213. A further explanation might be differences 
in gut microbiota composition. These have been shown to vary considerably between 
different animal facilities. Certain bacterial strains have recently been shown to have a big 
influence on DSS colitis susceptibility of mice171. It is additionally well known that 
colitogenic potential of DSS varies between vendors and manufacturing lot180, offering 
another possible explanation for differences in DSS colitis between different laboratories.  
In contrast, HFD and especially HFD ctrl fed mice showed protection against DSS-induced 
colitis, judged by reduced weight loss and disease symptoms. This observation is in line with 
other experiments, showing normal barrier function of these mice under homeostatic 
conditions. Hence, these results support the previously made hypothesis that HFD and HFD 
ctrl contain substances that confer protection against intestinal inflammation. For example it 
was shown that high content of dietary fiber protects against DSS-induced colitis214. Further, 
diet-induced changes in microbial composition might explain the relative mild colitis 
symptoms of mice on HFD and HFD ctrl, since changes in the microbial composition have 
been previously show to influence disease outcome in DSS colitis171. Despite differences with 
regard to loss of body weight, colon shortening and MPO values were similar in normal 
chow, HFD and HFD ctrl fed mice, indicating no differences in intestinal inflammation. 
Notably, LCN2 levels were highest in stool and serum of HFD fed mice. Recent studies 
identified LCN2 not only as a biomarker for intestinal inflammation, but also showed that 
LCN2 is produced by white adipose tissue and can control energy homeostasis and insulin 
sensitivity215. Interestingly WT mice on HFD ctrl displayed the lowest weight loss and the 
lowest LCN2 levels in stool and, especially, also in serum. On the one hand this can be 
explained by a lower degree of intestinal inflammation and better tolerance to DSS-induced 
colitis. On the other hand these mice probably possess less white adipose tissue, which would 
consequently lower the systemic LCN2 levels. 
Cytokines characterizing acute DSS-induced colitis are mainly proinflammatory. However, 
also pro-resolving chemokines and cytokines that initiate tissue repair are markedly increased 
in DSS colitis162. Consistently, normal chow fed mice displayed the highest levels of 
proinflammatory cytokines and chemokines (IL-6, IL-1β and CXCL1,), but also showed the 
highest levels of the barrier protective cytokine IL-22. This counterbalance might explain why 
these mice develop a relative mild colitis accompanied with fast recovery from colitis. Higher 
susceptibility to DSS colitis in AhR-/- mice and mice receiving an AhR ligand reduced diet, is 
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attributed to the lack of IELs, ILC3s and lower IL-22 levels produced by ILC3s and Th17 
cells119. This could be confirmed for LRD fed mice, as tissue IL-22 was strongly diminished 
after DSS colitis, while I3C supplementation elevated IL-22 levels, albeit not to the levels of 
normal chow fed mice. Interestingly, HFD and HFD ctrl fed mice displayed similar IL-22 
levels as LRD+I3C fed mice. These results indicate that despite low dietary AhR ligand 
concentrations in HFD and HFD ctrl, production of IL-22 is sufficiently induced to protect 
from DSS-induced colitis. Future studies will focus on analyzing the frequencies of IELs and 
ILC3s after feeding HFD or HFD ctrl since they could be reduced as a consequence of low 
AhR ligand concentration. As mice on HFD ctrl were clearly protected from DSS symptoms 
compared to normal chow fed animals, it is intriguing to speculate if components of this diet 
might activate other pathways to maintain intestinal homeostasis and confer protection against 
DSS-induced colitis. One recently described candidate is the mammalian pregnane X receptor 
(PXR), which is a xenobiotic receptor expressed in IECs. The PXR has recently been linked 
to processes like cell migration, cell survival and apoptosis, all of which are key functions of 
IECs. It could be shown that activation of the PXR enhaces intestinal epithelial cell migration 
and wound healing and thereby contributes to intestinal mucosal barrier function216,217. 
Although much less is known about endogenous PXR ligands and their physiological role, 
recent studies have identified that similar to the AhR, tryptophan metabolites activate the 
PXR pathway and control barrier function218. 
In summary, feeding mice with HFD and HFD ctrl does not lead to elevated colitis 
susceptibility in contrast to LRD, despite similar low activation of the AhR. Therefore it is 
likely that other mechanisms independent of AhR ligands convey protection against DSS-
induced colitis in HFD and HFD ctrl fed mice. 
6.2.4 Dietary composition contributes to the composition of the intestinal microbiota 
and the functionality of the intestinal immune system 
The composition of the gut microbiota is specific for every individual and has a profound 
impact on health. However, the interplay between microbiota and the host organism is still not 
fully understood84. Factors that influence the composition of the microbiota are host genetics, 
general lifestyle, medication, health/disease and the diet. Therefore, it was interesting to 
assess, whether the different diets used during this study have an influence on the composition 
of the intestinal gut microbiota. The utilized diets have been chosen due to their content or 
absence of AhR ligands. Previous studies could already show a role for the AhR in intestinal 
microbe composition and functionality219. The experiments performed in this thesis 
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highlighted that the dietary AhR activator I3C has a strong influence on the composition of 
the intestinal microbiota, since mice fed with LRD+I3C had a very different composition of 
microbial phyla and families than mice on LRD. While frequencies of Bacteroidetes were 
similar between both diets, LRD fed mice displayed an expansion of Proteobacteria, whereas 
supplementation with I3C expanded Firmicutes at the expense of the Proteobacteria. 
Proteobacteria, with Enterobacteriaceae being the dominant family within this phylum, are 
generally expanded in IBD patients and may induce IBD in genetically susceptible 
individuals220,221. These observations might also explain the highest DSS colitis susceptibility 
in LRD fed mice, because they had the highest abundance of Proteobacteria and 
Enterobacteriaceae. In humans, Firmicutes have been identified as dominant producers of 
butyrate, supplying energy to the gut epithelium and influencing immune cell functions222. 
Butyrate can limit intestinal inflammation by promoting the formation of Tregs223. Further, 
macrophages have been shown to produce less proinflammatory cytokines if treated with 
butyrate224. Thus, expansion of Firmicutes by application of dietary I3C might lead to 
suppression of intestinal inflammation through butyrate, partially explaining the positive 
effect of I3C on DSS colitis susceptibility. Future experiments should therefore focus on 
dissecting microbiota-derived metabolites and how they change upon different dietary 
conditions. 
Despite low AhR ligand concentration in HFD and HFD ctrl, mice receiving these diets did 
not show elevated susceptibility to DSS colitis, as observed in mice on LRD. The 
composition of the gut microbiota of HFD and HFD ctrl fed mice was very different from 
mice receiving LRD and more resembled the composition of bacteria in LRD+I3C fed mice, 
at least on phylum level. Both diets led to a relative expansion of Firmicutes and a reduction 
of Proteobacteria, similar to the I3C supplemented diet. Positive effects coming from the 
Firmicutes might therefore also explain the resistance to DSS-induced colitis of HFD and 
HFD ctrl fed mice. One family member of the Firmicutes phylum specifically expanded in 
HFD fed mice was the Lachnospiraceae. Interestingly, these bacteria have been shown to be 
depleted in patients with CD and UC79. Furthermore, strains of the Lachnospiraceae have 
been described to have beneficial effects, limiting DSS- or Clostridium difficile-induced 
intestinal inflammation225,226. The positive effects of Lachnospiraceae have also been 
previously explained by a high production of butyrate by these bacterial family227. Hence, 
expansion of Lachnospiraceae in HFD fed mice might explain the relative mild DSS colitis, 
despite low AhR ligands within the diet. However, the dietary components of the HFD 
responsible for this expansion process need to be further investigated. Candidates might be 
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dietary fibers, which increase short chain fatty acid production by the microbiota preventing 
growth of potentially pathogenic bacteria of the Enterobacteriaceae228. Another plausible 
candidate for this phenomenon might be dietary sugars. While complex carbohydrates 
increase levels of beneficial Bifidobacteria spp.229 refined sugars mediate overgrowth of 
opportunistic bacteria like C. difficile230. If and how these substances influence composition 
of intestinal microbiota will be subject of future studies. 
Another interesting observation could be made comparing WT and AhRRE/E mice on LRD. 
Although PCA of UniFrac distances could not detect general differences between WT and 
AhRRE/E mice, AhRRE/E mice harbored a population of Prevotellaceae that was not detected 
in WT mice. Intriguingly, this population was only apparent in absence of dietary AhR 
ligands in mice fed with LRD, suggesting that expansion of Prevotellaceae may depend on 
some residual AhR signaling, which is enhanced in absence of the AhRR. Of note, 
Prevotellaceae could be detected in WT and AhRRE/E mice on LRD+I3C, indicating that the 
stronger AhR signaling in these animal leads to selective expansion, independent of the 
presence of the AhRR. Since Prevotellaceae could not be detected in normal chow fed mice, 
also the type of AhR ligand and possibly the concentration could to be important for their 
expansion. A connection of AhR signaling and Prevotellaceae has not been described yet. 
Prevotela spp. have been described as pathobionts, causing disease when the host immunity is 
perturbed231. As AhRRE/E mice show a generally elevated DSS colitis susceptibility, presence 
of a commensal pathobiont might contribute to the disease. However, elevated colitis 
susceptibility has been shown for mice on normal chow diet, whereas genotype specific 
appearance of Prevotellaceae could be shown for AhRRE/E mice on LRD. If a true connection 
between Prevotellaceae and AhR signaling exists and what functional consequences this 
might have, needs to be investigated in future studies. 
In summary, these experiments showed that dietary AhR ligands have a strong influence on 
the composition of the intestinal microbiota, which can in turn influence the immune system 
of the harboring organism. The lack of the AhRR seems to rather influence individual 
bacterial families under specific circumstances than induce global changes in microbiota 
composition. Additionally, other dietary components contained in HFD and HFD ctrl have the 
potential to change microbial composition and influence the immune system. Future studies 
will focus on, which substances in these diets induce microbial changes and how this alters 
DSS colitis susceptibility.  
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